FORM 10-K
| FORM 10-K |
| x | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
26, 2016
| ¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
LAM RESEARCH CORPORATION
(Exact name of registrant as specified in its charter)
LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) |
Delaware | 94-2634797 | |
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |
4650 Cushing Parkway, Fremont, California | 94538 | |
| (Address of principal executive offices) | (Zip code) | |
Title of class | Name of exchange on which registered | |
| Common Stock, Par Value $0.001 Per Share | The ( | |
| Large accelerated filer | x | Accelerated filer | ¨ | |||
| Non-accelerated filer | ¨ (Do not check if a smaller reporting company) | Smaller reporting company | ¨ | |||
2015
| Page | ||||||
Item | ||||||
| Item 1B. | ||||||
| Item 2. | ||||||
| Item 3. | ||||||
| Item 4. | ||||||
| ||||||
| ||||||
| ||||||
| ||||||
| ||||||
Item 5. | ||||||
Item 6. | ||||||
Item 7. | ||||||
Item 7A. | ||||||
Item 8. | ||||||
Item 9. | ||||||
| Item 9A. | ||||||
| Item 9B. | ||||||
| ||||||
| ||||||
Item 10. | ||||||
Item 11. | ||||||
Item 12. | ||||||
Item 13. | ||||||
Item 14. | ||||||
Item 15. | ||||||
| Item 1. | Business |
The content on any website referred to in this Form 10-K is not a part of or incorporated by reference in this Form 10-K unless expressly noted.
specialized systems for logic and memory applications with multiple platform options. VECTOR Express offers a small footprint with four processing stations. VECTOR Excel is a modular tool for advanced technology nodes where pre-and-post film deposition treatments are needed. VECTOR Extreme accommodates up to 12 processing stations for high-throughput applications. VECTOR Q accommodates up to 16 processing stations for depositing multi-stack films. Applications include deposition of oxides, nitrides, and carbides for hardmasks;hardmasks, multiple patterning films;films, anti-reflective layers;layers, multi-layer stack films;films, and diffusion barriers.
yield, and exceptional process repeatability for BEOL processing. Applications include metal hardmask, multiple patterning, high-density aluminum line, and aluminum pad.
In addition, Flex systems can be configured to perform ALE, which delivers atomic-scale variability control to enable next-generation wafer processing for applications such as self-aligned contacts.
| Market | Process/Application | Technology | Products | |||
Thin Film Deposition | Metal Films
| ECD (Copper & Other) CVD, ALD (Tungsten)
|
SABRE® family
ALTUS® family
| |||
|
Dielectric
| PECVD, ALD Gapfill HDP-CVD | VECTOR® family SPEED® family | |||
| Film Treatment | UVTP | SOLA® family | ||||
| Plasma Etch | Conductor Etch | Reactive Ion Etch | Kiyo® family, Versys® Metal family | |||
| Dielectric Etch | Reactive Ion Etch | FlexTM family | ||||
TSV Etch | Deep Reactive Ion Etch |
| ||||
Single-Wafer Clean | Wafer Cleaning
| Wet Clean | EOS®, DV-Prime®, Da Vinci®, SP Series | |||
| Bevel Cleaning | Dry Plasma Clean |
Coronus® family | ||||
2014.
individual customers to develop solutions for their wafer processing needs. We maintain ongoing service relationships with our customers and have an extensive network of service engineers in place throughout the United States, Europe, Taiwan, Korea, Japan, China, and Southeast Asia. We believe that comprehensive
| Year Ended | ||||||||||||
| June 28, 2015 | June 29, 2014 | June 30, 2013 | ||||||||||
| (in thousands) | ||||||||||||
Revenue: | ||||||||||||
Korea | $ | 1,406,617 | $ | 1,127,406 | $ | 603,821 | ||||||
Taiwan | 1,084,239 | 1,049,214 | 1,026,548 | |||||||||
United States | 890,891 | 622,022 | 734,324 | |||||||||
China | 661,094 | 623,408 | 319,282 | |||||||||
Japan | 623,575 | 634,131 | 368,095 | |||||||||
Europe | 314,546 | 303,730 | 292,432 | |||||||||
Southeast Asia | 278,350 | 247,398 | 254,414 | |||||||||
|
|
|
|
|
| |||||||
Total revenue | $ | 5,259,312 | $ | 4,607,309 | $ | 3,598,916 | ||||||
|
|
|
|
|
| |||||||
| Year Ended | |||||||||||
| June 26, 2016 | June 28, 2015 | June 29, 2014 | |||||||||
| (in thousands) | |||||||||||
| Revenue: | |||||||||||
| Taiwan | $ | 1,485,037 | $ | 1,084,239 | $ | 1,049,214 | |||||
| Korea | 1,057,331 | 1,406,617 | 1,127,406 | ||||||||
| China | 1,039,951 | 661,094 | 623,408 | ||||||||
| Japan | 983,821 | 623,575 | 634,131 | ||||||||
| Southeast Asia | 605,236 | 278,350 | 247,398 | ||||||||
| United States | 495,123 | 890,891 | 622,022 | ||||||||
| Europe | 219,394 | 314,546 | 303,730 | ||||||||
| Total revenue | $ | 5,885,893 | $ | 5,259,312 | $ | 4,607,309 | |||||
require us to alter our current operations, to acquire significant additional equipment, or to incur substantial other expenses to comply with environmental regulations. Our failure to control the use, sale, transport, or disposal of hazardous substances could subject us to future liabilities.
providers.
of our patents generally exceeds the useful life of the technologies and processes disclosed and claimed in them. Our patents, which cover material aspects of our past and present core products, have current durations ranging from approximately one to twenty years. We believe that, although the patents we own and may obtain in the future will be of value, they alone will not determine our success. Our success depends principally upon our research and development, engineering, marketing, support, and delivery skills. However, in the absence of patent protection, we may be vulnerable to competitors who attempt to imitate our products, manufacturing techniques, and processes. In addition, other companies and inventors may receive patents that contain claims applicable or similar to our products and processes. The sale of products covered by patents of others could require licenses that may not be available on terms acceptable to us, or at all. For further discussion of legal matters, see Item 3, “Legal Proceedings,” of this report.
| Name | Age | Title | ||
Martin B. Anstice | President and Chief Executive Officer | |||
Timothy M. Archer | Executive Vice President and Chief Operating Officer | |||
Douglas R. Bettinger | Executive Vice President, Chief Financial Officer and Chief Accounting Officer | |||
Richard A. Gottscho | Executive Vice President, Global Products Group | |||
Sarah A. O’Dowd | Senior Vice President, Chief Legal Officer and Secretary | |||
Kingdom.
Douglas R.
Wisconsin in Madison.
| Item 1A. | Risk Factors |
Despite the recent reduction in cyclicality, the
work force, and other components of our business on a timely basis. If we do not adequately meet these challenges during periods of demand decline, our gross margins and earnings may be negatively impacted.
Business Change. We face a greater risk if our competitors enter into strategic relationships with leading semiconductor manufacturers covering products similar to those we sell or may develop, as this could adversely affect our ability to sell products to those manufacturers. the challenges noted above are applicable in China, which is a fast developing market for the semiconductor equipment industry and therefore an area of potential significant growth for our business. As the business volume between China and the rest of the world grows, there is inherent risk, based on the complex relationships among China, Taiwan, Japan, South Korea, and the United States, that political and diplomatic influences might lead to trade disruptions. This would adversely affect our business with China, Taiwan, Japan, and/or South Korea and perhaps the entire Asia Pacific region. A significant trade disruption in these areas could have a materially adverse impact on our future revenue and profits. In addition, there are risks that the Chinese government may, among other things: insist on the use of local suppliers; compel companies that do business in China to partner with local companies to design and supply equipment on a local basis, requiring the transfer of intellectual property rights and/or local manufacturing; and provide special incentives to government-backed local customers to buy from local competitors, even if their products are inferior to ours; all of which could adversely impact our revenues and margins. Which are Susceptible to Cybersecurity and Other Threats or Incidents maintained by us, our outsourced providers or third parties such as vendors and contractors. Many of these information systems and outsourced service providers, including certain hosted software applications that we use for confidential data (e.g., company related, whether intellectual property or not; customer related; supplier related; and / or employee related) storage, employ “cloud computing” technology for such storage (which refers to an information technology hosting and delivery system in which data is not stored within the user’s physical infrastructure but instead is delivered to and consumed by the user as an Internet-based service). All of these information systems are subject to attacks, failures, and access denials from a number of potential sources including viruses, destructive or inadequate code, power failures, and physical damage to computers, hard drives, communication lines, and networking equipment. Confidential and/or sensitive information stored on these information systems or transmitted to or from cloud storage could be intentionally or unintentionally compromised, lost and/or stolen. While we have implemented ISO 27001 compliant security procedures, such as virus protection software, intrusion prevention system and emergency recovery processes, to mitigate the outlined risks with respect to information systems that are under our control, they cannot be guaranteed to be failsafe and our inability to use or access these information systems at critical points in time, or unauthorized releases of proprietary or confidential information, could unfavorably impact the timely and efficient operation of our business, including our results of operations, and our reputation. product lines or technologies, or reduction in personnel or that our management, personnel, or systems will be adequate to support continued operations. Any such inabilities or inadequacies could have a material adverse effect on our business, operating results, financial condition, covenants, other third party claims that our products when used for their intended purposes infringe the intellectual property rights of such other third parties, or other claims made against certain parties. In such cases, it is our policy either to defend the claims or to negotiate licenses or other settlements on commercially reasonable terms. However, we may be unable in the future to negotiate necessary licenses or reach agreement on other settlements on commercially reasonable terms, or at all, and any litigation resulting from these claims by other parties may materially adversely affect our business and financial results, and we may be subject to substantial damage awards and penalties. Moreover, although we have insurance to protect us from certain claims and cover certain losses to our property, such insurance may not cover us for the full amount of any losses, or at all, and may be subject to substantial exclusions and deductibles. AmountsWe May Incur Impairments to Goodwill or Long-Lived AssetsWe review our long-lived assets, including goodwill and other intangible assets, for impairment annually or whenever events or changes in circumstances indicate that the carrying amount of these assets may not be recoverable. Negative industry or economic trends, including reduced market prices of our Common Stock, reduced estimates of future cash flows, disruptions to our business, slower growth rates, or lack of growth in our relevant business units, could lead to impairment charges against our long-lived assets, including goodwill and other intangible assets. If, in any period, our stock price decreases to the point where our fair value, as determined by our market capitalization, is less than the book value of our assets, this could also indicate a potential impairment, and we may be required to record an impairment charge in that period, which could adversely affect our result of operations. During the 2015 fiscal year, our goodwill and long-lived asset impairment assessments resulted in an impairment charge of $79.4 million associated with the single-wafer clean reporting unit and $9.8 million related to an intangible asset.Our valuation methodology for assessing impairment requires management to make judgments and assumptions based on historical experience and to rely heavily on projections of future operating performance. We operate in a highly competitive environment and projections of future operating results and cash flows may vary significantly from actual results. Additionally, if our analysis indicates potential impairment to goodwill in one or more of our business units, we may be required to record additional charges to earnings in our financial statements, which could negatively affect our results of operations.Our Leverage and Debt Service Obligations and Potential Note Conversion or Related Hedging Activities May Adversely Affect Our Financial Condition, Results of Operations and Earnings Per ShareAsWe have $4.55 billion in aggregate principal amount of senior unsecured notes and convertible note instruments outstanding. If the anticipated acquisition of KLA-Tencor is not completed on or prior to December 30, 2016, or the related merger agreement is terminated on or at any time prior to that date, the indenture governing the senior unsecured notes issued in June 2016 requires us to redeem $1.6 billion of those senior unsecured notes at a resultredemption price equal to 101% of the issuance of our 2020 and 2025 Senior Notes, our 2016 and 2018 Convertible Notes, and the assumption of the 2041 Convertible Notesprincipal amount, plus accrued interest. In addition, in connection with ourthe acquisition of Novellus Systems, Inc. (collectively the “Notes”),KLA-Tencor, we have also entered into a greaterterm loan agreement with certain term lenders pursuant to which the term lenders have agreed to provide a senior unsecured term loan facility in an aggregate amount of debt thanup to $1.53 billion, subject to certain terms and conditions. If the anticipated acquisition of KLA-Tencor is not completed on or prior to October 20, 2016, we will need to obtain consent from all of the lenders under the term loan agreement to extend their commitments past this date. Additionally, we have maintained$750 million available to us in revolving credit arrangements, with an option for us to request an increase in the past. Furthermore, in March 2014, we entered into an unsecured credit agreement providing us with the ability to borrowfacility of up to $300an additional $250 million, (and, under certain circumstances, to increase such availability to $500 million).for a potential total commitment of $1 billion. We may, in the future, decide to borrow amounts under this facility,the revolving credit agreement, or to enter into additional debt arrangements.In addition, we have entered, and in the future may enter, into derivative instrument arrangements to hedge against the variability of cash flows due to changes in the benchmark interest rate of fixed rate debt. We could be exposed to losses in the event of nonperformance by the counterparties to our derivative instruments.Our maintenance of higher levels of indebtedness could have adverse consequences including:increased risk associated with any inability to satisfy our obligations;Continues on next pageLam Research Corporation 2016 10-K 15increasing the portion of our cash flows that may have to be dedicated to interest and principal payments and may not be available for operations, working capital, capital expenditures, expansion, acquisitions or general corporate or other purposes; andimpairing our ability to obtain additional financing in the future.Our ability to meet our expenses and debt obligations will depend on our future performance, which will be affected by financial, business, economic, regulatory, and other factors. Furthermore, our operations may not generate sufficient cash flows, particularly in the United States, to enable us to meet our expenses and service our debt. As a result, we may need to enter into new financing arrangements to obtain the necessary funds. If we determine it is necessary to seek additional funding for any reason, we may not be able to obtain such funding or, if funding is available, obtain it on acceptable terms. If we fail to make a payment on our debt, we could be in default on such debt, and this default could cause us to be in default on our other outstanding indebtedness.Conversion of our Convertible Notes and resulting exercise of the related warrants may cause dilution to our stockholders and to our earnings per share. The number of shares of our Common Stock into which the Convertible Notes are convertible for and the related warrants are exercisable for may be adjusted from time to time, including increases in such rates as a result of dividends that we pay to our stockholders. Upon conversion of any Convertible Notes, we will deliver cash in the amount of the principal amount of the Convertible Notes and, with respect to any excess conversion value greater than the principal amount of the Convertible Notes, shares of our Common Stock, which would result in dilution to our stockholders. This dilution may not be completely mitigated to some extent by the hedging transactions we entered into in connection with the sale of the 2016 and 2018certain Convertible Notes or through share repurchases. Prior to the maturity of the Convertible Notes, if the price of our Common Stock exceeds the conversion price, U.S. generally accepted accounting principles require that we report an increase in diluted share count, which would result in lower reported earnings per share. The price of our Common Stock could also be affected by sales of our Common Stock by investors who view the Convertible Notes as a more attractive means of equity participation in our company and also by hedging activity that may develop involving our Common Stock by holders of the Convertible Notes.Our Credit Agreements Contain Covenant Restrictions That May Limit Our Ability To Operate Our Business.We may be unable to respond to changes in business and economic conditions, engage in transactions that might otherwise be beneficial to us, or obtain additional financing, because our debt agreements contain, and any of our other future similar agreements may contain, covenant restrictions that limit our ability to, among other things:incur additional debt, assume obligations in connection with letters of credit, or issue guarantees;create liens;enter into transactions with our affiliates;sell certain assets; andmerge or consolidate with any person.Our ability to comply with these covenants is dependent on our future performance, which will be subject to many factors, some of which are beyond our control, including prevailing economic conditions. In addition, our failure to comply with these covenants could result in a default under the Senior Notes, the Convertible Notes or our other debt, which could permit the holders to accelerate such debt. If any of our debt is accelerated, we may not have sufficient funds available to repay such debt, which could materially and negatively affect our financial condition and results of operation.We Have a Limited Number of Key CustomersSales to a limited number of large customers constitute a significant portion of our overall revenue, shipments, cash flows, collections, and profitability. For the years ended June 29, 2015,26, 2016, June 28, 20142015 and June 30, 2013,29, 2014, three customers collectively accounted for 51%45%, 52%51%, and 45%52% of total revenue, respectively. As a result, the actions of even one customer may subject us to variability in those areas that are difficult to predict. In addition, large customers may be able to negotiate requirements that result in decreased pricing;pricing, increased costs and/or lower margins for us; compliance towith specific environmental, social and corporate governance standards; andContinues on next pageLam Research Corporation 2016 10-K 16limitations on our ability to share jointly developed technology with others. Similarly, significant portions of our credit risk may, at any given time, be concentrated among a limited number of customers, so that the failure of even one of these key customers to pay its obligations to us could significantly impact our financial results.We Depend on Creating New Products and Processes and Enhancing Existing Products and Processes for Our Success. Consequently, We are Subject to Risks Associated with Rapid Technological ChangeRapid technological changes in semiconductor manufacturing processes subject us to increased pressure to develop technological advances that enable those processes. We believe that our future success depends in part upon our ability to develop and offer new products with improved capabilities and to continue to enhance our existing products. If new products or existing products have reliability, quality, design, or safety problems, our performance may be impacted by reduced orders, higher manufacturing costs, delays in acceptance of and payment for new products, and additional service and warranty expenses. We may be unable to develop and manufacture products successfully, or products that we introduce may fail in the marketplace. For over 25 years the primary driver of technology advancement in the semiconductor industry has been to shrink the lithography that prints the circuit design on semiconductor chips. That driver could be approaching its technological limit, leading semiconductor manufacturers to investigate more complex changes in multiple technologies in an effort to continue technology development. In the face of uncertainty on which technology solutions will become successful, we will need to focus our efforts on developing the technology changes that are ultimately successful in supporting our customer requirements. Our failure to develop and offer the correct technology solutions in a timely manner with productive and cost-effective products could adversely affect our business in a material way. Our failure to commercialize new products in a timely manner could result in loss of market share, unanticipated costs, and inventory obsolescence, which would adversely affect our financial results.In order to develop new products and processes and enhance existing products and processes, we expect to continue to make significant investments in R&D and to pursue joint development relationships with customers, suppliers, or other members of the industry. We must manage product transitions and joint development relationships successfully, as the introduction of new products could adversely affect our sales of existing products and certain jointly developed technologies may be subject to restrictions on our ability to share that technology with other customers, which could limit our market for products incorporating those technologies. Future technologies, processes or product developments may render our current product offerings obsolete, leaving us with non-competitive products, or obsolete inventory, or both. Moreover, customers may adopt new technologies or processes to address the complex challenges associated with next generation devices. This shift may result in a reduction in the size of our addressable markets or could increase the relative size of markets in which we either do not compete or have relatively low market share.We are Subject to Risks Relating to Product Concentration and Lack of Product Revenue DiversificationWe derive a substantial percentage of our revenues from a limited number of products. System sales constitute a significant portion of our total revenue. Our systemsproducts are priced up to approximately $9$9.7 million per system, and our revenues in any given quarter are dependent upon customer acceptance of a limited number of systems. As a result, the inability to recognize revenue on even a few systems can cause a significantly adverse impact on our revenues for a given quarter, and, in the longer term, the continued market acceptance of these products is critical to our future success. Our business, operating results, financial condition, and cash flows could therefore be adversely affected by:a decline in demand for even a limited number of our products;a failure to achieve continued market acceptance of our key products;export restrictions or other regulatory or legislative actions that could limit our ability to sell those products to key customers or customers within certain markets;an improved version of products being offered by a competitor in the markets in which we participate;increased pressure from competitors that offer broader product lines;technological changes that we are unable to address with our products; ora failure to release new or enhanced versions of our products on a timely basis.In addition, the fact that we offer limited product lines creates the risk that our customers may view us as less important to their business than our competitors that offer additional products. This may impact our ability to maintain or expand our business with certain customers. Such product concentration may also subject us toContinues on next pageLam Research Corporation 2016 10-K 17additional risks associated with technology changes. Our business is affected by our customers’ use of our products in certain steps in their wafer fabrication processes. Should technologies change so that the manufacture of semiconductors requires fewer steps using our products, this could have a larger impact on our business than it would on the business of our less concentrated competitors.Strategic Alliances and Customer Consolidation May Have Negative Effects on Our BusinessIncreasingly, semiconductor manufacturing companies are entering into strategic alliances or consolidating with one another to expedite the development of processes and other manufacturing technologies and/or achieve economies of scale. The outcomes of such an alliance can be the definition of a particular tool set for a certain function and/or the standardization of a series of process steps that use a specific set of manufacturing equipment; while the outcomes of consolidation can lead to an overall reduction in the market for semiconductor manufacturing equipment as customers’ operations achieve economies of scale and/or increased purchasing power based on their higher volumes. In certain instances, this could work to our disadvantage if a competitor’s tools or equipment become the standard equipment for such functions or processes. Additional outcomes of such consolidation may include our customers re-evaluating their future supplier relationships to consider other competitors’ products and/or gaining additional influence over the pricing of products and the control of intellectual property.Similarly, our customers may partner with, or follow the lead of, educational or research institutions that establish processes for accomplishing various tasks or manufacturing steps. If those institutions utilize a competitor’s equipment when they establish those processes, it is likely that customers will tend to use the same equipment in setting up their own manufacturing lines. Even if they select our equipment, the institutions and the customers that follow their lead could impose conditions on acceptance of that equipment, such as adherence to standards and requirements or limitations on how we license our proprietary rights that increase our costs or require us to take on greater risk. These actions could adversely impact our market share and financial results.We Depend On a Limited Number of Key Suppliers and Outsource Providers, and We Run the Risk That They Might Not Perform as We ExpectOutsource providers and component suppliers have played and will continue to play a key role in our manufacturing operations, field installation and insupport, and many of our transactional and administrative functions, such as information technology, facilities management, and certain elements of our finance organization. These providers and suppliers might suffer financial setbacks, be acquired by third parties, become subject to exclusivity arrangements that preclude further business with us or be unable to meet our requirements or expectation due to their independent business decisions, orforce majeure events that could interrupt or impair their continued ability to perform as we expect.Although we attempt to select reputable providers and suppliers, and we attempt to secure their performance on terms documented in written contracts, it is possible that one or more of these providers or suppliers could fail to perform as we expect, or fail to secure or protect intellectual property rights, and such failure could have an adverse impact on our business. In some cases, the requirements of our business mandate that we obtain certain components and sub-assemblies included in our products from a single supplier or a limited group of suppliers. Where practical, we endeavor to establish alternative sources to mitigate the risk that the failure of any single provider or supplier will adversely affect our business, but this is not feasible in all circumstances. There is therefore a risk that a prolonged inability to obtain certain components or secure key services could impair our ability to manage operations, ship products and generate revenues, which could adversely affect our operating results and damage our customer relationships.We Face Risks Related to the Disruption of Our Primary Manufacturing FacilitiesOur manufacturing facilities are concentrated in just a few locations. These locations are subject to disruption for a variety of reasons such as natural or man-made disasters, terrorist activities, disruptions of our information technology resources, and utility interruptions. Such disruptions may cause delays in shipping our products, which could result in the loss of business or customer trust, adversely affecting our business and operating results.Continues on next pageLam Research Corporation 2016 10-K 18Once a Semiconductor Manufacturer Commits to Purchase a Competitor’s Semiconductor Manufacturing Equipment, the Manufacturer Typically Continues to Purchase that Competitor’s Equipment, Making it More Difficult for Us to Sell Our Equipment to that CustomerSemiconductor manufacturers must make a substantial investment to qualify and integrate wafer processing equipment into a semiconductor production line. We believe that once a semiconductor manufacturer selects a particular supplier’s processing equipment, the manufacturer generally relies upon that equipment for that specific production line application for an extended period of time, especially iffor customers that are more focused on tool re-use than in the past.re-use. Accordingly, we expect it to be more difficult to sell our products to a given customer if that customer initially selects a competitor’s equipment for the same product line application.We Face a Challenging and Complex Competitive EnvironmentWe face significant competition from multiple competitors and with increased consolidation efforts in our industry we may face increasing competitive pressures. Other companies continue to develop systems and products that are competitive to ours and may introduce new products, which may affect our ability to sell our existing products.We believe that to remain competitive we must devote significant financial resources to offer a broad range of products that meet our customers' needs, to maintain customer service and support centers worldwide, and to invest in product and process R&D. Certain of our competitors, including those that are created and financially backed by foreign governments, have substantially greater financial resources and more extensive engineering, manufacturing, marketing, and customer service and support resources than we do and therefore have the potential to offer customers a more comprehensive array of products and to therefore achieve additional relative success in the semiconductor equipment industry. These competitors may deeply discount or give away products similar to those that we sell, challenging or even exceeding our ability to make similar accommodations and threatening our ability to sell those products. We also face competition from our own customers, who in some instances have established affiliated entities that manufacture equipment similar to ours. For these reasons, we may fail to continue to compete successfully worldwide.In addition, our competitors may be able to develop products comparable or superior to those we offer or may adapt more quickly to new technologies or evolving customer requirements. In particular, while we continue to develop product enhancements that we believe will address future customer requirements, we may fail in a timely manner to complete the development or introduction of these additional product enhancements successfully, or these product enhancements may not achieve market acceptance or be competitive. Accordingly, competition may intensify, and we may be unable to continue to compete successfully in our markets, which could have a material adverse effect on our revenues, operating results, financial condition, and/or cash flows.Our Future Success Depends Heavily on International Sales and the Management of Global OperationsNon-U.S. sales accounted for approximately 83%92%, 86%83%, and 80%86% of total revenue in fiscal years 2016, 2015, 2014, and 2013,2014, respectively. We expect that international sales will continue to account for a substantial majority of our total revenue in future years.We are subject to various challenges related to international sales and the management of global operations including, but not limited to:trade balance issues;tariffs and other barriers;global or national economic and political conditions;changes in currency controls;differences in the enforcement of intellectual property and contract rights in varying jurisdictions;our ability to respond to customer and foreign government demands for locally sourced systems, spare parts and services and develop the necessary relationships with local suppliers;Continues on next pageLam Research Corporation 2016 10-K 19compliance with U.S. and international laws and regulations affecting foreign operations; including U.S. and international trade restrictions and sanctions, anti-bribery, anti-corruption, environmental, and labor laws;fluctuations in interest and foreign currency exchange rates;our ability to repatriate cash in a tax-efficient manner;the need for technical support resources in different locations; andour ability to secure and retain qualified people, and effectively manage people, in all necessary locations for the successful operation of our business.Certain international sales depend on our ability to obtain export licenses from the U.S. government. Our failure or inability to obtain such licenses would substantially limit our markets and severely restrict our revenues. Many ofWe are exposed to potentially adverse movements in foreign currency exchange rates. The majority of our sales and expenses are denominated in U.S. dollars. However, we are exposed to foreign currency exchange rate fluctuations primarily related to revenues denominated in Japanese yen and expenses denominated in euro and Korean won. Currently, we enter into foreign currency forwardhedge contracts to minimize the short-term impact of the foreign currency exchange rate fluctuations on certain foreign currency monetary assets and liabilities; primarily third party accounts receivables, accounts payables and intercompany receivables and payables. In addition, we hedge certain anticipated foreign currency cash flows, primarily anticipated revenues denominated in Japanese yen and euro-denominated and Korean won-denominated expenses. We believe these are our primary exposures to currency rate fluctuation. We expect to continue to enter into hedging transactions, for the purposes outlined, for the foreseeable future. However, these hedging transactions may not achieve their desired effect because differences between the actual timing of the underlying exposures and our forecasts of those exposures may leave us either over-or under-hedgedover or under hedged on any given transaction. Moreover, by hedging these foreign currency denominated revenues, expenses, monetary assets and liabilities, with foreign currency forward contracts, we may miss favorable currency trends that would have been advantageous to us but for the hedges. Additionally, we are exposed to short-term foreign currency exchange rate fluctuations on non-U.S. dollar-denominated monetary assets and liabilities (other than those currency exposures previously discussed) and currently we do not enter into foreign currency hedge contracts against these exposures. Therefore, we are subject to both favorable andpotential unfavorable foreign currency exchange rate fluctuations to the extent that we transact business (including intercompany transactions) for these currencies.The magnitude of our overseas business also affects where our cash is generated. Certain uses of cash, such as share repurchases, payment of dividends or the repayment of our notes, can usually only be made with on-shore cash balances. Since the majority of our cash is generated outside of the United States, this may impact certain business decisions and adversely affect business outcomes.Our Ability to Attract, Retain, and Motivate Key Employees Is Critical to Our SuccessOur ability to compete successfully depends in large part on our ability to attract, retain, and motivate key employees. This is an ongoing challenge due to intense competition for top talent, as well as fluctuations in industry economic conditions that may require cycles of hiring activity and workforce reductions. Our success in hiring depends on a variety of factors, including the attractiveness of our compensation and benefit programs and our ability to offer a challenging and rewarding work environment. We periodically evaluate our overall compensation programs and make adjustments, as appropriate, to maintain or enhance their competitiveness. IfContinues on next pageLam Research Corporation 2016 10-K 20we are not able to successfully attract, retain, and motivate key employees, we may be unable to capitalize on market opportunities and our operating results may be materially and adversely affected.We Rely Upon Certain Critical Information Systems for the Operation of Our BusinessWe maintain and rely upon certain critical information systems for the effective operation of our business. These information systems include telecommunications, the internet,Internet, our corporate intranet, various computer hardware and software applications, network communications, and e-mail. These information systems may be owned andbusiness.Our Financial Results May be Adversely Impacted by Higher than Expected Tax Rates or Exposure to Additional Tax LiabilitiesAs a global company, our effective tax rate is highly dependent upon the geographic composition of worldwide earnings and tax regulations governing each region. We are subject to income taxes in the United States and various foreign jurisdictions, and significant judgment is required to determine worldwide tax liabilities. Our effective tax rate could be adversely affected by changes in the split of earnings between countries with differing statutory tax rates, in the valuation allowance of deferred tax assets, in tax laws, by material audit assessments, or changes in or expirations of agreements with tax authorities. These factors could affect our profitability. In particular, the carrying value of deferred tax assets, which are predominantly in the United States, is dependent on our ability to generate future taxable income in the United States. In addition, the amount of income taxes we pay is subject to ongoing audits in various jurisdictions, and a material assessment by a governing tax authority could affect our profitability.A Failure to Comply with Environmental Regulations May Adversely Affect Our Operating ResultsWe are subject to a variety of domestic and international governmental regulations related to the handling, discharge, and disposal of toxic, volatile, or otherwise hazardous chemicals. Failure to comply with present or future environmental regulations could result in fines being imposed on us, require us to suspend production, or cease operations, or cause our customers to not accept our products. These regulations could require us to alter our current operations, acquire significant additional equipment, incur substantial other expenses to comply with environmental regulations, or take other actions. Any failure to comply with regulations governing the use, handling, sale, transport or disposal of hazardous substances could subject us to future liabilities that may adversely affect our operating results, financial condition and ability to operate our business.If We Choose to Acquire or Dispose of Businesses, Product Lines and Technologies, We May Encounter Unforeseen Costs and Difficulties That Could Impair Our Financial PerformanceAn important element of our management strategy is to review acquisition prospects that would complement our existing products, augment our market coverage and distribution ability, or enhance our technological capabilities. As a result, we may make acquisitions of complementary companies, products or technologies as with our proposed acquisition of KLA-Tencor, or we may reduce or dispose of certain product lines or technologies that no longer fit our long-term strategies. Managing an acquired business, disposing of productContinues on next pageLam Research Corporation 2016 10-K 21technologies or reducing personnel entail numerous operational and financial risks, including difficulties in assimilating acquired operations and new personnel or separating existing business or product groups, diversion of management’s attention away from other business concerns, amortization of acquired intangible assets, adverse customer reaction to our decision to cease support for a product, and potential loss of key employees or customers of acquired or disposed operations. There can be no assurance that we will be able to achieve and manage successfully any such integration of potential acquisitions, disposition ofandand/or cash flows.In addition, any acquisition could result in changes such as potentially dilutive issuances of equity securities, the incurrence of debt and contingent liabilities, the amortization of related intangible assets, and goodwill impairment charges, any of which could materially adversely affect our business, financial condition, and results of operations, cash flows, and/or the price of our Common Stock.The Market for Our Common Stock is Volatile, Which May Affect Our Ability to Raise Capital, Make Acquisitions, or Subject Our Business to Additional CostsThe market price for our Common Stock is volatile and has fluctuated significantly over the past years. The trading price of our Common Stock could continue to be highly volatile and fluctuate widely in response to a variety of factors, many of which are not within our control or influence. These factors include but are not limited to the following:our ability to complete the contemplated acquisition of KLA-Tencor, or any delays thereto;general market, semiconductor, or semiconductor equipment industry conditions;economic or political events and trends occurring globally or in any of our key sales regions;variations in our quarterly operating results and financial condition, including our liquidity;variations in our revenues, earnings or other business and financial metrics from forecasts by us or securities analysts, or from those experienced by other companies in our industry;announcements of restructurings, reductions in force, departure of key employees, and/or consolidations of operations;government regulations;developments in, or claims relating to, patent or other proprietary rights;technological innovations and the introduction of new products by us or our competitors;commercial success or failure of our new and existing products;disruptions of relationships with key customers or suppliers; orconvertibility and dilutive impacts of our Convertible Notes and related warrants.In addition, the stock market experiences significant price and volume fluctuations. Historically, we have witnessed significant volatility in the price of our Common Stock due in part to the price of and markets for semiconductors. These and other factors have and may again adversely affect the price of our Common Stock, regardless of our actual operating performance. In the past, following volatile periods in the price of their stock, many companies became the object of securities class action litigation. If we are sued in a securities class action, we could incur substantial costs, and it could divert management’s attention and resources and have an unfavorable impact on our financial performance and the price for our Common Stock.Continues on next pageLam Research Corporation 2016 10-K 22Intellectual Property, Indemnity, and Other Claims Against Us Can be Costly and We Could Lose Significant Rights That are Necessary to Our Continued Business and ProfitabilityThird parties may assert infringement, unfair competition, product liability, breach of contract, or other claims against us. From time to time, other persons send us notices alleging that our products infringe their patent or other intellectual property rights. In addition, law enforcement authorities may seek criminal charges relating to intellectual property or other issues. We also face risks of claims arising from commercial and other relationships. In addition, our bylaws and other indemnity obligations provide that we will indemnify officers and members of our board of directors against losses that they may incur in legal proceedings resulting from their service to us. From time to time, in the normal course of business, we indemnify third parties with whom we enter into contractual relationships, including customers and suppliers, with respect to certain matters. We have agreed, under certain conditions, to hold these third parties harmless against specified losses, such as those arising from a breach of representations orWe May Fail to Protect Our Critical Proprietary Technology Rights, Which Could Affect Our BusinessOur success depends in part on our proprietary technology and our ability to protect key components of that technology through patents, copyrights and trade secret protection. Protecting our key proprietary technology helps us to achieve our goals of developing technological expertise and new products and systems that give us a competitive advantage; increasing market penetration and growth of our installed base; and providing comprehensive support and service to our customers. As part of our strategy to protect our technology we currently hold a number of U.S. and foreign patents and pending patent applications, and we keep certain information, processes and techniques as trade secrets. However, other parties may challenge or attempt to invalidate or circumvent any patents the United States or foreign governments issue to us, these governments may fail to issue patents for pending applications, or we may lose trade secret protection over valuable information due to the intentional or unintentional actions or omissions of third parties, of ours or even our own employees. Additionally, intellectual property litigation can be expensive and time-consuming and even when patents are issued or trade secret processes are followed, the legal systems in certain of the countries in which we do business do not enforce patents and other intellectual property rights as rigorously as the United States. The rights granted or anticipated under any of our patents, pending patent applications or trade secrets may be narrower than we expect or, in fact, provide no competitive advantages. Moreover, because we determine the jurisdictions in which to file patents at the time of filing, we may not have adequate protection in the future based on such previous decisions. Any of these circumstances could have a material adverse impact on our business.We Are Exposed to Various Risks from Our Regulatory EnvironmentWe are subject to various risks related to (i) new, different, inconsistent or even conflicting laws, rules and regulations that may be enacted by legislative bodies and/or regulatory agencies in the countries that we operate; (ii) disagreements or disputes between national or regional regulatory agencies related to international trade; and (iii) the interpretation and application of laws, rules and regulations. As a public company with global operations, we are subject to the laws of multiple jurisdictions and the rules and regulations of various governing bodies, including those related to financial and other disclosures, corporate governance, privacy, anti-corruption, such as the Foreign Corrupt Practices Act and other local laws prohibiting corrupt payments to governmental officials, conflict minerals or other social responsibility legislation, and antitrust regulations, among others. Each of these laws, rules and regulations imposes costs on our business, including financial costs and potential diversion of our management’s attention associated with compliance, and may present risks to our business, including potential fines, restrictions on our actions, and reputational damage if we are unable to fully comply.To maintain high standards of corporate governance and public disclosure, we intend to invest all reasonably necessary resources to comply with all evolving standards. Changes in or ambiguous interpretations of laws, regulations and standards may create uncertainty regarding compliance matters. Efforts to comply with new andContinues on next pageLam Research Corporation 2016 10-K 23changing regulations have resulted in, and are likely to continue to result in, increased selling, general and administrative expenses and a diversion of management’s time and attention from revenue generating activities to compliance activities. If we are found by a court or regulatory agency not to be in compliance with the laws and regulations, our business, financial condition, andand/or results of operations could be adversely affected.There Can Be No Assurance That We Will Continue To Declare Cash Dividends Or Repurchase Our Shares At All Or In Any Particular Amounts.Our Board of Directors has declared quarterly dividends since April 2014. Our intent to continue to pay quarterly dividends and to repurchase our shares is subject to capital availabilityavailability; in the case of share repurchases, contractual restrictions; and, in the case of dividends, periodic determinations by our Board of Directors that cash dividends are in the best interest of our stockholders and are in compliance with all laws and agreements applicable to the declaration and payment of cash dividends by us. Future dividends and share repurchases may also be affected by, among other factors: our views on potential future capital requirements for investments in acquisitions and the funding of our research and development; legal risks; stock repurchase programs; changes in federal and state income tax laws or corporate laws; contractual restrictions, such as financial or operating covenants in our debt arrangements; availability of onshore cash flow; and changes to our business model. Our dividend payments and share repurchases may change from time to time, and we cannot provide assurance that we will continue to declare dividends or repurchase shares at all or in any particular amounts. We currently are restricted from repurchasing our common stock and increasing our quarterly dividend pursuant to the KLA-Tencor merger agreement. A reduction or suspension in our dividend payments or share repurchase activity could have a negative effect on our stock price.If We are Unable to Complete Our Contemplated Acquisition of KLA-Tencor Corporation, Our Expected Financial Results and the Market Value of our Common Stock Could Be Adversely AffectedOn October 20, 2015, we entered into an Agreement and Plan of Merger and Reorganization (the “merger agreement”) with KLA-Tencor to acquire all of KLA-Tencor’s issued and outstanding stock through a merger of KLA-Tencor with our subsidiaries, Topeka Merger Sub 1, Inc. and Topeka Merger Sub 3, Inc. (as assignee of Topeka Merger Sub 2, Inc.) (the “merger”). Consummation of the merger is subject to customary conditions to closing, including the receipt of required regulatory approvals. If any condition to the merger is not satisfied or waived, the merger will not be completed. We and KLA-Tencor also may terminate the merger agreement under certain circumstances. Any or all of the preceding could jeopardize our ability to consummate the merger on the already negotiated terms. To the extent the merger is not completed for any reason, we would have devoted substantial resources and management attention to the transaction without realizing the accompanying benefits expected by our management, and our financial condition and results of operations and the market value of our stock may be adversely affected. Additional risks and uncertainties associated with the merger include:various conditions to the closing of the merger may not be satisfied or waived;the failure to consummate the merger may result in negative publicity and a negative impression of us in the investment community;we and KLA-Tencor are subject to litigation related to the merger, and may be subject to additional proceedings in the future, which may effect the merger from becoming effective within the expected time frame, or at all;required regulatory approvals from governmental entities may delay the merger or result in the imposition of conditions that could cause the abandonment of the merger;the merger agreement may be terminated in circumstances that would require us to pay KLA-Tencor a termination fee of up to $290 million;the merger agreement contains provisions that could discourage a potential acquirer of the Company;our ability to attract, recruit, retain and motivate current and prospective employees who may be uncertain about the timing of the merger or their future roles and relationships with us following the completion of the merger may be adversely affected;the increase in our leverage and debt service obligations as a result of the assumption of KLA-Tencor’s debt and the incurrence of additional financing in connection with the merger may adversely affect the combined company’s financial condition, results of operations and earnings per share; andthe attention of our employees and management may be diverted due to activities related to the merger; and disruptions from the merger, whether completed or not, may harm our relationshipsContinues on next pageLam Research Corporation 2016 10-K 24with our employees, customers, distributors, suppliers or other business partners, may impair our ability to continuously innovate to meet the industry inflections, and may result in a loss of or a substantial decrease in purchases by our customers.Even if the KLA-Tencor Merger is Consummated, We May Not Be Able to Integrate the Business of KLA-Tencor Successfully With our Own or Realize the Anticipated Benefits of the MergerThe merger involves the combination of two companies that currently operate as independent public companies. The combined company will be required to devote significant management attention and resources to integrating our business practices with those of KLA-Tencor. Potential difficulties that the combined company may encounter as part of the integration process include the following:the inability to successfully combine our business with KLA-Tencor in a manner that permits the combined company to achieve the full revenue and cost synergies and other benefits anticipated to result from the merger;required regulatory approvals from governmental entities may result in limitations, additional costs or placement of restrictions on the conduct of the combined company, imposition of additional material costs on or materially limiting the revenues of the combined company following the merger;complexities associated with managing the combined businesses, including difficulty addressing possible differences in corporate cultures and management philosophies and the challenge of integrating complex systems, technology, networks and other assets of each of the companies in a seamless manner that minimizes any adverse impact on customers, suppliers, employees and other constituencies; andpotential unknown liabilities and unforeseen increased expenses or delays associated with the merger.In addition, we have operated and, until the completion of the merger will continue to operate, independently. It is possible that the integration process could result in:diversion of the attention of our management; andthe disruption of, or the loss of momentum in, our ongoing business or inconsistencies in standards, controls, procedures or policies,any of which could adversely affect our ability to maintain relationships with customers, suppliers, employees and other constituencies or our ability to achieve the anticipated benefits of the merger, or could reduce our earnings or otherwise adversely affect the business and financial results of the combined company.The Future Results of the Combined Company Will Suffer if the Combined Company Does Not Effectively Manage its Expanded Operations Following the MergerFollowing the merger, the size of the business of the combined company will increase significantly beyond the current size of either our or KLA-Tencor’s business. The combined company’s future success depends, in part, upon its ability to manage this expanded business, which will pose substantial challenges for management, including challenges related to the management and monitoring of new operations and associated increased costs and complexity. There can be no assurances that the combined company will be successful or that it will realize the expected operating efficiencies, cost savings, revenue enhancements or other benefits currently anticipated from the merger.The Combined Company is Expected to Incur Substantial Expenses Related to the Merger With and the Integration of KLA-TencorWe have incurred and expect to continue to incur substantial expenses in connection with the merger with and the integration of KLA-Tencor. There are a large number of processes, policies, procedures, operations, technologies and systems that may need to be integrated, including purchasing, accounting and finance, sales, payroll, pricing, marketing and benefits. While we have assumed that a certain level of expenses will be incurred, there are many factors beyond our or their control that could affect the total amount or the timing of the integration expenses. Moreover, many of the expenses that will be incurred are, by their nature, difficult to estimate accurately. These expenses could, particularly in the near term, exceed the savings that the combined company expects to achieve from the elimination of duplicative expenses and the realization of economies of scale and cost savings. These integration expenses likely will result in the combined company taking significantContinues on next pageLam Research Corporation 2016 10-K 25charges against earnings following the completion of the merger, and the amount and timing of such charges are uncertain at present.The Merger May Result In a Loss of Customers or Strategic AlliancesAs a result of the merger, some of the customers, potential customers or strategic partners of ours or KLA-Tencor may terminate or scale back their business relationship with the combined company. Some customers may not wish to source a larger percentage of their needs from a single company, or may feel that we or KLA-Tencor, as applicable, and thus the combined company is too closely allied with one of their competitors. Potential customers or strategic partners may delay entering into, or decide not to enter into, a business relationship with the combined company because of the merger. If customer relationships or strategic alliances are adversely affected by the merger, the combined company’s business and financial performance could suffer.Third Parties May Terminate or Alter Existing Contracts with KLA-TencorKLA-Tencor has contracts with suppliers, distributors, customers, licensors, licensees, lessors and other business partners that have “change of control” or similar clauses that allow the counterparty to terminate or change the terms of their contract upon the closing of the transactions contemplated by the merger agreement. We or KLA-Tencor may seek to obtain consent from these other parties, but if these third party consents are not obtained, or are obtained on unfavorable terms, the combined company may lose the benefit of such contracts, including benefits that may be material to the business of the combined company.Our Indebtedness Following Completion of the Merger Will Be Substantially Greater Than Our Indebtedness on a Stand-alone Basis and Greater Than Our and KLA-Tencor's Combined Indebtedness Existing Prior to the Merger. This Increased Level of Indebtedness Could Adversely Affect Us, Including by Decreasing Our Business Flexibility, And Will Increase Our Borrowing Costs. Downgrades in Our Ratings Could Adversely Affect Our Business, Cash Flows, Financial Condition and/or Operating Results.We intend to fund the cash component of the merger consideration and related fees and expenses and to prepay KLA-Tencor’s term loan with a combination of the combined companies’ balance sheet cash and proceeds of approximately $4 billion under the term loans, the revolving credit agreement and debt securities. In connection with the anticipated KLA-Tencor merger, we also expect to offer to holders of KLA-Tencor's outstanding $2.5 billion aggregate principal amount of senior unsecured notes (the "KLA-Tencor Senior Notes") new series of our senior unsecured notes in exchange for the KLA-Tencor Senior Notes. Our substantially increased indebtedness and higher debt-to-equity ratio following completion of the merger in comparison to that prior to the merger will have the effect, among other things, of reducing our flexibility to respond to changing business and economic conditions and will increase our borrowing costs. In addition, the amount of cash required to service our increased indebtedness levels and thus the demands on our cash resources will be greater than the amount of cash flows required to service our indebtedness or that of KLA-Tencor individually prior to the merger. The increased levels of indebtedness could also reduce funds available for our investments in product development as well as capital expenditures, dividends, share repurchases and other activities and may create competitive disadvantages for us relative to other companies with lower debt levels.In addition, our credit ratings impact the cost and availability of future borrowings, and, as a result, our cost of capital. Our ratings reflect each rating agency's opinion of our financial strength, operating performance and ability to meet our debt obligations or obligations to our insureds. Each of the ratings agencies reviews our ratings periodically, and there can be no assurance that our current ratings will be maintained in the future. Downgrades in our ratings could adversely affect our business, cash flows, financial condition and/or operating results.There Can Be No Assurance that We Will be Able to Maintain the Financing We Intend to Use to Pay the Cash Portion of the Consideration for the Merger.We have (1) entered into a senior unsecured term loan agreement which provides up to $1.53 million in term loans, subject to certain conditions; and (2) issued $2.4 billion principal amount of senior unsecured notes. We have also entered into an amendment and restatement of our existing revolving credit agreement pursuant to which, among other things, the revolving lenders agreed to increase their aggregate commitments under the revolving credit agreement from $300 million to $750 million.Continues on next pageLam Research Corporation 2016 10-K 26We intend to fund the cash component of the merger consideration and related fees and expenses and to prepay KLA-Tencor’s outstanding term loans with a combination of the combined companies’ balance sheet cash and proceeds of approximately $4 billion under the term loans, from the issuance of senior unsecured notes and the revolving credit agreement.The availability of the term loans is subject to certain conditions precedent and will terminate on October 20, 2016 if the merger has not been consummated by such date. In addition, if the merger with KLA-Tencor is not completed on or prior to December 30, 2016, or if the merger agreement is terminated on or prior to such date, we will be required to redeem $1.6 billion principal amount of senior notes pursuant to a special mandatory redemption feature of such notes.Our obligation to complete the merger is not subject to a financing contingency. In the event that we and KLA-Tencor were to agree to extend the period of time in which to close the merger beyond October 20, 2016, there can be no assurance that we would be able to extend the availability of the term loans beyond that date. In the event that the term loans are not available, or in the event of the special mandatory redemption of certain of our senior notes, other financing may not be available on acceptable terms, in a timely manner, or at all. If we are unable to secure alternative financing, the merger may not be completed or we could find it necessary to fund the merger, related fees and expenses, and the prepayment of KLA-Tencor’s outstanding term loans from other sources of liquidity, or we could be liable to KLA-Tencor for breach of the merger agreement in connection with our failure to consummate the merger.Any delay in completing the KLA-Tencor Merger may reduce or eliminate the benefits expected to be achieved thereunder.In addition to the required regulatory clearances, the KLA-Tencor merger is subject to a number of other conditions beyond our and KLA-Tencor’s control that may prevent, delay or otherwise materially adversely affect its completion. We cannot predict whether and when these other conditions will be satisfied. Furthermore, the requirements for obtaining the required clearances and approvals could delay the completion of the KLA-Tencor Merger for a significant period of time or prevent it from occurring. Any delay in completing the KLA-Tencor Merger could cause the combined company not to realize some or all of the synergies that we and KLA-Tencor expect to achieve if the KLA-Tencor Merger is successfully completed within its expected time frame. Neither we nor KLA-Tencor will be obligated to close the KLA-Tencor Merger if the KLA-Tencor Merger is not consummated by October 20, 2016.Item 1B. Unresolved Staff Comments None.Item 2. Properties Our executive offices and principal operating and R&D facilities are located in Fremont, Livermore, and San Jose, California, Tualatin, Oregon, and Villach, Austria. The majority of the Fremont and Livermore facilities are held under operating leases expiring in 2020 and 2021, in addition the Villach facilities are held under capital leases expiring in calendar year 2016. The company owns one property in Fremont, as well as, the San Jose and Tualatin facilities. Our Fremont, Livermore, and Villach leases generally include options to renew or purchase the facilities. In addition, we lease or own properties for our service, technical support and sales personnel throughout the United States, Europe, Taiwan, Korea, Japan, China, and Southeast Asia, and lease or own manufacturing facilities located in Illinois, Ohio, Germany, and Korea. The company owns two properties in Fremont, as well as, the Tualatin facilities. During fiscal year 2016 we sold our San Jose facilities and entered into an operating lease for use of the buildings for a portion of calendar year 2016. Our facilities lease obligations are subject to periodic increases. We believe that our existing facilities are well-maintained and in good operating condition.Item 3. Legal Proceedings While the Company iswe are not currently party to any legal proceedings that it believeswe believe are material, the Company iswe are either a defendant or plaintiff in various actions that have arisen from time to time in the normal course of business, including intellectual property claims. The Company accruesWe accrue for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Significant judgment is required in both the determination of probability and the determination as to whether a loss is reasonably estimable. These accruals are reviewed atContinues on next pageLam Research Corporation 2016 10-K 27least quarterly and adjusted to reflect the effects of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to a particular matter. To the extent there is a reasonable possibility that the losses could exceed the amounts already accrued, the Company believeswe believe that the amount of any such additional loss would be immaterial to the Company’sour business, financial condition, and results of operations.Item 4. Mine Safety DisclosuresNot applicable.PART IIItem 4.Mine Safety DisclosuresNot applicable.
| Item 5. | Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities |
First Quarter Second Quarter Third Quarter Fourth Quarter First Quarter Second Quarter Third Quarter Fourth Quarter As part of our share repurchase program, we may from time-to-time enter into structured share repurchase arrangements with financial institutions using general corporate funds. Amount available at June 29, 2014 Quarter ending September 28, 2014 Quarter ending December 28, 2014 Quarter ended March 29, 2015 March 30, 2015 - April 26, 2015 April 27, 2015 - May 24, 2015 May 25, 2015 - June 28, 2015 Total Stock InformationOur Common Stock is traded on the NASDAQNasdaq Global Select Market under the symbol LRCX. As of August 5, 2015,10, 2016, we had 479454 stockholders of record. In fiscal year 20152016 we paid our stockholders a quarterly dividenddividends of $0.30 per share, and in fiscal year 2015, quarterly dividends of $0.18 per share. In May 2015, we announced an increase in our quarterly dividend to $0.30 per share, which is payable in the first quarter of fiscal year 2016. The table below sets forth the high and low prices of our Common Stock as reported by The NASDAQNasdaq Stock Market, LLC, for the period indicated: 2015 High Low $ 77.35 $ 66.70 $ 85.70 $ 65.78 $ 84.49 $ 69.92 $ 84.39 $ 69.07 2014 High Low $ 52.31 $ 44.11 $ 55.48 $ 49.54 $ 57.16 $ 48.45 $ 67.85 $ 50.54 2016 High Low First Quarter $ 84.13 $ 61.20 Second Quarter $ 80.85 $ 61.65 Third Quarter $ 81.29 $ 63.10 Fourth Quarter $ 87.19 $ 72.00 2015 High Low First Quarter $ 77.35 $ 66.70 Second Quarter $ 85.70 $ 65.78 Third Quarter $ 84.49 $ 69.92 Fourth Quarter $ 84.39 $ 69.07 Repurchase of Company SharesOn April 29, 2014, the Board of Directors authorized the repurchase of up to $850 million of Common Stock. These repurchases can be conducted on the open market or as private purchases and may include the use of derivative contracts with large financial institutions, in all cases subject to compliance with applicable law. Repurchases will be funded using our on-shore cash and on-shore cash generation. This repurchase program has no termination date and may be suspended or discontinued at any time. As part of our share repurchase program, we may from time-to-time enter into structured share repurchase arrangements with financial institutions using general corporate funds.During We currently are restricted from repurchasing our common stock pursuant to the three months ended SeptemberKLA-Tencor merger agreement.Continues on next pageLam Research Corporation 2016 10-K 28 2014, we entered into a collared accelerated share repurchase (“ASR”) transaction under a master repurchase arrangement. Under the ASR, we made an up-front cash paymentShare repurchases, including those under the repurchase program, were as follows:Period Total Number
of Shares
Repurchased (1) Average
Price Paid
Per Share (2) Total Number of
Shares Purchased
as Part of Publicly
Announced Plans
or Programs Amount
Available
Under
Repurchase
Program (in thousands, except per share data) $ 830,895 3,938 $ 69.86 3,818 $ 534,174 1,158 $ 78.10 869 $ 488,480 1,550 $ 78.57 1,434 $ 376,002 192 $ 73.51 178 $ 362,898 478 $ 77.33 264 $ 342,377 321 $ 82.66 312 $ 316,587 7,637 $ 75.04 6,875 $ 316,587 Period Total Numberof SharesRepurchased (1) AveragePrice PaidPer Share Total Number ofShares Purchasedas Part of PubliclyAnnounced Plansor Programs AmountAvailableUnderRepurchaseProgram (in thousands, except per share data) Available balance as of June 28, 2015 $ 316,587 Quarter Ended September 27, 2015 1,413 $ 72.69 1,205 $ 229,094 Quarter Ended December 27, 2015 184 $ 69.76 — $ 229,094 Quarter Ended March 27, 2016 297 $ 67.63 — $ 229,094 March 28, 2016 - April 24, 2016 127 $ 82.54 — $ 229,094 April 25, 2016 - May 22, 2016 10 $ 75.03 — $ 229,094 May 23, 2016 - June 26, 2016 99 $ 83.63 — $ 229,094 Total 2,130 $ 72.84 1,205 $ 229,094 __________________________________ (1) In addition to shares repurchased under the Board-authorized repurchase program, shown above, we acquired 761,883924,823 shares at a total cost of $58.8$67.6 million which we withheld through net share settlements to cover minimum tax withholding obligations upon the vesting of restricted stock unit awards granted under our equity compensation plans. The shares retained through these net share settlements are not a part of the Board-authorized repurchase program but instead are authorized under our equity compensation plans.(2)Average price paid per share excludes accelerated share repurchases for which cost was incurred during the September 2014 quarter, but that did not settle until the December 2014 quarter. See the section above for details regarding average price associated with these transactions.
| 6/10 | 6/11 | 6/12 | 6/13 | 6/14 | 6/15 | |||||||||||||||||||
Lam Research Corporation | 100.00 | 116.34 | 99.16 | 116.50 | 178.05 | 216.61 | ||||||||||||||||||
NASDAQ Composite | 100.00 | 132.14 | 142.90 | 169.55 | 223.20 | 253.21 | ||||||||||||||||||
S&P 500 | 100.00 | 130.69 | 137.81 | 166.20 | 207.10 | 222.47 | ||||||||||||||||||
RDG Semiconductor Composite | 100.00 | 131.61 | 128.78 | 143.95 | 195.98 | 196.30 | ||||||||||||||||||
PHLX Semiconductor | 100.00 | 135.83 | 139.10 | 165.22 | 223.35 | 233.52 | ||||||||||||||||||
2016.
| COMPARISON OF 5 YEAR CUMULATIVE TOTAL RETURN* | |||
| Among Lam Research Corporation, the NASDAQ Composite Index, the S&P 500 Index, and the PHLX Semiconductor Index | |||
| 6/11 | 6/12 | 6/13 | 6/14 | 6/15 | 6/16 | ||||||||||||
| Lam Research Corporation | 100.00 | 85.23 | 100.14 | 153.04 | 186.18 | 195.44 | |||||||||||
| NASDAQ Composite | 100.00 | 108.58 | 128.19 | 169.08 | 192.10 | 187.57 | |||||||||||
| S&P 500 | 100.00 | 105.45 | 127.17 | 158.46 | 170.22 | 177.02 | |||||||||||
| PHLX Semiconductor | 100.00 | 104.43 | 123.18 | 166.91 | 174.92 | 184.43 | |||||||||||
| Item 6. | Selected Financial Data |
| Year Ended | ||||||||||||||||||||
| June 28, 2015 (1) | June 29, 2014 (1) | June 30, 2013 (1) | June 24, 2012 (1) | June 26, 2011 | ||||||||||||||||
| (in thousands, except per share data) | ||||||||||||||||||||
OPERATIONS: | ||||||||||||||||||||
Revenue | $ | 5,259,312 | $ | 4,607,309 | $ | 3,598,916 | $ | 2,665,192 | $ | 3,237,693 | ||||||||||
Gross margin | 2,284,336 | 2,007,481 | 1,403,059 | 1,084,069 | 1,497,232 | |||||||||||||||
Goodwill impairment (2) | 79,444 | — | — | — | — | |||||||||||||||
Restructuring charges, net | — | — | 1,813 | 1,725 | 11,579 | |||||||||||||||
Operating income | 788,039 | 677,669 | 118,071 | 237,733 | 804,285 | |||||||||||||||
Net income | 655,577 | 632,289 | 113,879 | 168,723 | 723,748 | |||||||||||||||
Net income per share: | ||||||||||||||||||||
Basic | $ | 4.11 | $ | 3.84 | $ | 0.67 | $ | 1.36 | $ | 5.86 | ||||||||||
Diluted | $ | 3.70 | $ | 3.62 | $ | 0.66 | $ | 1.35 | $ | 5.79 | ||||||||||
Cash dividends declared per common share | $ | 0.84 | $ | 0.18 | $ | — | $ | — | $ | — | ||||||||||
BALANCE SHEET: | ||||||||||||||||||||
Working capital | $ | 3,639,488 | $ | 3,201,661 | $ | 2,389,354 | $ | 2,988,181 | $ | 2,592,506 | ||||||||||
Total assets | 9,364,648 | 7,993,306 | 7,250,315 | 8,004,652 | 4,053,867 | |||||||||||||||
Long-term obligations, less current portion | 1,388,335 | 1,198,221 | 1,170,048 | 1,255,600 | 903,263 | |||||||||||||||
Current portion of long-term debt and capital leases | 1,359,650 | 518,267 | 520,686 | 514,655 | 4,782 | |||||||||||||||
Year Ended(1) | |||||||||||||||||||
| June 26, 2016 | June 28, 2015 | June 29, 2014 | June 30, 2013 | June 24, 2012 | |||||||||||||||
| (in thousands, except per share data) | |||||||||||||||||||
| OPERATIONS: | |||||||||||||||||||
| Revenue | $ | 5,885,893 | $ | 5,259,312 | $ | 4,607,309 | $ | 3,598,916 | $ | 2,665,192 | |||||||||
| Gross margin | 2,618,922 | 2,284,336 | 2,007,481 | 1,403,059 | 1,084,069 | ||||||||||||||
Goodwill impairment (2) | — | 79,444 | — | — | — | ||||||||||||||
| Restructuring charges, net | — | — | — | 1,813 | 1,725 | ||||||||||||||
| Operating income | 1,074,256 | 788,039 | 677,669 | 118,071 | 237,733 | ||||||||||||||
| Net income | 914,049 | 655,577 | 632,289 | 113,879 | 168,723 | ||||||||||||||
| Net income per share: | |||||||||||||||||||
| Basic | $ | 5.75 | $ | 4.11 | $ | 3.84 | $ | 0.67 | $ | 1.36 | |||||||||
| Diluted | $ | 5.22 | $ | 3.70 | $ | 3.62 | $ | 0.66 | $ | 1.35 | |||||||||
| Cash dividends declared per common share | $ | 1.20 | $ | 0.84 | $ | 0.18 | $ | — | $ | — | |||||||||
| BALANCE SHEET: | |||||||||||||||||||
| Working capital | $ | 6,795,109 | $ | 3,639,488 | $ | 3,201,661 | $ | 2,389,354 | $ | 2,988,181 | |||||||||
| Total assets | 12,271,528 | 9,364,648 | 7,993,306 | 7,250,315 | 8,004,652 | ||||||||||||||
| Long-term obligations, less current portion | 3,749,657 | 1,388,335 | 1,198,221 | 1,170,048 | 1,255,600 | ||||||||||||||
| Current portion of long-term debt and capital leases | 949,494 | 1,359,650 | 518,267 | 514,655 | 511,139 | ||||||||||||||
| (1) | Fiscal years 2016, 2015, 2014, and 2013 amounts include operating results of Novellus. Fiscal year 2012 amounts include 20 days of operating results of Novellus from the acquisition date of June 4, 2012. The Novellus acquisition was accounted for as a business combination in accordance with the applicable accounting guidance. |
| (2) | Goodwill impairment analysis during fiscal year 2015 resulted in a non-cash impairment charge |
QUARTERLY FISCAL YEAR 2015: Revenue Gross margin Goodwill impairment Operating income Net income Net income per share Basic Diluted Number of shares used in per share calculations: Basic Diluted Three Months Ended (1) June 28,
2015 March 29,
2015 December 28,
2014 September 28,
2014 unaudited (in thousands, except per share data) $ 1,481,370 $ 1,393,333 $ 1,232,241 $ 1,152,368 641,538 600,602 536,657 505,539 79,444 — — — 191,035 239,965 188,741 168,298 131,271 206,285 176,940 141,081 $ 0.83 $ 1.30 $ 1.11 $ 0.87 $ 0.74 $ 1.16 $ 1.00 $ 0.80 158,590 158,992 159,248 161,685 176,575 177,531 177,046 177,118
| Three Months Ended (1) | ||||||||||||||||
| June 29, 2014 | March 30, 2014 | December 29, 2013 | September 29, 2013 | |||||||||||||
| unaudited | ||||||||||||||||
| (in thousands, except per share data) | ||||||||||||||||
QUARTERLY FISCAL YEAR 2014: | ||||||||||||||||
Revenue | $ | 1,248,797 | $ | 1,227,392 | $ | 1,116,061 | $ | 1,015,059 | ||||||||
Gross margin | 557,036 | 530,798 | 487,789 | 431,858 | ||||||||||||
Operating income | 215,850 | 191,937 | 164,474 | 105,408 | ||||||||||||
Net income | 233,395 | 164,396 | 148,992 | 85,506 | ||||||||||||
Net income per share | ||||||||||||||||
Basic | $ | 1.44 | $ | 1.01 | $ | 0.92 | $ | 0.52 | ||||||||
Diluted | $ | 1.35 | $ | 0.96 | $ | 0.87 | $ | 0.50 | ||||||||
Number of shares used in per share calculations: | ||||||||||||||||
Basic | 162,215 | 162,238 | 162,305 | 162,896 | ||||||||||||
Diluted | 173,345 | 171,636 | 171,757 | 171,363 | ||||||||||||
Three Months Ended (1) | |||||||||||||||
| June 26, 2016 | March 27, 2016 | December 27, 2015 | September 27, 2015 | ||||||||||||
unaudited (in thousands, except per share data) | |||||||||||||||
| QUARTERLY FISCAL YEAR 2016: | |||||||||||||||
| Revenue | $ | 1,546,261 | $ | 1,314,055 | $ | 1,425,534 | $ | 1,600,043 | |||||||
| Gross margin | 698,784 | 571,265 | 626,510 | 722,363 | |||||||||||
| Operating income | 309,241 | 190,753 | 238,834 | 335,428 | |||||||||||
| Net income | 258,939 | 143,451 | 222,980 | 288,679 | |||||||||||
| Net income per share | |||||||||||||||
| Basic | $ | 1.62 | $ | 0.90 | $ | 1.41 | $ | 1.82 | |||||||
| Diluted | $ | 1.46 | $ | 0.82 | $ | 1.28 | $ | 1.66 | |||||||
| Number of shares used in per share calculations: | |||||||||||||||
| Basic | 159,862 | 159,039 | 158,424 | 158,352 | |||||||||||
| Diluted | 177,649 | 174,373 | 174,242 | 174,374 | |||||||||||
Three Months Ended (1) | |||||||||||||||
| June 28, 2015 | March 29, 2015 | December 28, 2014 | September 28, 2014 | ||||||||||||
unaudited (in thousands, except per share data) | |||||||||||||||
| QUARTERLY FISCAL YEAR 2015: | |||||||||||||||
| Revenue | $ | 1,481,370 | $ | 1,393,333 | $ | 1,232,241 | $ | 1,152,368 | |||||||
| Gross margin | 641,538 | 600,602 | 536,657 | 505,539 | |||||||||||
| Goodwill impairment | 79,444 | — | — | — | |||||||||||
| Operating income | 191,035 | 239,965 | 188,741 | 168,298 | |||||||||||
| Net income | 131,271 | 206,285 | 176,940 | 141,081 | |||||||||||
| Net income per share | |||||||||||||||
| Basic | $ | 0.83 | $ | 1.30 | $ | 1.11 | $ | 0.87 | |||||||
| Diluted | $ | 0.74 | $ | 1.16 | $ | 1.00 | $ | 0.80 | |||||||
| Number of shares used in per share calculations: | |||||||||||||||
| Basic | 158,590 | 158,992 | 159,248 | 161,685 | |||||||||||
| Diluted | 176,575 | 177,531 | 177,046 | 177,118 | |||||||||||
| (1) | Our reporting period is a 52/53-week fiscal year. The fiscal years ended June |
| Item 7. | Management’s Discussion and Analysis of Financial Condition and Results of Operations |
Revenue Gross margin Gross margin as a percent of total revenue Total operating expenses Net income Diluted net income per share Shipments (in millions) Korea Taiwan United States Japan China Europe Southeast Asia Memory Foundry Logic/integrated device manufacturing 2014. client solid state drives. Foundry and logic spending decreased due to relatively lower spending levels at leading edge process nodes. Revenue (in millions) Korea Taiwan United States Japan China Europe Southeast Asia Gross margin Percent of total revenue a long lived asset in fiscal year 2015. Research & development (“R&D”) Percent of total revenue Selling, general & administrative (“SG&A”) Percent of total revenue assets net of associated exit costs. There were no impairment charges in fiscal year 2016 or 2014. Interest income Interest expense Gains on deferred compensation plan related assets, net Foreign exchange gains (losses), net Other, net Income tax expense (benefit) Effective tax rate consolidated financial statements. 2016. The valuation allowances were $102 million and $86 million at the end of fiscal years 2016 and 2015, respectively. results of operations and requires us to make difficult, complex and/or subjective judgments, often as a result of the need to make estimates about matters that are inherently uncertain. The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make certain judgments, estimates and assumptions that could affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. We accelerate their depreciation or amortization. Statements for additional information regarding our accounting policies. usage requirement is written down to its estimated market value if less than cost. Estimates of market value include, but are not limited to, management’s forecasts related to our future manufacturing schedules, customer demand, technological and/or market obsolescence, general semiconductor market conditions, and possible alternative uses. If future customer demand or market conditions are less favorable than our projections, additional inventory write-downs may be required and would be reflected in cost of goods sold in the period in which we make the revision. specific systems. We forfeiture estimate. equipment industry, or our failure to reach internal forecasts, which could impact our ability to achieve our forecasted levels of cash flows and reduce the estimated discounted cash flow value of our reporting units; and (2) a decline in our common stock price and resulting market capitalization, Statements, included in item 8 of this report. our total cash and investments as Net income Non-cash charges: Depreciation and amortization Equity-based compensation Deferred income taxes Amortization of note discounts and issuance costs Goodwill impairment Long-lived asset impairment Changes in operating asset and liability accounts Other Operating Leases Capital Leases Purchase Obligations Long-term Debt and Interest Expense (1) Total The following discussion of our financial condition and results of operations contains forward-looking statements, which are subject to risks, uncertainties and changes in condition, significance, value and effect. Our actual results could differ materially from those anticipated in the forward-looking statements as a result of certain factors, including but not limited to those discussed in “Risk Factors” and elsewhere in this 20152016 Form 10-K and other documents we file from time to time with the Securities and Exchange Commission. (See “Cautionary Statement Regarding Forward-Looking Statements” in Part I of this 20152016 Form 10-K).Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) provides a description of our results of operations and should be read in conjunction with our Consolidated Financial Statements and accompanying Notes to Consolidated Financial Statements included in this 20152016 Form 10-K. MD&A consists of the following sections:Executive Summary provides a summary of the key highlights of our results of operations and our management’s assessment of material trends and uncertainties relevant to our business.Results of Operations provides an analysis of operating results.Critical Accounting Policies and Estimates discusses accounting policies that reflect the more significant judgments and estimates used in the preparation of our Consolidated Financial Statements.Liquidity and Capital Resources provides an analysis of cash flows, contractual obligations and financial position.Executive SummaryLam Research has been an innovative supplier of wafer fabrication equipment and services to the semiconductor industry for more than 35 years. Our customers include semiconductor manufacturers that make memory, microprocessors, and other logic integrated circuits for a wide range of electronics; including cellmobile phones, computers, tablets, wearables, automotive features, storage devices, and networking equipment.Continues on next pageLam Research Corporation 2016 10-K 32Our market-leading products are designed to help our customers build the smaller, faster, and more powerful devices that are necessary to power the capabilities required by end users. The process of integrated circuits fabrication consists of a complex series of process and preparation steps, and our product offerings in deposition, etch, and clean address a number of the most critical steps in the fabrication process. We leverage our expertise in semiconductor processing to develop technology and/or productivity solutions that typically benefit our customers through lower defect rates, enhanced yields, faster processing time, and reduced cost as well as by facilitating their ability to meet more stringent performance and design standards.The semiconductor capital equipment industry has been highly competitive and characterized by rapid changes in demand. This cyclicality has been mitigated in recent years by market demands and consolidation among our customers. With a reduced number of customers, variability in their business plans may lead to changes in demand for Lam’s equipment and services. The variability in our customers’ investments during any particular period is dependent on several factors including but not limited to electronics demand, economic conditions (both general and in the semiconductor and electronics industries), industry supply and demand, prices for semiconductors, and our customers’ ability to develop and manufacture increasingly complex and costly semiconductor devices.DemandDuring the most recent fiscal year, demand for our products was strong throughout the fiscal yearimproved as semiconductor device manufacturers, particularly non volatile memory customers, made capacity and technology investments. We expect growth in the overall wafer fabrication equipment market in calendar year 2015 compared to calendar year 2014 related to leading edge investments by our customers. Technology inflections in our industry, including FinFET transistors, 3D NAND,3DNAND, multiple patterning, FINFET and advanced packaging have led to an increase in theour served addressable market for our deposition and etch market sizes.products. We believe that, over the longer term, demand for our products should increase as the proportion of customers’ capital expenditures rises in these technology inflection areas, and we continue to gain market share.In October 2015, as further described in Note 19 to our Consolidated Financial Statements, we announced that we had entered into an agreement to acquire KLA-Tencor Corporation.The following summarizes certain key annual financial information for the periods indicated below: Year Ended June 28,
2015 June 29,
2014 June 30,
2013 FY15 vs. FY14 FY14 vs. FY13 (in thousands, except per share data and percentages) $ 5,259,312 $ 4,607,309 $ 3,598,916 $ 652,003 14.2% $ 1,008,393 28.0% $ 2,284,336 $ 2,007,481 $ 1,403,059 $ 276,855 13.8% $ 604,422 43.1% 43.4% 43.6% 39.0% -0.2% 4.6% $ 1,496,297 $ 1,329,812 $ 1,284,988 $ 166,485 12.5% $ 44,824 3.5% $ 655,577 $ 632,289 $ 113,879 $ 23,288 3.7% $ 518,410 455.2% $ 3.70 $ 3.62 $ 0.66 $ 0.08 2.2% $ 2.96 448.5% Year Ended June 26,
2016 June 28,
2015 June 29,
2014 FY16 vs. FY15 FY15 vs. FY14 (in thousands, except per share data and percentages) Revenue $ 5,885,893 $ 5,259,312 $ 4,607,309 $ 626,581 11.9 % $ 652,003 14.2 % Gross margin $ 2,618,922 $ 2,284,336 $ 2,007,481 $ 334,586 14.6 % $ 276,855 13.8 % Gross margin as a percent of total revenue 44.5 % 43.4 % 43.6 % 1.1 % (0.2 )% Total operating expenses $ 1,544,666 $ 1,496,297 $ 1,329,812 $ 48,369 3.2 % $ 166,485 12.5 % Net income $ 914,049 $ 655,577 $ 632,289 $ 258,472 39.4 % $ 23,288 3.7 % Net income per diluted share $ 5.22 $ 3.70 $ 3.62 $ 1.52 41.1 % $ 0.08 2.2 % Fiscal year 2016 revenues increased 12% compared to fiscal year 2015, reflecting an increase in technology and capacity investments by our customers. Gross margin as a percentage of revenue improved 1.1%, which was primarily due to a more favorable customer and product mix.Fiscal year 2015 revenues increased 14% compared to fiscal year 2014, reflecting the steady increase in spending on technology inflections’ spending, as well as incremental market share gains.inflections. The small decrease in gross margin as a percentage of revenue for the fiscal year 2015 compared to fiscal year 2014 was due primarily to less favorable product mix partially offset by improved factory utilization due to higher production volumes.Operating expenses in fiscal year 2016 increased as compared to fiscal year 2015 primarily as a result of continued investments in research and development and increased employee headcount. Fiscal year 2016 also included KLA-Tencor acquisition related costs.Continues on next pageLam Research Corporation 2016 10-K 33Operating expenses in fiscal year 2015 increased as compared to fiscal year 2014 primarily related toas a result of continued investments in the next-generation research and development. In fiscal year 2015, we also recorded a goodwill impairment of approximately $79 million related to our single-wafer clean reporting unit.Our cash and cash equivalents, short-term investments, and restricted cash and investments balances totaled approximately $7.1 billion as of June 26, 2016 compared to $4.2 billion as of June 28, 2015 compared to $3.2 billion as of June 29, 2014.2015. This increase was primarily the result of $992 million netapproximately $2.4 billion proceeds from March 2015 Senior Notes issuance.June 2016 senior notes issuance, net of related issuance costs combined with cash flow provided from operating activities. Cash flowsflow provided from operating activities was $1.4 billion for fiscal year 2016 compared to $786 million for fiscal year 2015 compared to $717 million for fiscal year 2014.2015. Cash flowsflow provided from operating activities in fiscal 20152016 was primarily used for $573$451.5 million of principal payments on debt instruments, $158.4 million in treasury stock purchases, $116$190.4 million in dividends paid to our stockholders, and $198$175.3 million of capital expenditures, and are partially offset by $66$59.4 million of treasury stock reissuance and common stock issuance resulting from our employee equity-based compensation programs.Results of OperationsShipments and BacklogShipments for fiscal year 2016 were approximately $5.9 billion, an increase of 8% compared to fiscal year 2015. Shipments for fiscal year 2015 were approximately $5.5 billion, and increased byan increase of 20% compared to fiscal year 2014. Shipments for fiscal year 2014 were approximately $4.6 billion and increased by 23% compared to fiscal year 2013. The increase in shipments during the fiscal year 20152016 as compared to the last two fiscal year 2014, as well as theincrease in shipments during fiscal year 2014 as compared to fiscal year 2013years is related to continued strengthening of customer demand for semiconductor equipment. Year Ended June 28,
2015 June 29,
2014 June 30,
2013 $ 5,472 $ 4,551 $ 3,714 26% 24% 16% 22% 21% 29% 15% 15% 20% 14% 13% 11% 12% 15% 9% 6% 7% 8% 5% 5% 7% Year Ended June 26,
2016 June 28,
2015 June 29,
2014Shipments (in millions) $ 5,901 $ 5,472 $ 4,551 Taiwan 25 % 22 % 21 % Korea 17 % 26 % 24 % China 20 % 12 % 15 % Japan 16 % 14 % 13 % Southeast Asia 11 % 5 % 5 % United States 8 % 15 % 15 % Europe 3 % 6 % 7 % The percentage of total semiconductor processing system shipments to each of the markets we serve were as follows for fiscal years 2016, 2015, 2014, and 2013. Year Ended June 28,
2015 June 29,
2014 June 30,
2013 58 % 60 % 36 % 30 % 30 % 49 % 12 % 10 % 15 % Year Ended June 26,
2016 June 28,
2015 June 29,
2014Memory 68 % 58 % 60 % Foundry 23 % 30 % 30 % Logic/integrated device manufacturing 9 % 12 % 10 % Our shipments to memory customers remained strongincreased during fiscal year 2015 driven by mobile and enterprise demands. During fiscal year 2014, memory customer demand was higher2016 primarily due to node transitions in memory manufacturing, stable pricing for memory,higher demand from mobile, enterprise and tight industry supply.Unshipped orders in backlog as of June 28, 201526, 2016 were approximately $880$1,371 million, and increasedan increase from approximately $866$880 million as of June 29, 2014.28, 2015. Our unshipped orders backlog includes orders for systems, spares, and services. Please refer to “Backlog” in Part I Item 1, “Business” of this report for a description of our policies for adding to and adjusting backlog.Continues on next pageLam Research Corporation 2016 10-K 34Revenue Year Ended June 28,
2015 June 29,
2014 June 30,
2013 $ 5,259 $ 4,607 $ 3,599 27% 24% 17% 21% 23% 29% 17% 13% 20% 12% 14% 10% 12% 14% 9% 6% 7% 8% 5% 5% 7% Year Ended June 26,
2016 June 28,
2015 June 29,
2014Revenue (in millions) $ 5,886 $ 5,259 $ 4,607 Taiwan 25 % 21 % 23 % Korea 18 % 27 % 24 % China 18 % 12 % 14 % Japan 17 % 12 % 14 % Southeast Asia 10 % 5 % 5 % United States 8 % 17 % 13 % Europe 4 % 6 % 7 % The revenue increase in fiscal year 20152016 as compared to the last two fiscal year 2014 reflectedyears reflects an increase in technology and capacity investments by our customers. The revenue increase in fiscal year 2014 as compared to fiscal year 2013 reflected increased customer and industry demand. Our revenue levels are generally correlated to the amount of shipments and our installation and acceptance timelines.time lines. The overall Asia region continues to account for a majority of our revenues as a substantial amount of the worldwide capacity additions for semiconductor manufacturing continues to occur in this region. Our deferred revenue balance was $566 million as of June 26, 2016 compared to $518 million as of June 28, 2015 compared to $362 million as of June 29, 2014.2015. Our deferred revenue balance does not include shipments to Japanese customers, to whom title does not transfer until customer acceptance. Shipments to Japanese customers are classified as inventory at cost until the time of customer acceptance. The anticipated future revenue value from shipments to Japanese customers was approximately $132 million as of June 26, 2016 compared to $164 million as of June 28, 20152015.Gross Margin Year Ended June 26,
2016 June 28,
2015 June 29,
2014FY16 vs. FY15 FY15 vs. FY14 (in thousands, except percentages) Gross margin $ 2,618,922 $ 2,284,336 $ 2,007,481 $ 334,586 14.6 % $ 276,855 13.8 % Percent of total revenue 44.5 % 43.4 % 43.6 % 1.1 % (0.2 )% The increase in gross margin as a percentage of revenue for fiscal year 2016 compared to $34fiscal year 2015 was due to a more favorable customer mix and product mix. Additionally, there was a $10 million asimpairment charge of June 29, 2014.Gross Margin Year Ended June 28,
2015 June 29,
2014 June 30,
2013 FY15 vs. FY14 FY14 vs. FY13 (in thousands, except percentages) $ 2,284,336 $ 2,007,481 $ 1,403,059 $ 276,855 13.8% $ 604,422 43.1% 43.4% 43.6% 39.0% -0.2% 4.6% The decrease in gross margin as a percentage of revenue for fiscal year 2015 compared to fiscal year 2014 was due primarily to a less favorable product mix partially offset by improved factory utilization due to higher production volumes.The increase in gross margin as a percentageContinues on next pageLam Research Corporation 2016 10-K 35Research and Development Year Ended June 28,
2015 June 29,
2014 June 30,
2013 FY15 vs. FY14 FY14 vs. FY13 (in thousands, except percentages) $ 825,242 $ 716,471 $ 683,688 $ 108,771 15.2% $ 32,783 4.8% 15.7% 15.6% 19.0% 0.1% -3.4% Year Ended June 26,
2016 June 28,
2015 June 29,
2014FY16 vs. FY15 FY15 vs. FY14 (in thousands, except percentages) Research & development (“R&D”) $ 913,712 $ 825,242 $ 716,471 $ 88,470 10.7 % $ 108,771 15.2 % Percent of total revenue 15.5 % 15.7 % 15.6 % (0.2 )% 0.1 % We continued to make significant R&D investments focused on leading-edge deposition, plasma etch, single-wafer clean and other semiconductor manufacturing requirements. The increase in R&D expense during fiscal year 2016 compared to fiscal year 2015 was primarily due to a $36 million increase in employee compensation and benefits related to increased headcount, a $14 million increase in facility and information technology related spending, a $14 million increase in supplies, a $12 million increase in depreciation and lab maintenance, and an $8 million increase in costs associated with campus consolidation.The increase in R&D expense during fiscal year 2015 compared to fiscal year 2014 was primarily due to a $71 million increase in salaries and benefits related to increased headcount and higher incentive and equity compensation, a $12 million increase in supplies, a $5 million increase in depreciation and lab maintenance, and a $6 million increase in outside services.Selling, General and Administrative Year Ended June 26,
2016 June 28,
2015 June 29,
2014FY16 vs. FY15 FY15 vs. FY14 (in thousands, except percentages) Selling, general & administrative (“SG&A”) $ 630,954 $ 591,611 $ 613,341 $ 39,343 6.7 % $ (21,730 ) (3.5 )% Percent of total revenue 10.7 % 11.2 % 13.3 % (0.5 )% (2.1 )% The increase in R&DSG&A expense during fiscal year 20142016 compared to fiscal year 20132015 was primarily due to $51 million of KLA-Tencor acquisition related costs and a $41$3 million increase in salaries and benefits related to higher headcount and higher incentive and equity compensationrestructuring charges. This increase was offset by a reduction$15 million gain on sale of $7 million in supplies.Selling, General and Administrative Year Ended June 28,
2015 June 29,
2014 June 30,
2013 FY15 vs. FY14 FY14 vs. FY13 (in thousands, except percentages) $ 591,611 $ 613,341 $ 601,300 $ (21,730 ) -3.5% $ 12,041 2.0% 11.2% 13.3% 16.7% -2.1% -3.4% The decrease in SG&A expense during fiscal year 2015 compared to fiscal year 2014 was due primarily to ana decrease of $11 million decrease in integration costs, a $9 million decrease in costs associated with rationalization of product configurations, and an $8 million decrease related to impairment of long lived assets. This decrease iswas offset by an $8 million increase in compensation and benefits expense.The increase in SG&A expense during fiscal year 2014 compared to fiscal year 2013 was due primarily to a net increase of $11 million in salaries, benefits and incentive compensation, $20 million increase in marketing expenses and outside services, $7 million in costs associated with rationalization of certain product configurations, $8 million of impairment of long lived assets, and a $5 million cost related to the renewal of our Fremont and Livermore buildings’ operating leases. This increase was offset by a $34 million reduction in integration costs and a $10 million reduction in amortization of intangible assets related to the Novellus integration.Goodwill ImpairmentOur annual goodwill impairment analysis for fiscal year 2015 resulted in a non-cash impairment charge upon our single-wafer clean reporting unit of $79 million, extinguishing the goodwill ascribed to the reporting unit. Uncertainty surrounding future revenue growth in certain products resulted in the estimated discounted cash flow falling below the carrying value of the goodwill balance.Gain on Sale of Real EstateDuring fiscal year 2014, we sold our interest in nonessential property in Palo Alto, California, resulting in $135 million in net proceeds and a realized gain of $83 million from the transaction.Continues on next pageLam Research Corporation 2016 10-K 36Other Expense, NetOther expense, net, consisted of the following: Year Ended June 28,
2015 June 29,
2014 June 30,
2013 (in thousands) $ 19,268 $ 12,540 $ 14,737 (73,682 ) (61,692 ) (60,408 ) 9,071 9,559 9,764 2,331 1,529 (6,808 ) (4,177 ) 668 (8,698 ) $ (47,189 ) $ (37,396 ) $ (51,413 ) Year Ended June 26,
2016 June 28,
2015 June 29,
2014 (in thousands) Interest income $ 29,512 $ 19,268 $ 12,540 Interest expense (134,773 ) (73,682 ) (61,692 ) (Losses) gains on deferred compensation plan related assets, net (3,995 ) 9,071 9,559 Foreign exchange gains (losses), net 308 2,331 1,529 Other, net (5,191 ) (4,177 ) 668 $ (114,139 ) $ (47,189 ) $ (37,396 ) Interest income increased in fiscal year 2016 as compared to fiscal years 2015 and 2014, primarily as a result of higher cash and investment balances, as well as improvement to yield. The increase in interest expense during fiscal year 2016 as compared to fiscal year 2015 and 2014 was primarily due to the $1 billion Senior Note issuance in March 2015, combined with the note issuance cost amortization related to our KLA-Tencor acquisition bridge financing facility. The increase in interest expense during fiscal year 2015 as compared with fiscal years 2014 and 2013 was primarily due to the $1 billion Senior Note issuance in the March 2015 quarter.Foreign exchange gains in fiscal yearyears 2016, 2015 and 2014 and losses in fiscal years 2013 were related to un-hedged portions of the balance sheet exposures.The loss on deferred compensation plan related assets, net in fiscal year 2016, as compared to similar gains in fiscal years 2015 and 2014, was driven by decline in the fair market value of the underlying funds at year end.Other, net expense realized during fiscal year 2016 was primarily due to commitment fees related to our revolving loan and term loan commitments. Other, net expense realized during fiscal year 2015 was primarily due to a settlement of matters relating to certain investment transactions. Other, net income realized during fiscal year 2014 was primarily due to a gain on the disposition of a private equity investment. Other, net expenses during fiscal year 2013 included a $4 million other-than-temporary impairment of a public equity investment recognized during the March 2013 quarter.Income Tax Expense (benefit) Year Ended June 28,
2015 June 29,
2014 June 30,
2013 (in thousands, except
percentages) $ 85,273 $ 91,074 $ (47,221 ) 11.5% 12.6% -70.8% Year Ended June 26,
2016 June 28,
2015 June 29,
2014 (in thousands, except percentages) Income tax expense $ 46,068 $ 85,273 $ 91,074 Effective tax rate 4.8 % 11.5 % 12.6 % The decrease in the effective tax rate in fiscal year 2016 as compared to fiscal year 2015 was primarily due to the tax benefit of the Altera court ruling (discussed in more detail below), higher income in lower tax jurisdictions, and an increased federal tax benefit due to a retroactive and permanent extension of federal research and development tax credit in fiscal year 2016.The decrease in the effective tax rate in fiscal year 2015 as compared to fiscal year 2014 was primarily due to geographic mix of income between higher and lower tax jurisdictions, and an increased federal tax benefit in fiscal year 2015 due to a retroactive reinstatement of the second half of fiscal year 2014 federal research and development tax credit in fiscal year 2015.In July 2015, the United States Tax Court (the “Court”) issued an opinion favorable to Altera Corporation (“Altera”) with respect to Altera’s litigation with the Internal Revenue Service (“IRS”). The increaselitigation relates to theContinues on next pageLam Research Corporation 2016 10-K 37treatment of stock-based compensation expense in an inter-company cost-sharing arrangement with Altera’s foreign subsidiary. In its opinion, the effectiveCourt accepted Altera’s position of excluding stock-based compensation from its inter-company cost-sharing arrangement. However, the U.S. Department of the Treasury has not withdrawn the requirement to include stock-based compensation from its regulations. We have evaluated the opinion and have recorded a tax rate in fiscal year 2014 as comparedbenefit of $87.7 million related to fiscal year 2013 was primarily duereimbursement of cost share payments for the previously shared stock-based compensation costs. We have also recorded a tax benefit of $11.2 million related to stock-based compensation expense. In addition, we have recorded a tax liability of $73.6 million for the change inU.S. tax cost of potential repatriation of the level of income and geographic mix of income between higher and lower tax jurisdictions, U.S. income and applicable foreign withholding taxes on undistributedassociated contingent foreign earnings of certain ofbecause at this time we cannot reasonably conclude that we have the ability and the intent to indefinitely reinvest these contingent earnings. We will continue to monitor this matter and related potential impacts to our foreign subsidiaries for 2014, reduced tax benefit in fiscal year 2014 due to the expiration of the federal research and development tax credit as of December 31, 2013, and tax benefits in fiscal year 2013 related to the recognition of previously unrecognized tax benefits due to the lapse of the statute of limitations and successful resolution of certain tax matters.International revenues account for a significant portion of our total revenues, such that a material portion of our pre-tax income is earned and taxed outside the United States at rates that are generally lower than in the United States. Please refer to Note 76 of our Consolidated Financial Statements.Deferred Income TaxesDeferred income taxes reflect the net tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes, as well as the tax effect of carryforwards. Our gross deferred tax assets composed primarily of reserves and accruals that are not currently deductible and tax credit carryforwards, were $311$465 million and $343$311 million at the end of fiscal years 20152016 and 2014,2015, respectively. These gross deferred tax assets were offset by deferred tax liabilities of $318$429 million and $294$318 million at the end of fiscal years 20152016 and 2014,2015, respectively, and a valuation allowance of $86$102 million and $74$86 million at the end of fiscal years 20152016 and 2014,2015, respectively. The change in the gross deferred tax assets, and deferred tax liabilities, and valuation allowance between fiscal year 20152016 and 20142015 is primarily due to the reclassificationan increase related to tax credit carryforwards, recognition of a prepaid cost sharing deferred tax benefit related to the Altera case ruling and a decrease in deferred tax liabilities related to amortization of intangible assets as a resultoffset by an increase in deferred tax liabilities related to depreciation of the adoption of Accounting Standards Update 2013-11,tangible assets, convertible debt accretion and an accrual for future tax liabilities due to the expected repatriation of foreign earnings of certain foreign subsidiaries for 2015, and convertible debt accretion, offset by a decrease in deferred tax liabilities related to amortization of intangible assets.Our fiscal years 2015 and 2014 valuation allowance of $86 million and $74 million primarily relate to California and certain foreign deferred tax assets.As of our fiscal year end of June 28, 2015,26, 2016 we continue to record a valuation allowance to offset the entire California deferred tax asset balance due to the single sales factor apportionment election resulting in lower taxable income in California. We also recorded a valuation allowance on certain state tax credits and continue to record valuation allowances on certain foreign entities’ net operating losses.We evaluate if the deferred tax assets are realizable on a quarterly basis and will continue to assess the need for changes in valuation allowances, if any.Uncertain Tax PositionsWe re-evaluate uncertain tax positions on a quarterly basis. This evaluation is based on factors including, but not limited to, changes in facts or circumstances, changes in tax law, and effectively settled issues under audit. Such a change in recognition or measurement would result in the recognition of a tax benefit or an additional charge to the tax provision.Critical Accounting PoliciesContinues on next pageLam Research Corporation 2016 10-K 38CRITICAL ACCOUNTING POLICIES AND ESTIMATESA critical accounting policy is defined as one that has both a material impact on our financial condition and Estimatesbasedbase our estimates and assumptions on historical experience and on various other assumptions we believedbelieve to be applicable and evaluate them on an ongoing basis to ensure they remain reasonable under current conditions. Actual results could differ significantly from those estimates.The significant accounting policies used in the preparation of our financial statements are described in Note 2 of our Consolidated Financial Statements. Some of these significant accounting policies are considered to be critical accounting policies. A critical accounting policy is defined as one that has bothestimates, which could have a material impact on our financial condition andbusiness, results of operations, and requires us to make difficult, complex, and/financial condition. Our critical accounting estimates include:the recognition and valuation of revenue from multiple-element arrangements, which impacts revenue;the valuation of inventory, which impacts gross margin;the valuation of warranty reserves, which impacts gross margin;the valuation of equity based compensation expense, including forfeiture estimates, which impacts both gross margin and operating expenses;the recognition and measurement of current and deferred income taxes, including the measurement of uncertain tax positions, which impact our provision for income tax expenses; andthe valuation and recoverability of long-lived assets, which impacts gross margin and operating expenses when we record asset impairments or subjective judgments, often regarding estimates about matters that are inherently uncertain.We believe that the following critical accounting policies reflect the more significant judgments and estimates used in the preparation of our consolidated financial statements regarding the critical accounting estimates indicated above. See Note 2, "Summary of Significant Accounting Policies," of our Consolidated Financial Statements.Revenue Recognition: We recognize revenue when persuasive evidence of an arrangement exists, delivery has occurred and title has passed or services have been rendered, the selling price is fixed or determinable, collection of the receivable is reasonably assured, and we have received customer acceptance or are otherwise released from our customer acceptance obligations. If terms of the sale provide for a lapsing customer acceptance period, we recognize revenue upon the expiration of the lapsing acceptance period or customer acceptance, whichever occurs first. If the practices of a customer do not provide for a written acceptance or the terms of sale do not include a lapsing acceptance provision, we recognize revenue when it can be reliably demonstrated that the delivered system meets all of the agreed-to customer specifications. In situations with multiple deliverables, we recognize revenue upon the delivery of the separate elements to the customer and when we receive customer acceptance or are otherwise released from our customer acceptance obligations. We allocate revenue from multiple-element arrangements among the separate elements using their relative selling prices, based on our best estimate of selling price. Our sales arrangements do not include a general right of return. The maximum revenue recognized on a delivered element is limited to the amount that is not contingent upon the delivery of additional items. We generally recognize revenue related to sales of spare parts and system upgrade kits upon shipment. We generally recognize revenue related to services upon completion of the services requested by a customer order. We recognize revenue for extended maintenance service contracts with a fixed payment amount on a straight-line basis over the term of the contract. When goods or services have been delivered to the customer, but all conditions for revenue recognition have not been met, deferred revenue and deferred costs are recorded in deferred profit on our Consolidated Balance Sheet.Inventory Valuation: Inventories are stated at the lower of cost or market using standard costs that approximate actual costs on a first-in, first-out basis. Finished goods are reported as inventories until the point of title transfer to the customer. Unless specified in the terms of sale, title generally transfers at the physical transfer of the products to the freight carriers. Transfer of title for shipments to Japanese customers occurs at the time of customer acceptance.Management evaluates the need to record adjustments for impairment of inventory at least quarterly.Warranty: Typically, the saleContinues on next pageLam Research Corporation 2016 10-K 39Warranty: We record a provision for estimated warranty expenses to cost of sales for each system when we recognize revenue. We do not maintain general or unspecified reserves; all warranty reserves are related to specific systems. All actual or estimated parts and labor costs incurred in subsequent periods are charged to those established reserves on a system-by-system basis.While we periodically monitor the performance and cost of warranty activities, if actual costs incurred are different than our estimates, we may recognize adjustments to provisions in the period in which those differences arise or are identified. In additionWe do not maintain a general or unspecified reserves; all warranty reserves are related to the provision of standard warranties, we offer customer-paid extended warranty services. Revenues for extended maintenance and warranty services with a fixed payment amount are recognized on a straight-line basis over the term of the contract. Related costs are recorded as incurred.Equity-based Compensation —Compensation: Employee Stock Purchase Plan (“ESPP”) and Employee Stock Plans: We recognize the fair value of equity-based compensation expense. We determine the fair value of our restricted stock units (“RSUs”), excluding market-based performance RSUs, based upon the fair market value of our common stock at the date of grant, discounted for dividends. We estimate the fair value of our market-based performance RSUs using a Monte Carlo simulation model at the date of the grant. We estimate the fair value of our stock options and ESPP awards using a Black-Scholes option valuation model. This model requires the input of highly subjective assumptions, including expected stock price volatility and the estimated life of each award. We amortize the fair value of equity-based awards over the vesting periods of the award and we have elected to use the straight-line method of amortization.make quarterly assessmentsestimate expected equity award forfeitures based on historical forfeiture rate activity and expected future employee turnover. We recognize the effect of adjustments made to the adequacy of our tax credit pool related to equity-based compensation to determineforfeiture rate, if there are any deficienciesin the period that we are required to recognize in our Consolidated Statements of Operations. We will only recognize a benefit from equity-based compensation in paid-in-capital if we realize an incremental tax benefit after all other tax attributes currently available to us have been utilized. In addition, we have elected to account forchange the indirect benefits of equity-based compensation on the research tax credit through the income statement rather than through paid-in-capital. We have also elected to net deferred tax assets and the associated valuation allowance related to net operating loss and tax credit carryforwards for the accumulated stock award tax benefits for income tax footnote disclosure purposes. We will track these stock award attributes separately and will only recognize these attributes through paid-in-capital.Income Taxes:Taxes: Deferred income taxes reflect the net tax effect of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes, as well as the tax effect of carryforwards. We record a valuation allowance to reduce our deferred tax assets to the amount that is more-likely-than-not to be realized. Realization of our net deferred tax assets is dependent on future taxable income. We believe it is more-likely-than-not that such assets will be realized; however, ultimate realization could be negatively impacted by market conditions and other variables not known or anticipated at the time. In the event that we determine that we would not be able to realize all or part of our net deferred tax assets, an adjustment would be charged to earnings in the period such determination is made. Likewise, if we later determine that it is more-likely-than-not that the deferred tax assets would be realized, then the previously provided valuation allowance would be reversed.We recognize the benefit from a tax position only if it is more-likely-than-not that the position would be sustained upon audit based solely on the technical merits of the tax position. Our policy is to include interest and penalties related to unrecognized tax benefits as a component of income tax expense.Goodwill and Intangible Assets: The valuation of intangible assets acquired in a business combination requires the use of management estimates including but not limited to estimating future expected cash flows from assets acquired and determining discount rates. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. Estimates associated with the accounting for acquisitions may change as additional information becomes available.Goodwill represents the amount by which the purchase price in each business combination exceeds the fair value of the net tangible and identifiable intangible assets acquired. Each component of the Company for which discrete financial information is available and for which management regularly reviews the results of operations is considered a reporting unit. All goodwill acquired in a business combination is assigned to one or more reporting units as of the acquisition date. Goodwill is assigned to our reporting units that are expected to benefit from the synergies of the combination. The goodwill assigned to a reporting unit is the difference between the acquisition consideration assigned to the reporting unit on a relative fair value basis and the fair value of acquired assets and liabilities that can be specifically attributed to the reporting unit. We test goodwill and identifiable intangible assets with indefinite useful lives for impairment at least annually. We amortize intangible assets with estimable useful lives over their respective estimated useful lives, and we review for impairment whenever events or changes in circumstances indicate that the carrying amount of the intangible asset may not be recoverable and the carrying amount exceeds its fair value.Long-lived assets:We review goodwill at least annually for impairment. If certain events or indicators of impairment occur between annual impairment tests, we will perform an impairment test at that date. In testing for a potential impairment of goodwill, we: (1) allocate goodwill to the reporting units to which the acquired goodwill relates; (2) estimate the fair value of our reporting units; and (3) determine the carrying value (book value) of those reporting units. Prior to this allocation of the assets to the reporting units, we assess long-lived assets for impairment. Furthermore, if the estimated fair value of a reporting unit is less than the carrying value, we must estimate the fair value of all identifiable assets and liabilities of that reporting unit, in a manner similar to a purchase price allocation for an acquired business. This can require independent valuations of certain internally generated and unrecognized intangible assets such as in-process R&D and developed technology. Only after this process is completed can the amount of goodwill impairment, if any, be determined. In our goodwill impairment process we first assess qualitative factors to determine whether it is necessary to perform a quantitative analysis. We do not calculate the fair value of a reporting unit unless we determine, based on a qualitative assessment, that it is more-likely-than-notmore likely than not that the reporting unit’s fair value is less than its carrying amount. Our most recent annual goodwill impairment analysis, which was performed as of the first day of our fourth quarter of fiscal year 2015, March 30, 2015, resulted in the recognition of a $79.4 million goodwill impairment charge on our single-wafer clean systems reporting unit. We did not record any goodwill impairment in fiscal years 2014 or 2013.The process of evaluating the potential impairment of goodwill is subjective and requires significant judgment at many points during the analysis. We determine the fair value of our reporting units by using an income approach. Under the income approach, we determine fair value based on estimated future cash flows of each reporting unit, discounted by an estimated weighted-average cost of capital, which reflects the overall level of inherent risk of a reporting unit and the rate of return an outside investor would expect to earn.In estimating the fair value of a reporting unit, we make estimates and judgments about the future cash flows of our reporting units, including estimated growth rates and assumptions about the economic environment. Although our cash flow forecasts are based on assumptions that are consistent with the plans and estimates it iswe are using to manage the underlying businesses, there is significant judgment involved in determining the cashContinues on next pageLam Research Corporation 2016 10-K 40flows attributable to a reporting unit. In addition, we make certain judgments about allocating shared assets to the estimated balance sheets of our reporting units. Changes in judgment on these assumptions and estimates could result in a goodwill impairment charge.As a result, several factors could result in an impairment of a material amount of our goodwill balance in future periods, including, but not limited to: (1) weakening of the global economy, weakness in the semiconductor and to the extent we determine that the decline is sustained and indicates a reduction in the fair value of our reporting units below their carrying value. Further, the value assigned to intangible assets, other than goodwill, is based on estimates and judgments regarding expectations such as the success and life cycle of products and technology acquired. If actual product acceptance differs significantly from the estimates, we may be required to record an impairment charge to write down the asset to its realizable value.Recent Accounting PronouncementsIn July 2013,For other long-lived assets, we routinely consider whether indicators of impairment are present. If such indicators are present, we determine whether the FASB released Accounting Standards Update 2013-11 “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists.” The new standard requires that an unrecognized tax benefit should be presented as a reduction of a deferred tax asset for a net operating loss carryforward or other tax credit carryforward when settlement in this manner is available under the tax law. We adopted this standard during the fiscal year without significant impact on our financial position, results of operations, or cash flows.In April 2014, the FASB released Accounting Standards Update 2014-8 “Presentation of Financial Statements and Property, Plant and Equipment: Reporting Discontinued Operations and Disclosure of Disposals of Components of an Entity.” The new standard re-defines discontinued operations and requires only those disposals of components of an entity, including classifications as held for sale, that represent a strategic shift that has, or will have, a major effect on an entity’s operations and financial results to be reported as discontinued operations. In addition, the new standard expands the disclosure requirements of discontinued operations. We adopted this standard during the fiscal year without significant impact on our financial position, results of operations, or cash flows.In May 2014, the FASB released Accounting Standards Update 2014-9 “Revenue from Contracts with Customers” to supersede nearly all existing revenue recognition guidance under GAAP. The core principlesum of the standardestimated undiscounted cash flows attributable to the assets is toless than their carrying value. If the sum is less, we recognize revenues when promised goods or services are transferred to customers in an amount that reflectsimpairment loss based on the consideration that is expected to be received for those goods or services. The new standard defines a five step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing GAAP including identifying performance obligations in the contract, estimating the amountexcess of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. We are required to adopt this standard starting in the first quarter of fiscal year 2019 using either of two methods: (i) retrospective to each prior reporting period presented with the option to elect certain practical expedients as defined within the standard; or (ii) retrospective with the cumulative effect of initially applying the standard recognized at the date of initial application and providing certain additional disclosures as defined per the standard. We have not yet selected a transition method, and are in the process of determining the impact that the new standard will have on our Consolidated Financial Statements.In April 2015, the FASB released Accounting Standards Update 2015-3 “Interest — Imputation of Interest.” The amendment requires that debt issuance costs related to recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts.the assets over their respective fair values. Fair value is determined by discounted future cash flows, appraisals or other methods. We recognize an impairment charge to the extent the present value of anticipated net cash flows attributable to the asset are requiredless than the asset’s carrying value. The fair value of the asset then becomes the asset’s new carrying value, which we depreciate over the remaining estimated useful life of the asset. Assets to adopt this standard starting inbe disposed of are reported at the first quarterlower of fiscal year 2017, we do not anticipate thatthe carrying amount or fair value.Recent Accounting PronouncementsFor a description of recent accounting pronouncements, including the expected dates of adoption will have a material impactand estimated effects, if any, on our consolidated financial statements, see Note 3, “Recent Accounting Pronouncements,” of our Consolidated Financial Statements.Liquidity and Capital ResourcesTotal gross cash, cash equivalents, short-term investments, and restricted cash and investments balances were $7.1 billion at the end of fiscal year 2016 compared to $4.2 billion at the end of fiscal year 2015 compared to $3.2 billion at the end of fiscal year 2014.2015. This increase was primarily the result of $992 millionapproximately $2.4 billion net proceeds from the March 2015June 2016 debt issuances. Approximately $3.1 billion and $2.2 billion ofof bothJune 26, 2016 and June 28, 2015, and June 29, 2014,respectively, was held outside the United States in our foreign subsidiaries, the majority of which is held in U.S. dollars and, substantially all of which substantially all would be subject to tax at U.S. rates if it were to be repatriated. Refer to Note 76 of our Consolidated Financial Statements, included in Item 8 of this report, for information concerning the potential tax impact of repatriating earnings for certain non-U.S. subsidiaries that are permanently reinvested outside the United States.Cash FlowsFlow from Operating ActivitiesNet cash provided by operating activities of $785.5 million$1.4 billion during fiscal year 20152016 consisted of (in millions): $ 655.6 277.9 135.4 6.0 37.6 79.4 10.0 (420.9 ) 4.5 $ 785.5 Net income $ 914.0 Non-cash charges: Depreciation and amortization 291.0 Equity-based compensation expense 142.3 Deferred income taxes (49.0 ) Amortization of note discounts and issuance costs 70.5 Changes in operating asset and liability accounts (52.2 ) Gain on sale of assets (15.2 ) Other 48.9 $ 1,350.3 Continues on next pageLam Research Corporation 2016 10-K 41Significant changes in operating asset and liability accounts, net of foreign exchange impact, included the following uses of cash: increases in accounts receivable of $294.2$169.0 million, inventories of $207.5$66.4 million, and prepaid expenses and other assets of $52.5 million, combined with a decrease in accrued expenses and other liabilities of $29.5$46.7 million, partially offset by the following sources of cash: increases in accounts payable of $76.6$41.6 million, and deferred profit of $86.1$27.1 million, and accrued expenses and other liabilities of $161.1 million.Cash FlowsFlow from Investing ActivitiesNet cash used forprovided by investing activities during fiscal year 20152016 was $1,106.1$592.5 million, which was primarily due to net purchasessales and maturities of available-for-sale securities of $949.7$798.8 million, and proceeds on sale of assets of $79.7 million, off-set by net transfers to restricted cash and investments of $112.4 million and capital expenditures of $198.3 million, partially offset by cash proceeds on the sale of business of $41.2$175.3 million.Cash FlowsFlow from Financing ActivitiesNet cash provided by financing activities during fiscal year 20152016 was $378.5$1,595.7 million, which was primarily due to $992.2$2,338.1 million in proceeds from the issuance of long-term debt, partially offset by $573.2$451.5 million of principal payments related primarily to the maturity of $450.0 million of convertible notes in the June quarter, $158.4 million in treasury stock repurchases and $116.1$190.4 million of dividends paid to stockholders.LiquidityGiven the historical cyclical nature of the semiconductor equipment industry, we believe that maintaining sufficient liquidity reserves is important to support sustaining levels of investment in R&D and capital infrastructure. Based upon our current business outlook, we expect that our levels of cash, cash equivalents, and short-term investments at June 28, 201526, 2016 will be sufficient to support our presently anticipated levels of operations, investments, debt service requirements, and capital expenditures, through at least the next 12 months.In the longer term, liquidity will depend to a great extent on our future revenues and our ability to appropriately manage our costs based on demand for our products and services. While we have substantial cash balances inthe United States and offshore, we may require additional funding and need or choose to raise the required funds through borrowings or public or private sales of debt or equity securities. We believe that, if necessary, we will be able to access the capital markets on terms and in amounts adequate to meet our objectives. However, given the possibility of changes in market conditions or other occurrences, there can be no certainty that such funding will be available in needed quantities or on terms favorable to us.Continues on next pageLam Research Corporation 2016 10-K 42Off-Balance Sheet Arrangements and Contractual ObligationsWe have certain obligations to make future payments under various contracts, some of which are recorded on our balance sheet and some of which are not. Obligations that are recorded on our balance sheet in accordance with GAAP include our long-term debt which is outlined in the following table. Our off-balance sheet arrangements are presented as operating leases and purchase obligations in the table. Our contractual obligations and commitments as of June 28, 2015,26, 2016, relating to these agreements and our guarantees are included in the following table based on their contractual maturity date. The amounts in the table below exclude $203$231.5 million of liabilities related to uncertain tax benefits as we are unable to reasonably estimate the ultimate amount or time of settlement. See Note 76 of theour Consolidated Financial Statements for further discussion. Total Less than
1 year 1-3 years 3-5 years More than
5 years Sublease
Income (in thousands) $ 58,544 $ 17,593 $ 20,548 $ 10,071 $ 10,810 $ (478 ) 9,077 1,630 7,300 147 — — 193,855 189,954 1,961 1,940 — — 3,361,407 508,717 562,790 598,122 1,691,778 — $ 3,622,883 $ 717,894 $ 592,599 $ 610,280 $ 1,702,588 $ (478 ) Total Less than1 year 1-3 years 3-5 years More than5 years SubleaseIncome (in thousands) Operating Leases $ 62,417 $ 20,393 $ 19,902 $ 13,570 $ 8,758 $ (206 ) Capital Leases 7,425 7,208 160 57 — — Purchase Obligations 231,586 221,312 4,358 4,205 1,711 — Long-term Debt and Interest Expense (1)5,891,509 138,847 721,363 1,547,636 3,483,663 — Other long-term liabilities (2)134,562 1,050 589 8,373 124,550 — Total $ 6,327,499 $ 388,810 $ 746,372 $ 1,573,841 $ 3,618,682 $ (206 ) __________________________________(1) The conversion period for the Convertible Notes was open as of June 28, 2015 and as such the net carrying value of the Convertible Notes is included within current liabilities on our Consolidated Balance Sheet. The principal balances of the ConveribleConvertible Notes are reflected in the payment period in the table above based on the contractual maturity assuming no conversion. See Note 1413 of our ConsolidateConsolidated Financial Statements for additional information concerning the Convertible Notes and associated conversion features.
the amounts included in the preceding table were limited to the non-cancelable portion of the agreement terms or 2016. year. leases. $1.0 billion. Proceeds from the credit facility can be used for general corporate purposes. The facility matures on November 10, 2020.(2) Certain tax-related liabilities and post retirement benefits classified as other non-current liabilities on the consolidated balance sheet are included in the more than 5 years category due to the uncertainty in the timing and amount of future payments. Additionally the balance excludes contractual obligations recorded in our consolidated balance sheet as current liabilities. Operating LeasesWe lease most of our administrative, R&D and manufacturing facilities, regional sales/service offices and certain equipment under non-cancelable operating leases. Certain of our facility leases for buildings located in Fremont and Livermore, California, and certain other facility leases provide us with an option to extend the leases for additional periods or to purchase the facilities. Certain of our facility leases provide for periodic rent increases based on the general rate of inflation. In addition to amounts included in the table above, we have guaranteed residual values for certain of our Fremont and Livermore facility leases of up to $250$249.9 million. See Note 1615 to theour Consolidated Financial Statements for further discussion.Capital LeasesCapital leases reflect building and office equipment lease obligations. The amounts in the table above include the interest portion of payment obligations.Purchase ObligationsPurchase obligations consist of significant contractual obligations either on an annual basis or over multi-year periods related to our outsourcing activities or other material commitments, including vendor-consigned inventories. The contractual cash obligations and commitments table presented above contains our minimum obligations at June 28, 201526, 2016 under these arrangements and others. For obligations with cancellation provisions,Continues on next pageLam Research Corporation 2016 10-K 43the minimum cancellation fee. Actual expenditures will vary based on the volume of transactions and length of contractual service provided.Long-Term DebtIn May 2011, we issued and sold $450$450.0 million in aggregate principal amount of 0.50% Convertible Senior Notes due May 2016 (the “2016 Notes”) at par. At the same time, we issued and sold $450$450.0 million in aggregate principal amount of 1.25% Convertible Senior Notes due May 2018 (the “2018 Notes”) at par. We pay cash interest on the 2018 Notes at an annual rate of 0.5% and 1.25%, respectively, on the 2016 Notes and the 2018 Notes, on a semi-annual basis. The 2016 Notes matured in May 2016. Until their maturity in May 2016, we paid cash interest on the 2016 Notes at an annual rate of 0.5% on a semi-annual basis. Concurrently with the issuance of the 2016 Notes and 2018 Notes, we purchased convertible note hedges and sold warrants, which were structured to reduce the potential future economic dilution associated with the conversion of the 2016 Notes and the 2018 Notes.In connection with the maturity of the 2016 Notes, we paid approximately $451.6 million in settlement of the 2016 Notes. We did not issue any shares of our Common Stock in respect of the 2016 Notes on a net basis as a result of our exercise of the convertible note hedge we purchased concurrently with the issuance of the 2016 Notes. The maturity of the 2016 Notes did not affect the warrants sold concurrently with the issuance of the 2016 Notes and those warrants remain outstanding in accordance with their terms.The 2018 Notes may be converted into our Common Stock, under certain circumstances, based on a conversion rate of 16.080616.3354 shares of our Common Stock per $1,000 principal amount of Notes, which is equal to a conversion price of approximately $62.19$61.22 per share of our Common Stock. The conversion price will be subject to adjustment for certain corporate events, including dividends on our Common Stock. Concurrently with the issuance of the Notes, we purchased convertible note hedges and sold warrants, which were structured to reduce the potential future economic dilution associated with the conversion of the 2016 Notes and 2018 the Notes.In June 2012, with the acquisition of Novellus, we assumed $700$700.0 million in aggregate principal amount of 2.625% Convertible Senior Notes due May 2041 (the “2041 Notes,” and collectively with the 2016 Notes and the 2018 Notes, the “Convertible Notes”"2041 Notes"). We pay cash interest on the 2041 Notes at an annual rate of 2.625%, on a semi-annual basis. The 2041 Notes may be converted, under certain circumstances, into our Common Stock based on a conversion rate of 28.858529.3158 shares of Common Stock per $1,000 principal amount of notes, which represents a conversion price of approximately $34.65$34.11 per share of Common Stock. The conversion price will be subject to adjustment for certain events, including dividends on our Common Stock.During the quarter-ended June 28, 2015,26, 2016, the market value of our Common Stock was greater than or equal to 130% of the Convertible2018 Notes and 2041 Notes conversion prices for 20 or more trading days of the 30 consecutive trading days preceding the quarter end. As a result, the Convertible2018 Notes and the 2041 Notes are convertible at the option of the holder and are classified as current liabilities in our Consolidated Balance Sheets for fiscal year 2015.On March 12, 2015, we completed a public offering of $500$500.0 million aggregate principal amount of Senior Notes due March 15, 2020 (the “2020 Notes”) and $500$500.0 million aggregate principal amount of Senior Notes due March 15, 2025 (the “2025 Notes,” together with the 2020 Notes, the “Senior Notes”, and collectively with the Convertible Notes, the “Notes”). We will pay interest at an annual rate of 2.75% and 3.80%, respectively, on the 2020 Notes and 2025 Notes, on a semi-annual basis on March 15 and September 15 of each year, beginning September 15, 2015.We may redeem the Senior2020 Notes and 2025 Notes at a redemption price equal to 100% of the principal amount of such series (“par”), plus a “make whole” premium as described in the indenture in respect to the Senior2020 Notes and 2025 Notes and accrued and unpaid interest before February 15, 2020, for the 2020 Notes and before December 15, 2024, for the 2025 Notes. We may redeem the Senior2020 Notes and 2025 Notes at par, plus accrued and unpaid interest at any time on or after February 15, 2020 for the 2020 Notes and on or after December 24, 2024 for the 2025 Notes. In addition, upon the occurrence of certain events, as described in the indenture, we will be required to make an offer to repurchase the Senior2020 Notes and 2025 Notes at a price equal to 101% of the principal amount of the Senior Notes,respective note, plus accrued and unpaid interest.On June 7, 2016, we completed a public offering of $800.0 million aggregate principal amount of Senior Notes due June 15, 2021 (the "2021 Notes"), $600.0 million aggregate principal amount of Senior Notes due June 15, 2023 (the "2023 Notes") and $1 billion aggregate principal amount of Senior Notes due June 15, 2026 (the "2026 Notes" together with the 2020 Notes, 2021 Notes, 2023 Notes, and 2025 Notes, the “Senior Notes”, andContinues on next pageLam Research Corporation 2016 10-K 44collectively with the Convertible Notes, the “Notes”). We will pay interest at an annual rate of 2.80%, 3.45% and 3.90%, respectively, on the 2021 Notes, 2023 Notes and 2026 Notes, on a semi-annual basis on June 15 and December 15 of each year, beginning December 15, 2016.We may redeem the 2021 Notes, 2023 Notes, and 2026 Notes at a redemption price equal to 100% of the principal amount of such series (“par”), plus a “make whole” premium as described in the indenture in respect to the 2021 Notes, 2023 Notes, and 2026 Notes and accrued and unpaid interest before May 15, 2021, for the 2021 Notes, before April 15, 2023 for the 2023 Notes, and before March 15, 2026 for the 2026 Notes. We may redeem the 2021 Notes, 2023 Notes, and 2026 Notes at par, plus accrued and unpaid interest at any time on or after May 15, 2021 for the 2021 Notes, on or after April 15, 2023 for the 2023 Notes, and on or after March 15, 2026 for the 2026 Notes. In addition, upon the occurrence of certain events, as described in the indenture, we will be required to make an offer to repurchase the 2021 Notes, 2023 Notes and 2026 Notes at a price equal to 101% of the principal amount of the respective note, plus accrued and unpaid interest.In the event (i) the proposed merger with KLA-Tencor is not completed on or prior to December 30, 2016 or (ii) the Agreement and Plan of Merger and Reorganization, dated as of October 20, 2015, by and among us, KLA-Tencor, Topeka Merger Sub 1, Inc., and Topeka Merger Sub 3, Inc. (as assignee of Topeka Merger Sub 2, Inc.), is terminated on or at any time prior to such date (each such event referred to as a “Special Mandatory Redemption Event”), we will be required to redeem all of the 2023 Notes and the 2026 Notes then outstanding, at a special mandatory redemption price equal to 101% of the aggregate principal amount of such notes, plus accrued and unpaid interest from the date of initial issuance, or the most recent interest payment date on which interest was paid, whichever is later, to, but not including, the Special Mandatory Redemption Date (as defined below). The 2021 Notes are not subject to this special mandatory redemption. The “Special Mandatory Redemption Date” means the date specified in the notice of special mandatory redemption to be delivered to the holders of the notes no later than five business days following the Special Mandatory Redemption Event, which Special Mandatory Redemption Date shall be three business days after such notice is mailed.During fiscal year 2016, 2015, 2014, and 2013,2014, we made $451.5 million, $1.5 million, $1.7 million, and $2.2$1.7 million, respectively, in principal payments on long-term debt and capital leases, respectively.Term Loan AgreementOn May 13, 2016, we entered into an Amended and Restated Term Loan Agreement (the “Amended and Restated Term Loan Agreement”), which amends and restates the Term Loan Agreement we entered into on November 10, 2015 with a syndicate of lenders. The Amended and Restated Term Loan Agreement provides for a $1,530 million senior unsecured term loan facility composed of two tranches; (i) a $1,005 million tranche of 3-year senior unsecured loans (the "3-Year Tranche") maturing on the 3-year anniversary of the closing date of the acquisition of KLA-Tencor subject to several conditions; and (ii) a $525.0 million tranche of 5-year senior unsecured loans (the "5-Year Tranche") maturing on the 5-year anniversary of the closing date of the acquisition of KLA-Tencor subject to several conditions. The Amended and Restated Term Loan will terminate on October 20, 2016 if the merger has not been consummated by such date.Interest on amounts borrowed under the Amended and Restated Term Loan Agreement is, at our option, based on (i) a base rate, defined as the greatest of (a) prime rate, (b) Federal Funds rate plus 0.50%, or (c) one-month LIBOR plus 1.00%, plus a spread of 0.00% to 0.75% for the 3-Year Tranche or 0.125% to 1.000% for the 5-Year Tranche or (ii) LIBOR multiplied by the statutory reserve rate plus a spread of 1.000% to 1.750% for the 3-Year Tranche or 1.125% to 2.000% for the 5-Year Tranche, in each case as the applicable spread is determined based on the rating of the our non-credit enhanced, senior unsecured long-term debt.Principal and accrued and unpaid interest is due and payable in equal quarterly amounts as set forth in the Amended and Restated Term Loan Agreement, with any remaining balance due and accrued and unpaid interest due at maturity. Additionally, we will pay the lenders a quarterly commitment fee that varies based on our rating described above. The Amended and Restated Term Loan Agreement also contains financial covenants that require us to maintain (i) a consolidated debt to capitalization ratio of no more than 0.50 to 1.00 (the “Capitalization Covenant”), provided that, until and including the earlier of (x) the end of the first two consecutive full fiscal quarters following the Amended and Restated Term Loan Agreement's closing date that we are in compliance with the Capitalization Covenant and (y) December 31, 2017, if we are not in compliance with the Capitalization Covenant, we will be deemed not to have violated the Capitalization Covenant so long as ourContinues on next pageLam Research Corporation 2016 10-K 45consolidated debt to adjusted EBITDA ratio is less than or equal to 4.50 to 1.00 for the period of four fiscal quarters then ended, and (ii) liquidity of no less than $1.0 billion, in each case determined in accordance with the Amended and Restated Term Loan Agreement. The funding of the loans under the Amended and Restated Term Loan Agreement will be on the closing date of the acquisition of KLA-Tencor subject to several conditions.Revolving Credit ArrangementsOn November 10, 2015, we entered into an Amendment and Restatement Agreement (as amended on April 26, 2016, by Amendment No.1 to Amended and Restated Credit Agreement, and as further amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “Amended and Restated Credit Agreement”), which amends and restates our prior unsecured Credit Agreement, dated March 12, 2014 we entered into a $300 million(as amended by Amendment No. 1, dated March 5, 2015). The Amended and Restated Credit Agreement provides for an increase to our revolving unsecured credit facility, from $300.0 million to $750.0 million with a syndicate of lenders that matures on March 12, 2019. The facilitylenders. It includes an expansion option, for us to, subject to certain requirements, for us to request an increase in the facility of up to an additional $200$250.0 million, for a potential total commitment of $500 million.Interest on amounts borrowed under the credit facility is, at our option, based on (i) a base rate, defined as the greatest of (a) prime rate, (b) Federal Funds rate plus 0.5%, or (c) one-month LIBOR plus 1.0%, plus a spread of 0.0% to 0.5%, or (ii) LIBOR multiplied by the statutory reserve rate, plus a spread of 0.9% to 1.5%, in each case as the applicable spread is determined based on the rating of our non-credit enhanced, senior unsecured long-term debt. Principal and any accrued and unpaid interest is due and payable upon maturity. Additionally, we will pay the lenders a quarterly commitment fee that varies based on our rating described above.credit rating. The credit facilityAmended and Restated Credit Agreement contains certain restrictiveaffirmative covenants, including maintaining a consolidated debtnegative covenants, financial covenants and events of default that are substantially similar to total capitalization ratio of no more than 0.5 to 1.0those in the Amended and maintaining unrestricted or unencumbered cash and investments, of no less than $1.0 billion.Restated Term Loan Agreement. As of June 28, 2015,26, 2016, we had no borrowings outstanding under the credit facility and were in compliance with all financial covenants.Debt CommitmentOn October 20, 2015, we obtained a commitment for $4.2 billion of bridge financing from Goldman Sachs Bank USA and Goldman Sachs Lending Partners LLC (“the Commitment Parties”) to finance, in part, the acquisition of KLA-Tencor. The Commitment Parties' commitment to provide financing (the “Bridge Facility”) was subject to certain conditions, including consummation of the merger with KLA-Tencor. On November 10, 2015, we entered into the Term Loan Agreement for $0.9 billion and the Bridge Facility was reduced to $3.3 billion, correspondingly, both with a syndicate of lenders. Following the execution of our June 2016 debt offering and other available credit modifications (see Note 13 to our Consolidated Financial Statements), this commitment was terminated during the three months ended June 26, 2016.Other GuaranteesWe have issued certain indemnifications to our lessors for taxes and general liability under some of our agreements. We have entered into certain insurance contracts that may limit our exposure to such indemnifications. As of June 28, 2015,26, 2016, we had not recorded any liability on our Consolidated Financial Statements in connection with these indemnifications, as we do not believe, based on information available, that it is probable that we will pay any amounts under these guarantees.Generally, we indemnify, under pre-determined conditions and limitations, our customers for infringement of third-party intellectual property rights by our products or services. We seek to limit our liability for such indemnity to an amount not to exceed the sales price of the products or services subject to our indemnification obligations. We do not believe, based on information available, that it is probable that we will pay any material amounts under these guarantees.We provide guarantees and standby letters of credit to certain parties as required for certain transactions initiated during the ordinary course of business. As of June 28, 2015,26, 2016, the maximum potential amount of future payments that we could be required to make under these arrangements and letters of credit was $15.5$12.1 million. We do not believe, based on historical experience and information currently available, that it is probable that any amounts will be required to be paid.Continues on next pageLam Research Corporation 2016 10-K 46Item 7A. Quantitative and Qualitative Disclosures About Market Risk
the yield curve of plus or minus 50 basis points (“BPS”), 100 BPS, and 150 BPS. The hypothetical fair values as of June Time Deposit Municipal Notes and Bonds US Treasury & Agencies Government-Sponsored Enterprises Foreign Government Bonds Bank and Corporate Notes Mortgage Backed Securities - Residential Mortgage Backed Securities - Commercial Total Mutual Funds Cash Flow Hedge Sell Buy Buy Balance Sheet Hedge Sell Buy Sell Buy Buy Consolidated Balance Sheets — June 26, 2016 and June 28, 2015 Revenue Cost of goods sold Gross margin Research and development Selling, general and administrative Goodwill impairment Total operating expenses Operating income Gain on sale of real estate Other expense, net Income before income taxes Income tax (expense) benefit Net income Net income per share: Basic Diluted Number of shares used in per share calculations: Basic Diluted Net income Other comprehensive income (loss), net of tax: Foreign currency translation adjustment Cash flow hedges: Net unrealized gains during the period Net gains reclassified into earnings Available-for-sale investments: Net unrealized gains (losses) during the period Net losses reclassified into earnings Defined benefit plans, net change in unrealized component Other comprehensive income (loss), net of tax Comprehensive income Cash and cash equivalents Short-term investments Accounts receivable, less allowance for doubtful accounts of $4,890 as of June 28, 2015 and $4,962 as of June 29, 2014 Inventories Prepaid expenses and other current assets Total current assets Property and equipment, net Restricted cash and investments Goodwill Intangible assets, net Other assets Total assets Trade accounts payable Accrued expenses and other current liabilities Deferred profit Current portion of convertible notes and capital leases Total current liabilities Senior notes, convertible notes, and capital leases, less current portion Income taxes payable Other long-term liabilities Total liabilities Commitments and contingencies Temporary equity, convertible notes Stockholders’ equity: Preferred stock, at par value of $0.001 per share; authorized - 5,000 shares, none outstanding Commmon stock, at par value of $0.001 per share; authorized - 400,000 shares; issued and outstanding - 158,531 shares at June 28, 2015 and 162,350 shares at June 29, 2014 Additional paid-in capital Treasury stock, at cost, 99,562 shares at June 28, 2015 and 92,867 shares at June 24, 2014 Accumulated other comprehensive loss Retained earnings Total stockholders’ equity Total liabilities and stockholders’ equity CASH FLOWS FROM OPERATING ACTIVITIES: Net income Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization Deferred income taxes Impairment of long-lived assets Impairment of investment Equity-based compensation expense Income tax benefit (expense) on equity-based compensation plans Excess tax (benefit) expense on equity-based compensation plans Amortization of note discounts and issuance costs Gain on sale of business Gain on sale of real estate Goodwill impairment Other, net Changes in operating asset and liability accounts: Accounts receivable, net of allowance Inventories Prepaid expenses and other assets Trade accounts payable Deferred profit Accrued expenses and other liabilities Net cash provided by operating activities CASH FLOWS FROM INVESTING ACTIVITIES: Capital expenditures and intangible assets Business acquisitions, net of cash acquired Purchases of available-for-sale securities Sales and maturities of available-for-sale securities Purchase of other investments Issuance (repayment) of notes receivable Proceeds from sale of assets Proceeds from sale of business Transfer of restricted cash and investments Net cash used for investing activities CASH FLOWS FROM FINANCING ACTIVITIES: Principal payments on long-term debt and capital lease obligations Net proceeds from issuance of long-term debt Excess tax benefit (expense) on equity-based compensation plans Treasury stock purchases Dividends paid Reissuances of treasury stock related to employee stock purchase plan Proceeds from issuance of common stock Other Net cash provided by (used for) financing activities Effect of exchange rate changes on cash and cash equivalents Net increase (decrease) in cash and cash equivalents Cash and cash equivalents at beginning of year Cash and cash equivalents at end of year Schedule of noncash transactions Accrued payables for stock repurchases Supplemental disclosures: Cash payments for interest Cash payments for income taxes, net Balance at June 24, 2012 Sale of common stock Purchase of treasury stock Income tax benefits on equity-based compensation plans Reissuance of treasury stock Equity-based compensation expense Reclassification from temporary to permanent equity Net income Other comprehensive income Balance at June 30, 2013 Sale of common stock Purchase of treasury stock Income tax benefits on equity-based compensation plans Reissuance of treasury stock Equity-based compensation expense Reclassification from temporary to permanent equity Net income Other comprehensive income Cash dividends declared ($.18 per common share) Balance at June 29, 2014 Sale of common stock Purchase of treasury stock Income tax benefits on equity-based compensation plans Reissuance of treasury stock Equity-based compensation expense Reclassification to temporary from permanent equity, net Net income Other comprehensive income Cash dividends declared ($.84 per common share) Balance at June 28, 2015 well as the tax effect of carryforwards. The Company records a valuation allowance to reduce its deferred tax assets to the amount that is more-likely-than-not to be realized. Realization of our net deferred tax assets is dependent on future taxable income. The Company believes it is more-likely-than-not that such assets will be realized; however, ultimate realization could be negatively impacted by market conditions and other variables not known or anticipated at the time. In the event that the Company determines that it would not be able to realize all or part of our net deferred tax assets, an adjustment would be charged to earnings in the period such of each reporting unit, discounted by an estimated weighted-average cost of capital, which reflects the overall level of inherent risk of a reporting unit and the rate of return an outside investor would expect to earn. weeks. (ii) retrospective with the cumulative effect of initially applying the standard recognized at the date of initial application and providing certain additional disclosures as defined per the standard. The Company has not yet selected a transition method, and is in the process of determining the impact that the new standard will have on its consolidated financial statements. Equity-based compensation expense Income tax benefit recognized in the related to equity-based compensation Income tax benefit realized from the exercise and vesting of options and RSUs awards to eligible employees, consultants and advisors, and non-employee directors of the Company and its subsidiaries. The 2015 Stock Incentive Plan was approved by shareholders on November 4, 2015 and authorizes up to 18,000,000 shares available for issuance under the plan. Additionally, 1,232,068 Shares that remained available for grants under the Company’s 2007 Stock Incentive Plan were added to the shares available for issuance under the 2015 Stock Incentive Plan. Weighted-Average Price June 24, 2012 Granted Exercised Canceled Vested restricted stock June 30, 2013 Granted Exercised Canceled Vested restricted stock June 29, 2014 Granted Exercised Cancelled Vested restricted stock June 28, 2015 $9.44-$19.05 $21.04-$25.60 $26.87-$29.68 $31.45-$35.68 $42.41-$80.60 $9.44-$51.76 Expected volatility Risk-free interest rate Expected term (years) Dividend yield Intrinsic value - options outstanding Intrinsic value - options exercisable Intrinsic value - options exercised Expected volatility Risk-free interest rate Expected term (years) Dividend yield Expected term (years) Expected stock price volatility Risk-free interest rate Dividend Yield Interest income Interest expense Gains on deferred compensation plan related assets, net Foreign exchange gains (losses), net Other, net United States Foreign Federal: Current Deferred State: Current Deferred Foreign: Current Deferred Total Provision (Benefit) for Income Taxes Deferred tax assets: Tax carryforwards Allowances and reserves Equity-based compensation Inventory valuation differences Other Gross deferred tax assets Valuation allowance Net deferred tax assets Deferred tax liabilities: Intangible Assets Convertible debt Temporary differences for captial assets Amortization of goodwill Unremitted earnings of foreign subsidiaries Other Gross deferred tax liabilities Net deferred tax liabilities The tax benefits relating to approximately $46.4 million of state net operating loss carryforwards will be credited to additional paid-in-capital when recognized. 2017. Income tax expense computed at federal statutory rate State income taxes, net of federal tax benefit Foreign income taxed at different rates Tax credits State valuation allowance, net of federal tax benefit Equity-based compensation Other permanent differences and miscellaneous items 2014. increased by approximately Balance as of June 24, 2012 Settlements and effective settlements with tax authorities Lapse of statute of limitations Increases in balances related to tax positions taken during prior periods Decreases in balances related to tax positions taken during prior periods Increases in balances related to tax positions taken during current period Tax positions assumed in Novellus transaction Balance as of June 30, 2013 Lapse of statute of limitations Increases in balances related to tax positions taken during prior periods Decreases in balances related to tax positions taken during prior periods Increases in balances related to tax positions taken during current period Balance as of June 29, 2014 Settlements and effective settlements with tax authorities Lapse of statute of limitations Increases in balances related to tax positions taken during prior periods Decreases in balances related to tax positions taken during prior periods Increases in balances related to tax positions taken during current period Balance as of June 28, 2015 for dilutive stock options, restricted stock units (“RSUs”), and Convertible Notes. The following table reconciles the numerators and denominators of the basic and diluted computations for net income per share. Numerator: Net income Denominator: Basic average shares outstanding Effect of potential dilutive securities: Employee stock plans Convertible notes Warrants Diluted average shares outstanding Net income per share - basic Net income per share - diluted Number of options and RSUs excluded Restricted Investments Cash Level 1: Time Deposit Money Market Funds US Treasury and Agencies Mutual Funds Level 1 Total Level 2: Municipal Notes and Bonds US Treasuries and Agencies Government-Sponsored Enterprises Foreign Government Bonds Corporate Notes and Bonds Mortgage Backed Securities - Residential Mortgage Backed Securities - Commercial Level 2 Total Total Restricted Cash & Investments Cash Level 1: Time Deposit Money Market Funds US Treasury and Agencies Mutual Funds Level 1 Total Level 2: Municipal Notes and Bonds Government-Sponsored Enterprises Foreign Government Bonds Corporate Notes and Bonds Mortgage Backed Securities - Residential Mortgage Backed Securities - Commercial Level 2 Total Total 28, 2015: Municipal Notes and Bonds US Treasury & Agencies Retail Funds Government-Sponsored Enterprises Foreign Government Bonds Corporate Notes and Bonds Mortgage Backed Securities - Residential Mortgage Backed Securities - Commercial Due in one year or less Due after one year through five years Due in more than five years and euro-denominated and Korean won-denominated expenses. The Company’s policy is to mitigate Foreign Currency Forward Contracts Japanese yen Swiss franc Euro Korean won Taiwan dollar Balance Sheet Location Balance Location Derivatives designated as hedging instruments: Foreign exchange forward contracts Derivatives not designated as hedging instruments: Foreign exchange forward contracts Total derivatives Location of Foreign Exchange Contracts Foreign Exchange Contracts Foreign Exchange Contracts Interest Rate Contracts Foreign Exchange Contracts Raw materials Work-in-process Finished goods Manufacturing, engineering and office equipment Computer equipment and software Land Buildings Leasehold improvements Furniture and fixtures Less: accumulated depreciation and amortization The balance of Goodwill The Company recognized a $79.4 million impairment of goodwill on the Company's single-wafer clean reporting unit during the year ended June 28, 2015. No goodwill impairment was recognized in fiscal years 2016 or 2014. Customer relationships Existing technology Patents Other intangible assets Intangible assets subject to amortization Development rights Intangible assets not subject to amortization Total intangible assets 26, 2016: Customer relationships Existing technology Patents Other intangible assets Intangible assets subject to amortization In process research and development Development rights Intangible assets not subject to amortization Total intangible assets 28, 2015: No impairments were recognized in fiscal year 2016. 2016 2017 2018 2019 2020 Thereafter Accrued compensation Warranty reserves Income and other taxes payable Dividend payable Other As of June 26, 2016, these notes were convertible at the option of the bondholder, as a result of the condition described in (2) below. Upon closure of the conversion period, Notes not converted will be reclassified back into noncurrent liabilities and the temporary equity will be reclassified into permanent equity. The 2016 Notes were extinguished upon maturity on May 15, 2016. Just prior to the 2016 Note's scheduled maturity, the notes were convertible at the bondholders' option. During the three months ended June 28, 2016, 449.7 thousand of the 2016 Notes, with a total par value of $449.7 million were converted, in settlement of the conversion the bondholders received a cash payment equal to the par value of the 2016 Notes converted, as well as 1.6 million shares of Common Stock. To off-set the dilutive impact of the Common Stock consideration paid, the Company exercised the associated note hedge and received 1.6 million shares from counterparties. The remaining 2016 Notes were settled at par value, without conversion. 2041 Notes Carrying value, long-term Carrying value, current portion Unamortized discount Principal amount Carrying amount of permanent equity component, net of tax Carrying amount of temporary equity component, net of tax Remaining amortization period (years) Effective interest rate on liability component Fair Value of Notes (Level 2) Conversion rate (shares of common stock per $1,000 principal amount of notes) Conversion price (per share of common stock) If-converted value in excess of par value is as follows: The warrants settlement is contractually defined as net share settlement. convertible note hedge transactions will be settled in net Warrants: Number of shares to be delivered upon exercise Exercise price Expiration date range Convertible Note Hedge: Number of shares available from counterparties Exercise price 26, 2016: During the year ended June 26, 2016, the Company entered into a series of interest rate contracts hedging the fair value of a portion of the 2025 Notes par value, whereby the company receives a fixed rate and pays a variable rate based on a certain benchmark interest rate. Refer to Note 8 for additional information regarding these interest rate contracts. Carrying value, long-term Unamortized discount Principal amount Remaining amortization period (years) Fair Value of Notes (Level 2) Contractual interest coupon Amortization of interest discount Amortization of issuance costs Amortization of interest rate contract Total interest cost recognized The facility matures on November 10, 2020. Payments due by period: 2016* 2017 2018 2019 2020 Thereafter Total Current portion of long-term debt Long-term debt Payments due by period: 2016 2017 2018 2019 2020 Total Interest on capital leases Current portion of capital leases Long-term portion of capital leases 26, 2016. Payments due by period: 2016 2017 2018 2019 2020 thereafter Less: Sublease Income Total Payments due by period: 2016 2017 2018 2019 2020 Total Balance at beginning of period Warranties issued during the period Settlements made during the period Changes in liability for pre-existing warranties Balance at end of period Available balance as of June 29, 2014 Quarter ended September 28, 2014 Quarter ended December 28, 2014 Quarter ended March 29, 2015 Quarter ended June 28, 2015 Balance as of June 29, 2014 Other comprehensive income (loss) before reclassifications (Gains) losses reclassified from accumulated other comprehensive income (loss) to net income Net current-period other comprehensive income (loss) Balance as of June 28, 2015 Tax benefit (expense) on change in unrealized gains/losses on cash flow hedges: Tax benefit (expense) on unrealized gains/losses arising during the period Tax (benefit) expense on gains/losses reclassified to earnings Tax benefit (expense) on change in unrealized gains/losses on available-for-sale investments: Tax benefit (expense) on unrealized gains/losses arising during the period Tax (benefit) expense on gains/losses reclassified to earnings Tax benefit (expense) on change in unrealized components of defined benefit plans Tax benefit (expense) on other comprehensive income(loss) Revenue: Korea Taiwan United States China Japan Europe Southeast Asia Total revenue Long-lived assets: United States Europe Korea Taiwan China Japan Southeast Asia 16, 2016 16, 2016 Director” and "Voting Proposals — Proposal No. 2: — Election of Additional Directors — 2016 Nominees for Director." Consolidated Statements of Operations — Years Ended June 26, 2016, June 28, 2015, and June 29, 2014 Consolidated Statements of Comprehensive Income — Years Ended June Consolidated Balance Sheets — June 26, 2016 and June 28, 2015 Consolidated Statements of Stockholders’ Equity — Years Ended June 26, 2016, June 28, 2015, and June 29, 2014 Notes to Consolidated Financial Statements Reports of Independent Registered Public Accounting Firm 2. Index to Financial Statement Schedules Schedule II — Valuation and Qualifying Accounts Schedules, other than those listed above, have been omitted since they are not applicable/not required, or the information is included elsewhere herein. 3. See (b) of this Item 15, which is incorporated herein by reference. Date: /s/ YEAR ENDED JUNE 28, 2015 Deducted from asset accounts: Allowance for doubtful accounts YEAR ENDED JUNE 29, 2014 Deducted from asset accounts: Allowance for doubtful accounts YEAR ENDED JUNE 30, 2013 Deducted from asset accounts: Allowance for doubtful accounts Exhibit Description 2.1(25) 3.3(2) 4.23(30) 10.107(3) 10.108(3) 21 23.1 24 31.1 31.2 32.1 32.2 101 101 101 101 101 101InvestmentsWe maintain an investment portfolio of various holdings, types, and maturities. As of June 28, 2015,26, 2016, our mutual funds are classified as trading securities. Investments classified as trading securities are recorded at fair value based upon quoted market prices. Any material differences between the cost and fair value of trading securities is recognized as “Other income (expense)” in our Consolidated Statement of Operations. All of our other short-term investments are classified as available-for-sale and consequently are recorded in the Consolidated Balance Sheets at fair value with unrealized gains or losses reported as a separate component of accumulated other comprehensive income, net of tax.Interest Rate RiskFixed Income SecuritiesOur investments in various interest earning securities carry a degree of market risk for changes in interest rates. At any time, a sharp rise in interest rates could have a material adverse impact on the fair value of our fixed income investment portfolio. Conversely, declines in interest rates could have a material adverse impact on interest income for our investment portfolio. We target to maintain a conservative investment policy, which focuses on the safety and preservation of our capital by limiting default risk, market risk, reinvestment risk, and concentration risk. The following table presents the hypothetical fair values of fixed income securities that would result from selected potential decreases and increases in interest rates. Market changes reflect immediate hypothetical parallel shifts in28, 201526, 2016 were as follows: Valuation of Securities
Given an Interest Rate
Decrease of X Basis Points Fair Value
as of
June 28, 2015 Valuation of Securities
Given an Interest Rate
Increase of X Basis Points (150 BPS) (100 BPS) (50 BPS) 0.00% 50 BPS 100 BPS 150 BPS (in thousands) $ 177,567 $ 177,567 $ 177,567 $ 177,567 $ 177,567 $ 177,567 $ 177,567 664,269 663,950 662,706 659,644 656,254 652,863 649,473 360,447 359,598 356,415 352,223 347,915 343,611 339,307 54,961 54,678 54,032 53,365 52,696 52,025 51,355 51,364 51,170 50,719 50,206 49,694 49,181 48,668 1,355,199 1,347,658 1,337,307 1,326,475 1,315,444 1,304,414 1,293,385 32,523 32,372 32,200 32,011 31,815 31,619 31,423 143,246 142,688 142,066 141,426 140,788 140,148 139,509 $ 2,839,576 $ 2,829,681 $ 2,813,012 $ 2,792,917 $ 2,772,173 $ 2,751,428 $ 2,730,687 Valuation of SecuritiesGiven an Interest RateDecrease of X Basis Points Fair Valueas of Valuation of SecuritiesGiven an Interest RateIncrease of X Basis Points June 26, 2016 (150 BPS) (100 BPS) (50 BPS) —% 50 BPS 100 BPS 150 BPS (in thousands) Time Deposit $ 904,243 $ 904,243 $ 904,243 $ 904,243 $ 904,243 $ 904,243 $ 904,243 Municipal Notes and Bonds 266,956 266,857 266,532 265,725 264,913 264,101 263,290 US Treasury & Agencies 461,378 461,378 460,090 456,788 453,313 449,837 446,361 Government-Sponsored Enterprises 32,316 32,309 32,201 31,963 31,726 31,488 31,250 Foreign Government Bonds 42,093 42,037 41,789 41,512 41,233 40,956 40,678 Bank and Corporate Notes 1,000,189 996,383 989,991 983,341 976,693 970,045 963,397 Mortgage Backed Securities - Residential 17,715 17,626 17,458 17,280 17,100 16,922 16,743 Mortgage Backed Securities - Commercial 55,947 55,635 55,317 54,999 54,681 54,363 54,045 Total $ 2,780,837 $ 2,776,468 $ 2,767,621 $ 2,755,851 $ 2,743,902 $ 2,731,955 $ 2,720,007 We mitigate default risk by investing in high credit quality securities and by positioning our portfolio to respond appropriately to a significant reduction in a credit rating of any investment issuer or guarantor. The portfolio includes only marketable securities with active secondary or resale markets to achieve portfolio liquidity and maintain a prudent amount of diversification.Continues on next pageLam Research Corporation 2016 10-K 47Long-Term DebtAs of June 28, 2015,26, 2016, we had $3.6$4.55 billion in principal amount of fixed-rate long-term debt outstanding, with a fair value of $3.9$5.88 billion. The fair value of our Notes is subject to interest rate risk, market risk, and other factors due to the convertible feature, as applicable. Generally, the fair value of Notes will increase as interest rates fall and decrease as interest rates rise. Additionally, the fair value of the Convertible Notes will increase as our Common Stock price increases and decrease as our Common Stock price decreases. The interest and market value changes affect the fair value of our Notes but do not impact our financial position, cash flows, or results of operations due to the fixed nature of the debt obligations. We do not carry the Notes at fair value, but present the fair value of the principal amount of our Notes for disclosure purposes.Equity Price RiskPublicly Traded SecuritiesThe values of our investments in publicly traded securities, including mutual funds related to our obligations under our deferred compensation plans, are subject to market price risk. The following table presents the hypothetical fair values of our publicly traded securities that would result from potential decreases and increases in the price of each security in the portfolio. Potential fluctuations in the price of each security in the portfolio of plus or minus 10%, 15%, or 25% were selected based on potential near-term changes in those security prices. The hypothetical fair values as of June 28, 201526, 2016 were as follows: Valuation of Securities
Given an X% Decrease
in Stock Price Fair Value as of
June 28, 2015 Valuation of Securities
Given an X% Increase
in Stock Price (25%) (15%) (10%) 0.00% 10% 15% 25% (in thousands) $ 25,097 $ 28,444 $ 30,117 33,463 $ 36,809 $ 38,482 $ 41,829 Valuation of SecuritiesGiven an X% Decreasein Stock Price Fair Valueas of Valuation of SecuritiesGiven an X% Increasein Stock Price June 26, 2016 (25)% (15)% (10)% —% 10% 15% 25% Mutual Funds $ 30,241 $ 34,273 $ 36,289 40,321 $ 44,353 $ 46,369 $ 50,401 Foreign Currency Exchange (“FX”) RiskWe conduct business on a global basis in several major international currencies. As such, we are potentially exposed to adverse as well as beneficial movements in foreign currency exchange rates. The majority of our revenues and expenses are denominated in U.S. dollars. However, we are exposed to foreign currency exchange rate fluctuations primarily related to revenues denominated in Japanese yen and euro-denominated and Korean won-denominated expenses.We enter into foreign currency forward and option contracts to minimize the short-term impact of foreign currency exchange rate fluctuations on certain foreign currency denominated monetary assets and liabilities, primarily third party accounts receivables, accounts payables and intercompany receivables and payables. In addition, we hedge certain anticipated foreign currency cash flows, primarily on Japanese yen-denominated revenues and euro-denominated and Korean won-denominated expenses.To protect against the reduction in value of anticipated revenues denominated in Japanese yen and euro-denominated and Korean won-denominated expenses, we enter into foreign currency forward and option contracts that generally expire within 12 months, and no later than 24 months. These foreign currency forwardhedge contracts are designated as cash flow hedges and are carried on our balance sheet at fair value, with the effective portion of the contracts’ gains or losses included in accumulated other comprehensive income (loss) and subsequently recognized in earnings in the same period the hedged revenue and/or expense is recognized. We also enter into foreign currency forward contracts to hedge the gains and losses generated by the remeasurement of certain non-U.S.-dollar denominated monetary assets and liabilities, primarily third party accounts receivables, accounts payables and intercompany receivables and payables. The change in fair value of these balance sheet hedge contracts is recorded into earnings as a component of other income (expense), net and offsets the change in fair value of the foreign currency denominated monetary assets and liabilities also recorded in other income (expense), net, assuming the hedge contract fully covers the intercompany and trade receivable balances. The notional amount and unrealized gain of our outstanding forward and option contracts that are designated as cash flow hedges, as of June 28, 201526, 2016 are shown in the table below. This table alsoContinues on next pageLam Research Corporation 2016 10-K 48shows the change in fair value of these cash flow hedges assuming a hypothetical foreign currency exchange rate movement of plus-or-minus 10 percent and plus-or-minus 15 percent. Notional
Amount Unrealized FX
Gain / (Loss)
June 28, 2015 Valuation of Fx Contracts Given an X%
Increase (+)/Decrease(-) in Each + / - (10%) + / - (15%) (in $ Millions) Japanese Yen $ 18.9 $ 2.8 $ 1.6 $ 2.4 Korean Won $ 7.3 ($ 0.1 ) $ 0.7 $ 1.1 Euro $ 34.4 ($ 0.2 ) $ 3.4 $ 5.1 $ 2.5 $ 5.7 $ 8.6 NotionalAmount Unrealized FXGain / (Loss) Valuation of FX Contracts Given an X%Increase (+)/Decrease(-) in EachJune 26, 2016 =+ / - (10%) =+ / - (15%) (in $ Millions) Forward contracts Sell Japanese Yen $ 219.1 $ (11.8 ) $ 23.0 $ 34.5 Buy Korean Won 8.6 0.1 0.9 1.3 Buy Euro 36.3 0.8 3.7 5.5 $ (10.9 ) $ 27.6 $ 41.3 Option contracts Buy Put (1)Japanese Yen $ 39.1 $ (0.4 ) $ 0.5 $ 0.8 Sell put (2)Japanese Yen 39.1 — 0.1 0.3 $ (0.4 ) $ 0.6 $ 1.1 (1) Contracts were entered into and designated as cash flow hedges under ASC 815, during the fiscal year as part of our cash flow hedge program. The contracts were subsequently de-designated during the year ended June 26, 2016. Changes in fair market value subsequent to de-designation affect current earnings.(2) Contracts were entered into to off-set the buy put contracts, and while not designated as a cash flow hedge they are considered to be part of our cash flow hedge program. Changes in fair market value effect current earnings.The notional amount and unrealized loss of our outstanding foreign currency forward contracts that are designated as balance sheet hedges, as of June 28, 201526, 2016 are shown in the table below. This table also shows the change in fair value of these balance sheet hedges, assuming a hypothetical foreign currency exchange rate movement of plus-or-minus 10 percent and plus-or-minus 15 percent. These changes in fair values would be offset in other income (expense), net, by corresponding change in fair values of the foreign currency denominated monetary assets and liabilities, assuming the hedge contract fully covers the intercompany and trade receivable balances. Notional
Amount Unrealized FX
Gain / (Loss)
June 28, 2015 Valuation of Fx Contracts Given an X%
Increase (+)/Decrease(-) in Each + / - (10%) + / - (15%) (in $ Millions) Japanese Yen $ 49.9 $ — $ 5.0 $ 7.5 Korean Won $ 8.9 $ — $ 0.9 $ 1.3 Swiss Francs $ 3.3 $ — $ 0.3 $ 0.5 Taiwan Dollar $ 22.1 ($ 0.4 ) $ 2.1 $ 3.2 Euro $ 4.0 $ — $ 0.4 $ 0.6 ($ 0.4 ) $ 8.7 $ 13.1 Item 8.Financial Statements and Supplementary Data NotionalAmount Unrealized FXGain / (Loss) Valuation of FX Contracts Given an X%Increase (+)/Decrease(-) in Each June 26, 2016 =+ / - (10%) =+ / - (15%) (in $ Millions) Forward contracts, balance sheet hedge Sell Japanese Yen $ 56.9 $ 1.3 $ 5.8 $ 8.5 Sell Korean Won 5.0 (0.1 ) 0.5 0.7 Buy Swiss Francs 4.5 — 0.4 0.7 Buy Taiwan Dollar 23.3 (0.1 ) 2.3 3.5 Buy Chinese Renminbi 9.1 — 0.9 1.4 Buy Singapore Dollar 18.3 — 1.8 2.7 Buy Euro 16.0 (0.4 ) 1.6 2.4 $ 0.7 $ 13.3 $ 19.9 Continues on next pageLam Research Corporation 2016 10-K 49Interest Rate ContractsInterest rate risk is present with both fixed and floating-rate debt. Interest rate swap agreements designated as fair value hedges are used to mitigate our exposure to changes in the fair value of fixed-rate debt resulting from fluctuations in benchmark interest rates. Accordingly, benchmark interest rate fluctuations impact the fair value of our fixed-rate debt, which are offset by corresponding changes in the fair value of the swap agreements. Interest rate swaps may also be used to adjust interest rate exposures when appropriate, based on market conditions, and for qualifying hedges, the interest differential of swaps is included in interest expense. During the fiscal year ended June 26, 2016, we entered into a series of interest rate contracts with a total notional value of $400.0 million where we received fixed rates and paid variable rates based on certain benchmark interest rates. Such interest rate swap arrangements were designated as fair value hedges of the fair value of the underlying debt instrument.The following table shows the change in fair value of these fair value hedges, assuming a hypothetical benchmark interest rate movement of plus-or-minus 10 BPS and plus-or-minus 15 BPS.Fair Value as of June 26, 2016 Valuation of Fair Value Hedge Given an Interest Rate Increase of X Basis Points Valuation of Fair Value Hedge Given an Interest Rate Decrease of X Basis Points 10 BPS 15 BPS 10 BPS 15 BPS (in $ Millions) $ 8.6 $ 5.5 $ 3.9 $ 11.6 $ 13.2 Interest rate risk is also present on anticipated issuances of debt. We manage our interest rate exposure on anticipated issuances of debt through forward starting interest rate swap agreements. Forward-starting interest rate swap agreements designated as cash flow hedges are used to mitigate our exposure to changes in future interest payments that results from fluctuations in benchmark interest rates prior to the issuance of the debt. Accordingly, benchmark interest rate fluctuations impact the interest cash flows of the Company’s anticipated debt issuances, which are offset by corresponding changes in the fair value of the forward-starting interest rate swap agreements. During the fiscal year ended June 26, 2016, we entered into and settled a series of forward-starting interest rate swap agreements with a total notional value of $600.0 million, associated with our June 2016 debt offering. Such forward-starting interest rate swap agreements were designated as hedges of the cash flows associated with benchmark interest rates underlying future interest payments on the June 2016 debt issuances.Continues on next pageLam Research Corporation 2016 10-K 50Item 8. Financial Statements and Supplementary DataIndex to Consolidated Financial Statements Page 4950Consolidated Balance Sheets —26, 2016, June 28, 2015, and June 29, 201451Consolidated Statements of Cash Flows — Years Ended June 26, 2016, June 28, 2015, and June 29, 2014 and June 30, 201352545589Continues on next pageLam Research Corporation 2016 10-K 51LAM RESEARCH CORPORATIONCONSOLIDATED STATEMENTS OF OPERATIONS(in thousands, except per share data) Year Ended June 28,
2015 June 29,
2014 June 30,
2013 $ 5,259,312 $ 4,607,309 $ 3,598,916 2,974,976 2,599,828 2,195,857 2,284,336 2,007,481 1,403,059 825,242 716,471 683,688 591,611 613,341 601,300 79,444 — — 1,496,297 1,329,812 1,284,988 788,039 677,669 118,071 — 83,090 — (47,189 ) (37,396 ) (51,413 ) 740,850 723,363 66,658 (85,273 ) (91,074 ) 47,221 $ 655,577 $ 632,289 $ 113,879 $ 4.11 $ 3.84 $ 0.67 $ 3.70 $ 3.62 $ 0.66 159,629 164,741 168,932 177,067 174,503 173,430 Year Ended June 26,
2016 June 28,
2015 June 29,
2014Revenue $ 5,885,893 $ 5,259,312 $ 4,607,309 Cost of goods sold 3,266,971 2,974,976 2,599,828 Gross margin 2,618,922 2,284,336 2,007,481 Research and development 913,712 825,242 716,471 Selling, general and administrative 630,954 591,611 613,341 Goodwill impairment — 79,444 — Total operating expenses 1,544,666 1,496,297 1,329,812 Operating income 1,074,256 788,039 677,669 Gain on sale of real estate — — 83,090 Other expense, net (114,139 ) (47,189 ) (37,396 ) Income before income taxes 960,117 740,850 723,363 Income tax expense (46,068 ) (85,273 ) (91,074 ) Net income $ 914,049 $ 655,577 $ 632,289 Net income per share: Basic $ 5.75 $ 4.11 $ 3.84 Diluted $ 5.22 $ 3.70 $ 3.62 Number of shares used in per share calculations: Basic 158,919 159,629 164,741 Diluted 175,159 177,067 174,503 See Notes to Consolidated Financial StatementsContinues on next pageLam Research Corporation 2016 10-K 52LAM RESEARCH CORPORATIONCONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME(in thousands) Year Ended June 28,
2015 June 29,
2014 June 30,
2013 $ 655,577 $ 632,289 $ 113,879 (22,139 ) 4,192 5,303 1,595 8,004 10,607 (4,388 ) (10,892 ) (7,573 ) (2,793 ) (2,888 ) 3,034 (5,389 ) 1,407 (3,844 ) 71 165 4,137 (5,318 ) 1,572 293 1,109 (2,838 ) (3,505 ) (29,141 ) 38 5,125 $ 626,436 $ 632,327 $ 119,004 Year Ended June 26,
2016 June 28,
2015 June 29,
2014Net income $ 914,049 $ 655,577 $ 632,289 Other comprehensive income (loss), net of tax: Foreign currency translation adjustment (4,403 ) (22,139 ) 4,192 Cash flow hedges: Net unrealized (losses) gains during the period (17,725 ) 1,595 8,004 Net losses (gains) reclassified into earnings 4,961 (4,388 ) (10,892 ) (12,764 ) (2,793 ) (2,888 ) Available-for-sale investments: Net unrealized gains (losses) during the period 9,028 (5,389 ) 1,407 Net (gains) losses reclassified into earnings (371 ) 71 165 8,657 (5,318 ) 1,572 Defined benefit plans, net change in unrealized component (3,027 ) 1,109 (2,838 ) Other comprehensive (loss) income, net of tax (11,537 ) (29,141 ) 38 Comprehensive income $ 902,512 $ 626,436 $ 632,327 See Notes to Consolidated Financial StatementsContinues on next pageLam Research Corporation 2016 10-K 53LAM RESEARCH CORPORATIONCONSOLIDATED BALANCE SHEETS(in thousands, except per share data) June 28,
2015 June 29,
2014 ASSETS $ 1,501,539 $ 1,452,677 2,574,947 1,612,967 1,093,582 800,616 943,346 740,503 157,435 176,899 6,270,849 4,783,662 621,418 543,496 170,969 146,492 1,387,509 1,466,225 728,140 894,078 185,763 159,353 $ 9,364,648 $ 7,993,306 LIABILITIES AND STOCKHOLDERS’ EQUITY $ 300,203 $ 223,515 �� 649,438 604,296 322,070 235,923 1,359,650 518,267 2,631,361 1,582,001 1,001,382 817,202 202,930 258,357 184,023 122,662 4,019,696 2,780,222 241,808 183,349 — — 159 162 5,366,773 5,239,567 (4,302,847 ) (3,757,076 ) (57,796 ) (28,655 ) 4,096,855 3,575,737 5,103,144 5,029,735 $ 9,364,648 $ 7,993,306 June 26,
2016 June 28,
2015ASSETS Cash and cash equivalents $ 5,039,322 $ 1,501,539 Investments 1,788,612 2,574,947 Accounts receivable, less allowance for doubtful accounts of $5,155 as of June 26, 2016 and $4,890 as of June 28, 2015 1,262,145 1,093,582 Inventories 971,911 943,346 Prepaid expenses and other current assets 152,921 157,435 Total current assets 9,214,911 6,270,849 Property and equipment, net 639,608 621,418 Restricted cash and investments 250,421 170,969 Goodwill 1,386,276 1,387,509 Intangible assets, net 564,921 728,140 Other assets 215,391 185,763 Total assets $ 12,271,528 $ 9,364,648 LIABILITIES AND STOCKHOLDERS’ EQUITY Trade accounts payable $ 348,199 $ 300,203 Accrued expenses and other current liabilities 772,910 649,438 Deferred profit 349,199 322,070 Current portion of convertible notes and capital leases 949,494 1,359,650 Total current liabilities 2,419,802 2,631,361 Senior notes, convertible notes, and capital leases, less current portion 3,383,581 1,001,382 Income taxes payable 231,514 202,930 Other long-term liabilities 134,562 184,023 Total liabilities 6,169,459 4,019,696 Commitments and contingencies Temporary equity, convertible notes 207,552 241,808 Stockholders’ equity: Preferred stock, at par value of $0.001 per share; authorized - 5,000 shares, none outstanding — — Common stock, at par value of $0.001 per share; authorized - 400,000 shares; issued and outstanding 160,201 shares at June 26, 2016 and 158,531 shares at June 28, 2015 160 159 Additional paid-in capital 5,572,898 5,366,773 Treasury stock, at cost, 101,071 shares at June 26, 2016 and 99,562 shares at June 28, 2015 (4,429,317 ) (4,302,847 ) Accumulated other comprehensive loss (69,333 ) (57,796 ) Retained earnings 4,820,109 4,096,855 Total stockholders’ equity 5,894,517 5,103,144 Total liabilities and stockholders’ equity $ 12,271,528 $ 9,364,648 See Notes to Consolidated Financial StatementsContinues on next pageLam Research Corporation 2016 10-K 54CONSOLIDATED STATEMENTS OF CASH FLOWS(in thousands) Year Ended June 26,
2016 June 28,
2015 June 29,
2014CASH FLOWS FROM OPERATING ACTIVITIES: Net income $ 914,049 $ 655,577 $ 632,289 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 291,028 277,920 292,254 Deferred income taxes (49,003 ) 5,551 7,537 Impairment of long-lived assets — 9,821 11,632 Equity-based compensation expense 142,348 135,354 103,700 Income tax (expense) benefit on equity-based compensation plans (1,023 ) 11,316 5,973 Excess tax expense (benefit) on equity-based compensation plans 1,020 (11,398 ) (6,065 ) Amortization of note discounts and issuance costs 70,522 37,550 35,482 Gain on sale of business — (7,431 ) — Gain on sale of assets (15,223 ) — (83,090 ) Goodwill impairment — 79,444 — Other, net 48,788 12,656 12,669 Changes in operating asset and liability accounts: Accounts receivable, net of allowance (169,034 ) (294,155 ) (201,549 ) Inventories (66,371 ) (207,462 ) (190,058 ) Prepaid expenses and other assets (46,664 ) (52,496 ) (11,923 ) Trade accounts payable 41,645 76,617 18,704 Deferred profit 27,129 86,146 10,886 Accrued expenses and other liabilities 161,066 (29,507 ) 78,608 Net cash provided by operating activities 1,350,277 785,503 717,049 CASH FLOWS FROM INVESTING ACTIVITIES: Capital expenditures and intangible assets (175,330 ) (198,265 ) (145,503 ) Business acquisitions, net of cash acquired — (1,137 ) (30,227 ) Purchases of available-for-sale securities (874,998 ) (3,086,808 ) (1,312,244 ) Sales and maturities of available-for-sale securities 1,673,826 2,137,068 1,028,278 Purchase of other investments — (2,500 ) — Proceeds from sale of assets 79,730 — 156,397 Proceeds from sale of business — 41,212 — Transfer of restricted cash and investments (112,381 ) 356 28,085 Other, net 1,636 3,978 10,000 Net cash provided by (used for) investing activities 592,483 (1,106,096 ) (265,214 ) CASH FLOWS FROM FINANCING ACTIVITIES: Principal payments on long-term debt and capital lease obligations (451,497 ) (1,515 ) (1,658 ) Net proceeds from issuance of long-term debt 2,338,144 992,225 — Excess tax (expense) benefit on equity-based compensation plans (1,020 ) 11,398 6,065 Treasury stock purchases (158,389 ) (573,240 ) (244,859 ) Dividends paid (190,402 ) (116,059 ) — Reissuances of treasury stock related to employee stock purchase plan 55,992 48,803 42,926 Proceeds from issuance of common stock 3,405 17,520 34,791 Other, net (488 ) (660 ) — Net cash provided by (used for) financing activities $ 1,595,745 $ 378,472 $ (162,735 ) Continues on next page Year Ended June 28,
2015 June 29,
2014 June 30,
2013 $ 655,577 $ 632,289 $ 113,879 277,920 292,254 304,116 5,551 7,537 (70,155 ) 9,821 11,632 — — — 3,711 135,354 103,700 99,330 11,316 5,973 (483 ) (11,398 ) (6,065 ) 539 37,550 35,482 33,920 (7,431 ) — (83,090 ) — 79,444 — — 12,656 12,669 37,201 (294,155 ) (201,549 ) 162,634 (207,462 ) (190,058 ) 76,351 (52,496 ) (11,923 ) 518 76,617 18,704 (58,081 ) 86,146 10,886 60,205 (29,507 ) 78,608 (43,752 ) 785,503 717,049 719,933 (198,265 ) (145,503 ) (160,795 ) (1,137 ) (30,227 ) (9,916 ) (3,086,808 ) (1,312,244 ) (1,097,956 ) 2,137,068 1,028,278 1,039,551 (2,500 ) — — 3,978 10,000 (10,000 ) — 156,397 660 41,212 — — 356 28,085 (181 ) (1,106,096 ) (265,214 ) (238,637 ) (1,515 ) (1,658 ) (2,234 ) 992,225 — — 11,398 6,065 (539 ) (573,240 ) (244,859 ) (955,661 ) (116,059 ) — — 48,803 42,926 31,265 17,520 34,791 39,379 (660 ) — — 378,472 (162,735 ) (887,790 ) Year Ended June 28,
2015 June 29,
2014 June 30,
2013 $ (9,017 ) $ 1,104 $ 4,215 48,862 290,204 (402,279 ) 1,452,677 1,162,473 1,564,752 $ 1,501,539 $ 1,452,677 $ 1,162,473 $ 3,255 $ 3,392 $ — $ 26,393 $ 26,489 $ 26,635 $ 114,512 $ 18,157 $ 7,695 Lam Research Corporation 2016 10-K 55 Year Ended June 26,
2016 June 28,
2015 June 29,
2014Effect of exchange rate changes on cash and cash equivalents $ (722 ) $ (9,017 ) $ 1,104 Net increase in cash and cash equivalents 3,537,783 48,862 290,204 Cash and cash equivalents at beginning of year 1,501,539 1,452,677 1,162,473 Cash and cash equivalents at end of year $ 5,039,322 $ 1,501,539 $ 1,452,677 Schedule of noncash transactions Accrued payables for stock repurchases $ — $ 3,255 $ 3,392 Accrued payables for capital expenditures 27,953 22,436 8,085 Dividends payable 48,052 47,659 29,240 Transfers of finished goods inventory to property and equipment, net 37,822 4,547 — Supplemental disclosures: Cash payments for interest $ 58,810 $ 26,393 $ 26,489 Cash payments for income taxes, net 39,745 114,512 18,157 See Notes to Consolidated Financial StatementsContinues on next pageLam Research Corporation 2016 10-K 56CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY(in thousands) Common
Stock
Shares Common
Stock Additional
Paid-in
Capital Treasury
Stock Accumulated
Other
Comprehensive
Income(Loss) Retained
Earnings Total 186,656 $ 187 $ 4,943,539 $ (2,636,936 ) $ (33,818 ) $ 2,858,809 $ 5,131,781 3,301 3 39,377 — — — 39,380 (28,157 ) (28 ) — (934,780 ) — — (934,808 ) — — (483 ) — — — (483 ) 1,073 1 (622 ) 31,886 — — 31,265 — — 99,310 — — — 99,310 — — 3,423 — — — 3,423 — — — — — 113,879 113,879 — — — — 5,125 — 5,125 162,873 163 5,084,544 (3,539,830 ) (28,693 ) 2,972,688 4,488,872 3,140 3 34,788 — — — 34,791 (4,860 ) (5 ) — (253,180 ) — — (253,185 ) — — 5,973 — — — 5,973 1,197 1 6,991 35,934 — — 42,926 — — 103,700 — — — 103,700 — — 3,571 — — — 3,571 — — — — — 632,289 632,289 — — — — 38 — 38 — — — — — (29,240 ) (29,240 ) 162,350 162 5,239,567 (3,757,076 ) (28,655 ) 3,575,737 5,029,735 2,876 4 17,519 — — — 17,523 (7,638 ) (8 ) — (573,096 ) — — (573,104 ) — — 11,316 — — — 11,316 943 1 21,477 27,325 — — 48,803 — — 135,354 — — — 135,354 — — (58,460 ) — — — (58,460 ) — — — — — 655,577 655,577 — — — — (29,141 ) — (29,141 ) — — — — — (134,459 ) (134,459 ) 158,531 $ 159 $ 5,366,773 $ (4,302,847 ) $ (57,796 ) $ 4,096,855 $ 5,103,144 Common
Stock
Shares Common
Stock Additional
Paid-in
Capital Treasury
Stock Accumulated
Other
Comprehensive
Income(Loss) Retained
Earnings Total Balance at June 30, 2013 162,873 $ 163 $ 5,084,544 $ (3,539,830 ) $ (28,693 ) $ 2,972,688 $ 4,488,872 Sale of common stock 3,140 3 34,788 — — — 34,791 Purchase of treasury stock (4,860 ) (5 ) — (253,180 ) — — (253,185 ) Income tax benefits on equity-based compensation plans — — 5,973 — — — 5,973 Reissuance of treasury stock 1,197 1 6,991 35,934 — — 42,926 Equity-based compensation expense — — 103,700 — — — 103,700 Reclassification from temporary to permanent equity — — 3,571 — — — 3,571 Net income — — — — — 632,289 632,289 Other comprehensive income — — — — 38 — 38 Cash dividends declared ($.18 per common share) — — — — — (29,240 ) (29,240 ) Balance at June 29, 2014 162,350 162 5,239,567 (3,757,076 ) (28,655 ) 3,575,737 5,029,735 Sale of common stock 2,876 4 17,519 — — — 17,523 Purchase of treasury stock (7,638 ) (8 ) — (573,096 ) — — (573,104 ) Income tax benefits on equity-based compensation plans — — 11,316 — — — 11,316 Reissuance of treasury stock 943 1 21,477 27,325 — — 48,803 Equity-based compensation expense — — 135,354 — — — 135,354 Reclassification from temporary to permanent equity — — (58,460 ) — — — (58,460 ) Net income — — — — — 655,577 655,577 Other comprehensive income — — — — (29,141 ) — (29,141 ) Cash dividends declared ($.84 per common share) — — — — — (134,459 ) (134,459 ) Balance at June 28, 2015 158,531 159 5,366,773 (4,302,847 ) (57,796 ) 4,096,855 5,103,144 Sale of common stock 2,863 2 3,403 — — — 3,405 Purchase of treasury stock (2,130 ) (2 ) — (155,132 ) — — (155,134 ) Income tax benefits on equity-based compensation plans — — (1,023 ) — — — (1,023 ) Reissuance of treasury stock 937 1 27,329 28,662 — — 55,992 Equity-based compensation expense — — 142,348 — — — 142,348 Effect of conversion of convertible notes — — (188 ) — — — (188 ) Reclassification to temporary from permanent equity, net — — 34,256 — — — 34,256 Net income — — — — — 914,049 914,049 Other comprehensive income — — — — (11,537 ) — (11,537 ) Cash dividends declared ($1.20 per common share) — — — — — (190,795 ) (190,795 ) Balance at June 26, 2016 160,201 $ 160 $ 5,572,898 $ (4,429,317 ) $ (69,333 ) $ 4,820,109 $ 5,894,517 See Notes to Consolidated Financial StatementsContinues on next pageLam Research Corporation 2016 10-K 57NOTES TO CONSOLIDATED FINANCIAL STATEMENTSJune 26, 2016JUNE 28, 2015Note 1: Company and Industry InformationThe Company designs, manufactures, markets, refurbishes and services semiconductor processing equipment used in the fabrication of integrated circuits. Semiconductor wafers are subjected to a complex series of process and preparation steps that result in the simultaneous creation of many individual integrated circuits. The Company leverages its expertise in the areas of deposition, etch, and single-wafer clean to develop processing solutions that are designed to benefit its customers through lower defect rates, enhanced yields, faster processing time, and/or reduced cost.The Company sells its products and services primarily to companies involved in the production of semiconductors in the United States, Europe, Taiwan, Korea, Japan, China, and Southeast Asia.The semiconductor industry is cyclical in nature and has historically experienced periodic downturns and upturns. Today’s leading indicators of changes in customer investment patterns, such as electronics demand, memory pricing, and foundry utilization rates, may not be any more reliable than in prior years. Demand for the Company’s equipment can vary significantly from period to period as a result of various factors, including, but not limited to, economic conditions, supply, demand, and prices for semiconductors, customer capacity requirements, and the Company’s ability to develop and market competitive products. For these and other reasons, the Company’s results of operations for fiscal years 2016, 2015, 2014, and 20132014 may not necessarily be indicative of future operating results.Note 2: Summary of Significant Accounting PoliciesThe preparation of financial statements in conformity with U.S. Generally Accepted Accounting Principles (“GAAP”), requires management to make judgments, estimates, and assumptions that could affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates and assumptions on historical experience and on various other assumptions it believes to be applicable, and evaluates them on an on-going basis to ensure they remain reasonable under current conditions. Actual results could differ significantly from those estimates.Revenue Recognition: The Company recognizes revenue when persuasive evidence of an arrangement exists, delivery has occurred and title has passed or services have been rendered, the selling price is fixed or determinable, collection of the receivable is reasonably assured, and the Company has received customer acceptance or is otherwise released from its customer acceptance obligations. If terms of the sale provide for a lapsing customer acceptance period, the Company recognizes revenue upon the expiration of the lapsing acceptance period or customer acceptance, whichever occurs first. If the practices of a customer do not provide for a written acceptance or the terms of sale do not include a lapsing acceptance provision, the Company recognizes revenue when it can be reliably demonstrated that the delivered system meets all of the agreed-to customer specifications. In situations with multiple deliverables, the Company recognizes revenue upon the delivery of the separate elements to the customer and when the Company receives customer acceptance or is otherwise released from its customer acceptance obligations. The Company allocates revenue from multiple-element arrangements among the separate elements using their relative selling prices based on the Company’s best estimate of selling price. The Company’s sales arrangements do not include a general right of return. The maximum revenue recognized on a delivered element is limited to the amount that is not contingent upon the delivery of additional items. The Company generally recognizes revenue related to sales of spare parts and system upgrade kits upon shipment. The Company generally recognizes revenue related to services upon completion of the services requested by a customer order. The Company recognizes revenue for extended maintenance service contracts with a fixed payment amount on a straight-line basis over the term of the contract. When goods or services have been delivered to the customer but all conditions for revenue recognition have not been met deferred revenue and deferred costs are recognized in deferred profit on the Consolidated Balance Sheet.Inventory Valuation: Inventories are stated at the lower of cost or market using standard costs that approximate actual costs on a first-in, first-out basis. Finished goods are reported as inventories until the point of title transferContinues on next pageLam Research Corporation 2016 10-K 58to the customer. Unless specified in the terms of sale, title generally transfers at the physical transfer of the products to the freight carriers. Transfer of title for shipments to Japanese customers occurs at the time of customer acceptance.Management evaluates the need to record adjustments for impairment of inventory at least quarterly. The Company’s policy is to assess the valuation of all inventories including manufacturing raw materials, work-in-process, finished goods, and spare parts in each reporting period. Obsolete inventory or inventory in excess of management’s estimated usage requirement is written down to its estimated market value if less than cost. Estimates of market value include, but are not limited to, management’s forecasts related to the Company’s future manufacturing schedules, customer demand, technological and/or market obsolescence, general semiconductor market conditions, and possible alternative uses. If future customer demand or market conditions are less favorable than the Company’s projections, additional inventory write-downs may be required and would be reflected in cost of goods sold in the period in which the revision is made.Warranty: Typically, the sale of semiconductor capital equipment includes providing parts and service warranties to customers as part of the overall price of the system. The Company provides standard warranties for its systems. The Company records a provision for estimated warranty expenses to cost of sales for each system when it recognizes revenue. The Company does not maintain general or unspecified reserves; all warranty reserves are related to specific systems. All actual or estimated parts and labor costs incurred in subsequent periods are charged to those established reserves on a system-by-system basis.While the Company periodically monitors the performance and cost of warranty activities, if actual costs incurred are different than its estimates, the Company may recognize adjustments to provisions in the period in which those differences arise or are identified. In addition to the provision of standard warranties, the Company offers customer-paid extended warranty services. Revenues for extended maintenance and warranty services with a fixed payment amount are recognized on a straight-line basis over the term of the contract. Related costs are recorded as incurred.Equity-based Compensation — Employee Stock Purchase Plan (“ESPP”) and Employee Stock Plans: The Company recognizes the fair value of equity-based compensation expense. The Company determines the fair value of its restricted stock units (“RSUs”), excluding market-based performance RSUs, based upon the fair market value of Company’s common stock at the date of grant, discounted for dividends. The Company estimates the fair value of its market-based performance RSUs using a Monte Carlo simulation model at the date of the grant. The Company estimates the fair value of its stock options and ESPP awards using a Black-Scholes option valuation model. This model requires the input of highly subjective assumptions, including expected stock price volatility and the estimated life of each award. The Company amortizes the fair value of equity-based awards over the vesting periods of the award and the Company has elected to use the straight-line method of amortization.The Company makes quarterly assessments of the adequacy of its tax credit pool related to equity-based compensation to determine if there are any deficiencies that it is required to recognize in the Company’s Condensed Consolidated Statements of Operations. The Company will only recognize a benefit from equity-based compensation in paid-in-capital if it realizes an incremental tax benefit after all other tax attributes currently available to us have been utilized. In addition, the Company has elected to account for the indirect benefits of equity-based compensation on the research tax credit through the income statement rather than through paid-in-capital. The Company also elected to net deferred tax assets and the associated valuation allowance related to net operating loss and tax credit carryforwards for the accumulated stock award tax benefits for income tax footnote disclosure purposes. The Company tracks these stock award attributes separately and will only recognize these attributes through paid-in-capital.Income Taxes:Deferred income taxes reflect the net tax effect of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes, asContinues on next pageLam Research Corporation 2016 10-K 59determination is made. Likewise, if the Company later determine that it is more-likely-than-not that the deferred tax assets would be realized, then the previously provided valuation allowance would be reversed.The Company recognizes the benefit from a tax position only if it is more-likely-than-not that the position would be sustained upon audit based solely on the technical merits of the tax position. The Company’s policy is to include interest and penalties related to unrecognized tax benefits as a component of income tax expense.Goodwill and Intangible Assets: The valuation of intangible assets acquired in a business combination requires the use of management estimates including but not limited to estimating future expected cash flows from assets acquired and determining discount rates. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. Estimates associated with the accounting for acquisitions may change as additional information becomes available.Goodwill represents the amount by which the purchase price in each business combination exceeds the fair value of the net tangible and identifiable intangible assets acquired. Each component of the Company for which discrete financial information is available and for which management regularly reviews the results of operations is considered a reporting unit. All goodwill acquired in a business combination is assigned to one or more reporting units as of the acquisition date. Goodwill is assigned to the Company’s reporting units that are expected to benefit from the synergies of the combination. The goodwill assigned to a reporting unit is the difference between the acquisition consideration assigned to the reporting unit on a relative fair value basis and the fair value of acquired assets and liabilities that can be specifically attributed to the reporting unit. The Company tests goodwill and identifiable intangible assets with indefinite useful lives for impairment at least annually. The Company amortizes intangible assets with estimable useful lives over their respective estimated useful lives, and the Company reviews for impairment whenever events or changes in circumstances indicate that the carrying amount of the intangible asset may not be recoverable and the carrying amount exceeds its fair value.The Company reviews goodwill at least annually for impairment. If certain events or indicators of impairment occur between annual impairment tests, the Company would perform an impairment test at that date. In testing for a potential impairment of goodwill, the Company: (1) allocates goodwill to its reporting units to which the acquired goodwill relates; (2) estimates the fair value of its reporting units; and (3) determines the carrying value (book value) of those reporting units. Furthermore, if the estimated fair value of a reporting unit is less than the carrying value, the Company must estimate the fair value of all identifiable assets and liabilities of that reporting unit, in a manner similar to a purchase price allocation for an acquired business. This can require independent valuations of certain internally generated and unrecognized intangible assets such as in-process R&D and developed technology. Only after this process is completed can the amount of goodwill impairment, if any, be determined. In the Company’s goodwill impairment process it first assesses qualitative factors to determine whether it is necessary to perform a quantitative analysis. The Company does not calculate the fair value of a reporting unit unless the Company determines, based on a qualitative assessment, that it is more-likely-than-not that its fair value is less than its carrying amount. The Company performed the most recentperforms an annual goodwill impairment analysis as of the first day of its fourth quarterfiscal quarter. The Company did not record impairments of fiscalgoodwill during the years ended June 26, 2016 and June 29, 2014. For the year ended June 28, 2015 March 30, 2015, resulted inthe Company recorded an impairment charge on the Company’sits single-wafer clean reporting unit of approximately $79.4 million. The Company did not record any goodwill impairment in fiscal years 2014 or 2013.The process of evaluating the potential impairment of goodwill is subjective and requires significant judgment at many points during the analysis. The Company determines the fair value of its reporting units by using an income approach. Under the income approach, the Company determines fair value based on estimated future cash flowsIn estimating the fair value of a reporting unit, the Company makes estimates and judgments about the future cash flows of its reporting units, including estimated growth rates and assumptions about the economic environment. Although the Company’s cash flow forecasts are based on assumptions that are consistent with the plans and estimates it is using to manage the underlying businesses, there is significant judgment involved in determining the cash flows attributable to a reporting unit. In addition, the Company makes certain judgments about allocating shared assets to the estimated balance sheets of its reporting units. Changes in judgment on these assumptions and estimates could result in a goodwill impairment charge.Continues on next pageLam Research Corporation 2016 10-K 60As a result, several factors could result in impairment of a material amount of the Company’s goodwill balance in future periods, including, but not limited to: (1) weakening of the global economy, weakness in the semiconductor equipment industry, or failure of the Company to reach its internal forecasts, which could impact the Company’s ability to achieve its forecasted levels of cash flows and reduce the estimated discounted cash flow value of its reporting units; and (2) a decline in the Company’s stock price and resulting market capitalization, and to the extent the Company determines that the decline is sustained and indicates a reduction in the fair value of the Company’s reporting units below their carrying value. Further, the value assigned to intangible assets, other than goodwill, is based on estimates and judgments regarding expectations such as the success and life cycle of products and technology acquired. If actual product acceptance differs significantly from the estimates, the Company may be required to record an impairment charge to write down the asset to its realizable value.The Company reviews indefinite-lived intangible assets for an impairment annually, or when events or circumstances indicate the carrying value may not be recoverable. Factors that may be a change in circumstances, indicating the carrying value of amortizable intangible assets subject to amortization may not be recoverable, include a reduced future cash flow estimate, and slower growth rates in the industry segment in which the Company participates. The Company determines whether the sum of the estimated undiscounted cash flows attributable to the assets is less than their carrying value. If the sum is less, the Company recognizes an impairment loss based on the excess of the carrying amount of the assets over their respective fair values. Fair value is determined by discounted future cash flows, appraisals or other methods. The Company recognizes an impairment charge to the extent the present value of anticipated net cash flows attributable to the asset are less than the asset’s carrying value. The Company did not record an impairment charge on indefinite-lived assets during the years ended June 26, 2016 or June 28, 2015. The Company recognized a $4.0 million impairment charge related to indefinite-lived intangible assetassets during the year ended June 29, 2014. The Company did not record an impairment charge on indefinite-lived intangible assets during the years ended June 28, 2015 or June 30, 2013.Impairment of Long-Lived Assets (Excluding Goodwill and indefinite-lived Intangibles): The Company routinely considers whether indicators of impairment of long-lived assets are present. If such indicators are present, the Company determines whether the sum of the estimated undiscounted cash flows attributable to the assets is less than their carrying value. If the sum is less, the Company recognizes an impairment loss based on the excess of the carrying amount of the assets over their respective fair values. Fair value is determined by discounted future cash flows, appraisals or other methods. The Company recognizes an impairment charge to the extent the present value of anticipated net cash flows attributable to the asset are less than the asset’s carrying value. The fair value of the asset then becomes the asset’s new carrying value, which the Company depreciates over the remaining estimated useful life of the asset. Assets to be disposed of are reported at the lower of the carrying amount or fair value. The Company did not record an impairment loss in the year ended June 26, 2016. The Company recorded a $9.8 million and $7.6 million impairment loss on long-lived assets during the years ended June 28, 2015 and June 29, 2014, respectively. The Company did not record any impairment loss in the year ended June 30, 2013.Fiscal Year: The Company follows a 52/53-week fiscal reporting calendar, and its fiscal year ends on the last Sunday of June each year. The Company’s most recent fiscal years ended on June 26, 2016, June 28, 2015, and June 29, 2014 and June 30, 2013 andeach included 52 weeks, 52 weeks, and 53 weeks, respectively.Principles of Consolidation: The Consolidated Financial Statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.Cash Equivalents and Short-Term Investments:Investments purchased with an original maturity of three months or less are considered cash equivalents. The Company also invests in certain mutual funds, which include equity and fixed income securities, related to its obligations under its deferred compensation plan, and such investments are classified as trading securities on the consolidated balance sheets. All of the Company’s other short-term investments are classified as available-for-sale at the respective balance sheet dates. The Company accounts for its investment portfolio at fair value. Investments classified as trading securities are recorded at fair value based upon quoted market prices. Differences between the cost and fair value of trading securities are recognized as “Other income (expense)” in the Consolidated Statement of Operations. The investments classified as available-for-sale are recorded at fair value based upon quoted market prices, and difference between the cost and fair value of available-for-sale securities is presented as a component of accumulated other comprehensive income (loss). Unrealized losses on available-for-sale securities are charged against “Other income (expense)” when a decline in fair value is determined to be other-than-temporary. The Company considers several factors to determine whether a loss is other-than-temporary. These factors include but are not limited to: (i) the extent to which the fair value is less than cost basis, (ii) the financial condition and near term prospects of the issuer, (iii) the length ofContinues on next pageLam Research Corporation 2016 10-K 61time a security is in an unrealized loss position and (iv) the Company’s ability to hold the security for a period of time sufficient to allow for any anticipated recovery in fair value. The Company’s ongoing consideration of these factors could result in additional impairment charges in the future, which could adversely affect its results of operation. An other-than-temporary impairment is triggered when there is an intent to sell the security, it is more-likely-than-not that the security will be required to be sold before recovery, or the security is not expected to recover the entire amortized cost basis of the security. Other-than-temporary impairments attributed to credit losses are recognized in the income statement. The specific identification method is used to determine the realized gains and losses on investments.Allowance for Doubtful Accounts: The Company evaluates its allowance for doubtful accounts based on a combination of factors. In circumstances where specific invoices are deemed to be uncollectible, the Company provides a specific allowance for bad debt against the amount due to reduce the net recognized receivable to the amount it reasonably believes will be collected. The Company also provides allowances based on its write-off history.Property and Equipment: Property and equipment is stated at cost. Equipment is depreciated by the straight-line method over the estimated useful lives of the assets, generally three to five years. Furniture and fixtures are depreciated by the straight-line method over the estimated useful lives of the assets, generally five years. Software is amortized by the straight-line method over the estimated useful lives of the assets, generally three to five years. Buildings are depreciated by the straight-line method over the estimated useful lives of the assets, generally twenty-five years. Leasehold improvements are generally amortized by the straight-line method over the shorter of the life of the related asset or the term of the underlying lease. Amortization of capital leases is included with depreciation expense.Derivative Financial Instruments: In the normal course of business, the Company’s financial position is routinely subjected to market risk associated with foreign currency exchange rate fluctuations. The Company’s policy is to mitigate the effect of these exchange rate fluctuations on certain foreign currency denominated business exposures. The Company has a policy that allows the use of derivative financial instruments to hedge foreign currency exchange rate fluctuations on forecasted revenue and expenses and net monetary assets or liabilities denominated in various foreign currencies. The Company carries derivative financial instruments (derivatives) on the balance sheet at their fair values. The Company does not use derivatives for trading or speculative purposes. The Company does not believe that it is exposed to more than a nominal amount of credit risk in its interest rate and foreign currency hedges, as counterparties are large, global and well-capitalized financial institutions. The Company’s exposures are in liquid currencies (Japanese yen, Swiss francs, euros, Taiwanese dollars, Chinese renminbi, Singapore dollar, and Korean won), so there is minimal risk that appropriate derivatives to maintain the Company’s hedging program would not be available in the future.To hedge foreign currency risks, the Company uses foreign currency exchange forward and option contracts, where possible and prudent. These forwardhedge contracts are valued using standard valuation formulas with assumptions about future foreign currency exchange rates derived from existing exchange rates, interest rates, and other market factors.The Company considers its most current forecast in determining the level of foreign currency denominated revenue and expenses to hedge as cash flow hedges. The Company combines these forecasts with historical trends to establish the portion of its expected volume to be hedged. The revenue and expenses are hedged and designated as cash flow hedges to protect the Company from exposures to fluctuations in foreign currency exchange rates. If the underlying forecasted transaction does not occur, or it becomes probable that it will not occur, the related hedge gains and losses on the cash flow hedge are reclassified from accumulated other comprehensive income (loss) to other income (expense), net on the consolidated statement of operations at that time.Guarantees: The Company has certain operating leases that contain provisions whereby the properties subject to the operating leases may be remarketed at lease expiration. The Company has guaranteed to the lessor an amount approximating the lessor’s investment in the property. Also, the Company’s guarantees generally include certain indemnifications to its lessors under operating lease agreements for environmental matters, potential overdraft protection obligations to financial institutions related to one of the Company’s subsidiaries, indemnifications to the Company’s customers for certain infringement of third-party intellectual property rights by its products and services, and the Company’s warranty obligations under sales of its products.Continues on next pageLam Research Corporation 2016 10-K 62Foreign Currency Translation: The Company’s non-U.S. subsidiaries that operate in a local currency environment, where that local currency is the functional currency, primarily generate and expend cash in their local currency. Accordingly, all balance sheet accounts of these local functional currency subsidiaries are translated into U.S. dollars at the fiscal period-end exchange rate, and income and expense accounts are translated into U.S. dollars using average rates in effect for the period, except for costs related to those balance sheet items that are translated using historical exchange rates. The resulting translation adjustments are recorded as cumulative translation adjustments and are a component of accumulated other comprehensive income (loss). Translation adjustments are recorded in other income (expense), net, where the U.S. dollar is the functional currency.Note 3: Recent Accounting PronouncementsIn July 2013, the FASB released Accounting Standards Update 2013-11 “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists.” The new standard requires that an unrecognized tax benefit should be presented as a reduction of a deferred tax asset for a net operating loss carryforward or other tax credit carryforward when settlement in this manner is available under the tax law. The Company adopted this standard during the fiscal year without significant impact on its financial position, results of operations, or cash flows.In April 2014, the FASB released Accounting Standards Update 2014-8 “Presentation of Financial Statements and Property, Plant and Equipment: Reporting Discontinued Operations and Disclosure of Disposals of Components of an Entity.” The new standard re-defines discontinued operations and requires only those disposals of components of an entity, including classifications as held for sale, that represent a strategic shift that has, or will have, a major effect on an entity’s operations and financial results to be reported as discontinued operations. In addition, the new standard expands the disclosure requirements of discontinued operations. The Company adopted this standard during the fiscal year without significant impact on its financial position, results of operations, or cash flows.In May 2014, the FASB released Accounting Standards Update (“ASU”) 2014-9, “Revenue from Contracts with Customers” to supersede nearly all existing revenue recognition guidance under GAAP. The core principle of the standard is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. The new standard defines a five step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing GAAP, including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The Company is required to adopt this standard starting in the first quarter of fiscal year 2019 using either of two methods: (i) retrospective to each prior reporting period presented with the option to elect certain practical expedients as defined within the standard; orIn April 2016, FASB released ASU 2016-10, "Revenue from Contracts with Customers." The amendment clarifies guidance in ASU 2014-09, “Revenue from Contracts with Customers” to improve guidance on criteria in assessing whether promises to transfer goods and services are separately identifiable and improve the understanding of the licensing implementation guidance. In May 2016, FASB released ASU 2016-12, "Revenue from Contracts with Customers." which also clarifies guidance in ASU 2014-09 on assessing collectability, non cash consideration, presentation of sales tax and completed contracts and contract modification in transition. The Company is required to adopt these standards starting in the first quarter of fiscal year 2019. Early adoption is permitted. The Company is currently in the process of evaluating the impact of adoption on its Consolidated Financial Statements.In April 2015, the FASB released Accounting Standards UpdateASU 2015-3, “Interest —– Imputation of Interest.” The amendment requires that debt issuance costs related to recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The Company is required to adopt this standard starting in the first quarter of fiscal year 2017 and does not anticipate the adoptionthat implementation will have a material impact on its Consolidated Financial Statements.Note 4: ReclassificationsCertain amounts in fiscal years 2014 and 2013In September 2015, the FASB released ASU 2015-16, “Business Combinations - Simplifying the Accounting for Measurement-Period Adjustments”, which eliminates the requirement to restate prior period financial statements for measurement period adjustments. Instead, the cumulative impact of measurement period adjustments, including the impact on prior periods, is required to be recognized in the reporting period in which the adjustment is identified. The standard update will be effective for the Company beginning in its first quarter of fiscal year 2017.In November 2015, the FASB issued ASU 2015-17, “Balance Sheet Classification of Deferred Taxes.” This ASU amends existing guidance to require that deferred income tax assets and liabilities be classified as non-current in a classified balance sheet, and eliminates the prior guidance which required an entity to separate deferred tax assets and liabilities into a current amount and a non-current amount in a classified balance sheet. The amendments in this ASU are effective for the Company beginning in its first quarter of fiscal year 2018. Earlier application is permitted as of the beginning of an interim or annual period. Additionally, the new guidance may be applied either prospectively to all deferred tax assets and liabilities or retrospectively to all periods presented. The Company is evaluating the timing of adoption, but plans to adopt the guidance prospectively with anContinues on next pageLam Research Corporation 2016 10-K 63anticipated reclassification from current assets and liabilities to non-current assets and liabilities on its Consolidated Balance Sheet.In January 2016, FASB released ASU 2016-1, “Financial Instruments - Overall - Recognition and Measurement of Financial Assets and Financial Liabilities.” The amendment changes the accounting for and financial statement presentation of equity investments, other than those accounted for under the equity method of accounting or those that result in consolidation of the investee. The amendment provides clarity on the measurement methodology to be used for the required disclosure of fair value of financial instruments measured at amortized cost on the balance sheet and clarifies that an entity should evaluate the need for a valuation allowance on deferred tax assets related to available-for-sale securities in combination with the entity's other deferred tax assets, among other changes. The Company is required to adopt this standard starting in the first quarter of fiscal year 2019 and does not anticipate that implementation will have been reclassifieda material impact on its Consolidated Financial Statements.In January 2016, FASB released ASU 2016-2, "Leases." The amendment requires an entity to conformrecognize right-of-use assets and lease liabilities on its balance sheet and disclose key information about leasing arrangements. The amendment offers specific accounting guidance for a lessee, a lessor and sale and leaseback transactions. Lessees and lessors are required to disclose qualitative and quantitative information about leasing arrangements to enable a user of the financial statements to assess the amount, timing and uncertainty of cash flows arising from leases. The Company is required to adopt this standard starting in the first quarter of fiscal year 2020. Early adoption is permitted. The Company is currently in the process of evaluating the impact of adoption on its Consolidated Financial Statements.In March 2016, FASB released ASU 2016-9, "Compensation - Stock Compensation." Key changes in the amendment include:entities will be required to recognize all excess tax benefits or deficiencies as an income tax benefit or expense in the income statement, eliminating APIC pools;entities will no longer be required to delay recognition of excess tax benefits until they are realized;entities will be required to classify the excess tax benefits as an operating activity in the statement of cash flows;entities will be allowed to elect an accounting policy to either estimate the number of forfeitures, or account for forfeitures as they occur; andentities can withhold up to the maximum individual statutory tax rate without classifying the awards as a liability, the cash paid to satisfy the statutory income tax withholding obligations shall be classified as a financing activity in the statement of cash flows.The Company is required to adopt this standard starting in the first quarter of fiscal year 2015 presentation.2018. Early adoption is permitted. The Company is currently in the process of evaluating the impact of adoption on its Consolidated Financial Statements.In June 2016, FASB released ASU 2016-13, "Financial Instruments - Credit Losses." The amendment revises the impairment model to utilize an expected loss methodology in place of the currently used incurred loss methodology, which will result in more timely recognition of losses on financial instruments, including, but not limited to, available for sale debt securities and accounts receivable. The Company is required to adopt this standard starting in the first quarter of fiscal year 2021. Early adoption is permitted. The Company is currently in the process of evaluating the impact of adoption on its Consolidated Financial Statements.Note 5:4: Equity-Based Compensation PlansThe Company has stock plans that provide for grants of equity-based awards to eligible participants, including stock options and restricted stock units, (“RSUs”), of Lam Research common stock (“Common Stock”). An option is a right to purchase Common Stock at a set price. An RSU award is an agreement to issue a set number of shares of Common Stock at the time of vesting. The Company’s options and RSU awards typically vest over a period of three years or less, although awards assumed in connection with the acquisition of Novellus Systems, Inc. (“Novellus”), have vesting terms up to four years.less. The Company also has an employee stock purchase plan that allows employees to purchase its Common Stock at a discount through payroll deductions.Continues on next pageLam Research Corporation 2016 10-K 64The Company recognized the following equity-based compensation expense and benefits in the Condensed Consolidated Statements of Operations: Year Ended June 28,
2015 June 29,
2014 June 30,
2013 (in thousands) $ 135,354 $ 103,700 $ 99,310 $ 23,660 $ 16,937 $ 17,647 $ 40,401 $ 31,993 $ 21,625 Year Ended June 26,
2016 June 28,
2015 June 29,
2014 (in thousands) Equity-based compensation expense $ 142,348 $ 135,354 $ 103,700 Income tax benefit recognized related to equity-based compensation $ 37,814 $ 23,660 $ 16,937 Income tax benefit realized from the exercise and vesting of options and RSUs $ 67,756 $ 40,401 $ 31,993 The estimated fair value of the Company’s equity-based awards, less expected forfeitures, is amortized over the awards’ vesting term on a straight-line basis.Stock Options and RSUsThe Lam Research Corporation 2007 Stock Incentive Plan, as amended and restated, and 2011 Stock Incentive Plan, as amended and restated, and the 2015 Stock Incentive Plan (collectively the “Stock Plans”), provide for the grant of non-qualified equity-basedA summary of stock plan transactions is as follows: Options Outstanding Restricted Stock Units Outstanding Number of
Shares
Exercise Number of
Shares Weighted-Average
Fair Market Value
at Grant 3,902,077 $ 25.14 4,331,478 $ 41.01 288,867 $ 42.59 2,563,670 $ 38.76 (1,546,028 ) $ 25.47 N/A N/A (73,993 ) $ 26.24 (299,079 ) $ 39.70 N/A N/A (1,754,273 ) $ 42.52 2,570,923 $ 26.87 4,841,796 $ 39.32 166,455 $ 51.76 2,811,602 $ 53.21 (1,403,019 ) $ 24.75 N/A N/A (2,473 ) $ 30.21 (281,476 ) $ 41.16 N/A N/A (1,736,453 ) $ 40.39 1,331,886 $ 32.20 5,635,469 $ 45.83 76,659 $ 80.60 1,804,937 $ 79.74 (564,558 ) $ 31.05 N/A N/A (8,155 ) $ 29.32 (174,879 ) $ 50.16 N/A N/A (2,311,439 ) $ 41.17 835,832 $ 37.44 4,954,088 $ 60.13 Options Outstanding Restricted Stock Units Outstanding Number of
Shares Weighted-Average
Exercise
Price Number of
Shares Weighted-Average
Fair Market Value
at GrantJune 30, 2013 2,570,923 $ 26.87 4,841,796 $ 39.32 Granted 166,455 $ 51.76 2,811,602 $ 53.21 Exercised (1,403,019 ) $ 24.75 N/A N/A Canceled (2,473 ) $ 30.21 (281,476 ) $ 41.16 Vested restricted stock N/A N/A (1,736,453 ) $ 40.39 June 29, 2014 1,331,886 $ 32.20 5,635,469 $ 45.83 Granted 76,659 $ 80.60 1,804,937 $ 79.74 Exercised (564,558 ) $ 31.05 N/A N/A Canceled (8,155 ) $ 29.32 (174,879 ) $ 50.16 Vested restricted stock N/A N/A (2,311,439 ) $ 41.17 June 28, 2015 835,832 $ 37.44 4,954,088 $ 60.13 Granted 196,167 $ 75.57 2,230,851 $ 71.87 Exercised (123,726 ) $ 24.92 N/A N/A Canceled (862 ) $ 21.43 (110,131 ) $ 69.17 Vested restricted stock N/A N/A (2,739,704 ) $ 54.04 June 26, 2016 907,411 $ 47.41 4,335,104 $ 69.30 Continues on next pageLam Research Corporation 2016 10-K 65Outstanding and exercisable options presented by price range at June 28, 201526, 2016 were as follows: Options Outstanding Options Exercisable Range of Exercise Prices Number of
Options
Outstanding Weighted-Average
Remaining Life
(Years) Weighted-Average
Exercise Price Number of
Options
Exercisable Weighted-Average
Exercise Price 130,682 0.52 $ 12.94 130,682 $ 12.94 89,907 0.30 $ 22.13 86,845 $ 22.08 193,978 0.86 $ 29.26 190,025 $ 29.32 30,042 0.21 $ 32.94 30,042 $ 32.94 391,223 2.53 $ 53.54 185,101 $ 43.58 835,832 4.42 $ 37.44 622,695 $ 29.29 Range of Exercise Prices Options Outstanding Options Exercisable Number of
Options
Outstanding Weighted-Average
Remaining Life
(Years) Weighted-Average
Exercise Price Number of
Options
Exercisable Weighted-Average
Exercise Price$9.44-$19.05 112,372 0.30 $ 13.18 112,372 $ 13.18 $21.28-$23.59 40,623 0.17 $ 21.88 40,623 $ 21.88 $26.87-$29.68 147,427 0.50 $ 29.24 147,427 $ 29.24 $32.04-$35.68 27,795 0.15 $ 33.02 27,795 $ 33.02 $42.61-$80.60 579,194 3.31 $ 61.16 294,929 $ 49.38 $9.44-$80.60 907,411 4.43 $ 47.41 623,146 $ 35.56 As of June 28, 2015,26, 2016, there were a total of 5,789,9205,242,515 shares subject to options and RSUs issued and outstanding under the Company’s Stock Plans. As of June 28, 2015,26, 2016, there were a total of 6,572,35014,758,224 shares available for future issuance under the Stock Plans.Stock OptionsThe fair value of the Company’s stock options granted during fiscal years 2016, 2015, 2014, and 2013,2014, was estimated using a Black-Scholes option valuation model. This model requires the input of highly subjective assumptions, including expected stock price volatility and the estimated life of each award: Year Ended June 28,
2015 June 29,
2014 June 30,
2013 34.45% 35.28% 36.60% 1.46% 1.39% 0.81% 4.80 4.78 4.79 0.89% — — Year Ended June 26,
2016 June 28,
2015 June 29,
2014Expected volatility 33.08 % 34.45 % 35.28 % Risk-free interest rate 1.27 % 1.46 % 1.39 % Expected term (years) 4.79 4.80 4.78 Dividend yield 1.59 % 0.89 % — The year-end intrinsic value relating to stock options for fiscal years 2016, 2015, 2014, and 20132014 is presented below: Year Ended June 28,
2015 June 29,
2014 June 30,
2013 (in thousands) $ 37,961 $ 46,283 $ 44,919 $ 33,360 $ 31,653 $ 36,870 $ 26,806 $ 41,379 $ 25,430 Year Ended June 26,
2016 June 28,
2015 June 29,
2014 (in thousands) Intrinsic value - options outstanding $ 31,643 $ 37,961 $ 46,283 Intrinsic value - options exercisable $ 29,112 $ 33,360 $ 31,653 Intrinsic value - options exercised $ 6,562 $ 26,806 $ 41,379 As of June 28, 2015,26, 2016, there was $2.9$4.8 million of total unrecognized compensation expense related to unvested stock options granted and outstanding; that expense is expected to be recognized over a weighted-average remaining vesting period of 2.12.4 years.Restricted Stock UnitsThe fair value of the Company’s RSUs was calculated based upon the fair market value of the Company’s stock at the date of grant, discounted for dividends. As of June 28, 2015,26, 2016, there was $197.6$221.3 million of totalContinues on next pageLam Research Corporation 2016 10-K 66unrecognized compensation expense related to all unvested RSUs granted; that expense is expected to be recognized over a weighted-average remaining vesting period of 2.12.2 years.During the fiscal years 2016, 2015 and 2014, the Company issued certain RSUs with both a market condition and a service condition (market-based performance RSUs, or “market-based PRSUs”). Based upon the terms of such awards, the number of shares that can be earned over the performance periods is based on the Company’s Common Stock price performance compared to the market price performance of the Philadelphia Semiconductor Sector Index (“SOX”), ranging from 0% to 150% of target. The stock price performance or market price performance is measured using the closing price for the 50-trading days prior to the dates the performance period begins and ends. The target number of shares represented by the market-based PRSUs is increased by 2% of target for each 1% that Common Stock price performance exceeds the market price performance of the SOX index. The result of the vesting formula is rounded down to the nearest whole number. Total stockholder return is a measure of stock price appreciation in this performance period. As of June 28, 2015, 0.926, 2016, 1.1 million market-based PRSUs were outstanding. These market-based PRSUs generally vest two or three years from the grant date and require continued employment. Stock compensation expense for the market-based PRSUs was $19.6 million, $13.5 million and $3.8 million for the years ended June 26, 2016, June 28, 2015 and June 29, 2014, respectively. No market-based PRSUs were awarded in earlier periods.The fair value of the Company’s market-based PRSUs granted during fiscal years 2016, 2015 and 2014, was calculated using a Monte Carlo simulation model at the date of the grant. This model requires the input of highly subjective assumptions, including expected stock price volatility and the estimated life of each award: Year Ended June 28,
2015 June 29,
2014 27.93% 29.27% 1.05% 0.55% 2.98 2.67 0.89% — Year Ended June 26,
2016 June 28,
2015 June 29,
2014Expected volatility 29.81 % 27.93 % 29.27 % Risk-free interest rate 0.97 % 1.05 % 0.55 % Expected term (years) 2.92 2.98 2.67 Dividend yield 1.59 % 0.89 % — ESPPThe 1999 Employee Stock Purchase Plan (the “1999 ESPP”) allows employees to designate a portion of their base compensation to be deducted and used to purchase the Company’s Common Stock at a purchase price per share of the lower of 85% of the fair market value of the Company’s Common Stock on the first or last day of the applicable purchase period. Typically, each offering period lasts 12twelve months and comprises three interim purchase dates. The Plan Administrator (the Compensation Committee of the Board) is authorized to set a limit on the number of shares a plan participant can purchase on any single plan exercise date. During fiscal years 2016, 2015, 2014, and 2013,2014, there was no increase to the number of shares of Lam Research Common Stock reserved for issuance under the 1999 ESPP.During fiscal year 2015,2016, a total of 943,055936,466 shares of the Company’s Common Stock were sold to employees under the 1999 ESPP. At June 28, 2015, 7,434,52326, 2016, 6,498,057 shares were available for purchase under the 1999 ESPP.The 1999 ESPP rights were valued using thea Black-Scholes option valuation model. During fiscal years 2016, 2015, 2014, and 2013,2014, the 1999 ESPP was valued using the following weighted-average assumptions: Year Ended June 28,
2015 June 29,
2014 June 30,
2013 0.67 0.68 0.64 27.60% 30.24% 32.42% 0.07% 0.07% 0.15% 0.69% — — Year Ended June 26,
2016 June 28,
2015 June 29,
2014Expected term (years) 0.67 0.67 0.68 Expected stock price volatility 35.48 % 27.60 % 30.24 % Risk-free interest rate 0.29 % 0.07 % 0.07 % Dividend Yield 1.18 % 0.69 % — Continues on next pageLam Research Corporation 2016 10-K 67As of June 28, 2015,26, 2016, there was $2.6$3.1 million of total unrecognized compensation cost related to the 1999 ESPP that is expected to be recognized over a remaining vesting period of 2 months.Note 6:5: Other Income (Expense), NetThe significant components of other income (expense), net, were as follows: Year Ended June 28,
2015 June 29,
2014 June 30,
2013 (in thousands) $ 19,268 $ 12,540 $ 14,737 (73,682 ) (61,692 ) (60,408 ) 9,071 9,559 9,764 2,331 1,529 (6,808 ) (4,177 ) 668 (8,698 ) $ (47,189 ) $ (37,396 ) $ (51,413 ) Year Ended June 26,
2016 June 28,
2015 June 29,
2014 (in thousands) Interest income $ 29,512 $ 19,268 $ 12,540 Interest expense (134,773 ) (73,682 ) (61,692 ) (Losses) gains on deferred compensation plan related assets, net (3,995 ) 9,071 9,559 Foreign exchange gains (losses), net 308 2,331 1,529 Other, net (5,191 ) (4,177 ) 668 $ (114,139 ) $ (47,189 ) $ (37,396 ) Interest expense in the year ended June 26, 2016 increased, as compared to the years ended June 28, 2015 and June 29, 2014, primarily due to interest expense associated with the $1.0 billion Senior Note 7:issuance in March 2015 and the amortization of bridge loan financing issuance costs of approximately $31.9 million in the year ended June 26, 2016 (see Note 13 and Note 15 for additional information regarding the Senior Note and bridge loan financing).Note 6: Income TaxesThe components of income (loss) before income taxes were as follows: June 28,
2015 June 29,
2014 June 30,
2013 (in thousands) $ 72,728 $ 78,076 $ (46,392 ) 668,122 645,287 113,050 $ 740,850 $ 723,363 $ 66,658 June 26,
2016 June 28,
2015 June 29,
2014 (in thousands) United States $ (113,607 ) $ 72,728 $ 78,076 Foreign 1,073,724 668,122 645,287 $ 960,117 $ 740,850 $ 723,363 Continues on next pageLam Research Corporation 2016 10-K 68Significant components of the provision (benefit) for income taxes attributable to income before income taxes were as follows: June 28,
2015 June 29,
2014 June 30,
2013 (in thousands) $ 16,795 $ 31,762 $ (1,096 ) 12,115 10,692 (60,172 ) $ 28,910 $ 42,454 $ (61,268 ) $ 1,376 $ 3,192 $ 3,332 158 (869 ) (6,351 ) $ 1,534 $ 2,323 $ (3,019 ) $ 61,551 $ 49,273 $ 20,640 (6,722 ) (2,976 ) (3,574 ) $ 54,829 $ 46,297 $ 17,066 $ 85,273 $ 91,074 $ (47,221 ) June 26,
2016 June 28,
2015 June 29,
2014 (in thousands) Federal: Current $ 1,426 $ 16,795 $ 31,762 Deferred (38,616 ) 12,115 10,692 (37,190 ) 28,910 42,454 State: Current 2,892 1,376 3,192 Deferred (7,600 ) 158 (869 ) (4,708 ) 1,534 2,323 Foreign: Current 90,752 61,551 49,273 Deferred (2,786 ) (6,722 ) (2,976 ) 87,966 54,829 46,297 Total Provision (Benefit) for Income Taxes $ 46,068 $ 85,273 $ 91,074 Deferred income taxes reflect the net tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes, and the amounts used for income tax purposes, as well as the tax effect of carryforwards. Significant components of the Company’s net deferred tax assets and liabilities were as follows: June 28,
2015 June 29,
2014 (in thousands) $ 129,234 $ 170,028 131,079 126,895 21,086 18,019 15,167 16,257 13,942 12,661 310,508 343,860 (85,620 ) (74,439 ) 224,888 269,421 (64,725 ) (87,329 ) (130,991 ) (117,112 ) (37,635 ) (32,350 ) (12,502 ) (11,409 ) (66,412 ) (40,286 ) (6,100 ) (5,673 ) (318,365 ) (294,159 ) $ (93,477 ) $ (24,738 ) June 26,
2016 June 28,
2015 (in thousands) Deferred tax assets: Tax carryforwards $ 176,767 $ 129,234 Allowances and reserves 128,416 131,079 Equity-based compensation 29,414 21,086 Inventory valuation differences 17,178 15,167 Prepaid cost sharing 88,522 — Other 24,540 13,942 Gross deferred tax assets 464,837 310,508 Valuation allowance (101,689 ) (85,620 ) Net deferred tax assets 363,148 224,888 Deferred tax liabilities: Intangible assets (46,774 ) (64,725 ) Convertible debt (151,483 ) (130,991 ) Temporary differences for capital assets (61,845 ) (37,635 ) Amortization of goodwill (14,176 ) (12,502 ) Unremitted earnings of foreign subsidiaries (146,459 ) (66,412 ) Other (8,594 ) (6,100 ) Gross deferred tax liabilities (429,331 ) (318,365 ) Net deferred tax liabilities $ (66,183 ) $ (93,477 ) The change in the gross deferred tax assets, gross deferred tax liabilities and valuation allowance between fiscal year 20152016 and 20142015 is primarily due to the reclassificationan increase related to tax credit carryforwards, recognition of a prepaid cost sharing deferred tax benefit related to the Altera case ruling and a decrease in deferred tax liabilities relatedContinues on next pageLam Research Corporation 2016 10-K 69to amortization of intangible assets as a resultoffset by an increase in deferred tax liabilities related to depreciation of the adoption of Accounting Standards Updated 2013-11,tangible assets, convertible debt accretion and an accrual for future tax liabilities due to the expected repatriation of foreign earnings of certain foreign subsidiaries for 2015, and convertible debt accretion, offset by a decrease in deferred tax liabilities related to amortization of intangible assets. 2016.Realization of the Company’s net deferred tax assets is based upon the weighting of available evidence, including such factors as the recent earnings history and expected future taxable income. The Company believes it is more-likely-than-not that such deferred tax assets will be realized with the exception of $85.6$101.7 million primarily related to California and certain foreign deferred tax assets.The provisions related to the tax accounting for equity-based compensation prohibit the recognition of a deferred tax asset for an excess benefit that has not yet been realized. As a result, the Company will only recognize an excess benefit from equity-based compensation in additional paid-in-capital if an incremental tax benefit is realized after all other tax attributes currently available to us have been utilized. In addition, the Company continued to elect to account for the indirect benefits of equity-based compensation such as the research and development tax credit through the Consolidated Statement of Operations.At June 28, 2015,26, 2016, the Company had federal net operating loss carryforwards of approximately $126.3$181.2 million. The majority of these losses will begin to expire in fiscal year 2019, and are subject to limitations on their utilization.As The tax benefits relating to approximately $59.6 million of federal net operating loss carryforwards will be credited to additional paid-in-capital when recognized.At June 28, 2015,26, 2016, the Company had state net operating loss carryforwards of approximately $36.7$164.5 million. If not utilized, the net operating loss carryforwards will begin to expire in fiscal year 2016,2020, and are subject to limitations on their utilization.At June 28, 2015,26, 2016, the Company had federal tax credit carryforwards of approximately $134.3$193.6 million, of which $19.2$28.0 million of foreign tax credit will begin to expire in fiscal year 2017 and $113.3$163.7 million of research and development tax credit will begin to expire in fiscal year 2030. The remaining balance of $1.8 million of creditsAMT credit may be carried forward indefinitely. The tax benefits relating to approximately $20.3$19.7 million of federal tax credit carryforwards will be credited to additional paid-in-capital when recognized.At June 28, 2015,26, 2016, the Company had state tax credit carryforwards of approximately $236.4$264.0 million. Substantially all state tax credit carryforwards may be carried forward indefinitely.At June 28, 2015, the Company had federal and state capital loss carryforwards of approximately $12.0 million, which will begin to expire in fiscal year 2020.At June 28, 2015,26, 2016, the Company had foreign net operating loss carryforwards of approximately $31.2$30.6 million, of which approximately $10.2$15.6 million may be carried forward indefinitely and $21.0$15.0 million will begin to expire in fiscal year 2016.A reconciliation of income tax expense provided at the federal statutory rate (35% in fiscal years 2016, 2015, 2014, and 2013)2014) to actual income tax expense (benefit) is as follows: June 28,
2015 June 29,
2014 June 30,
2013 (in thousands) $ 259,297 $ 253,177 $ 23,332 (8,611 ) 1,884 (13,588 ) (175,581 ) (164,130 ) (40,255 ) (24,416 ) (15,650 ) (42,593 ) 8,594 (1,707 ) 11,538 28,845 23,167 20,318 (2,855 ) (5,667 ) (5,973 ) $ 85,273 $ 91,074 $ (47,221 ) June 26,
2016 June 28,
2015 June 29,
2014 (in thousands) Income tax expense computed at federal statutory rate $ 336,041 $ 259,297 $ 253,177 State income taxes, net of federal tax benefit (14,070 ) (8,611 ) 1,884 Foreign income taxed at different rates (265,123 ) (175,581 ) (164,130 ) Tax credits (48,277 ) (24,416 ) (15,650 ) State valuation allowance, net of federal tax benefit 17,948 8,594 (1,707 ) Equity-based compensation 12,366 28,845 23,167 Other permanent differences and miscellaneous items 7,183 (2,855 ) (5,667 ) $ 46,068 $ 85,273 $ 91,074 In July 2015, the United States Tax Court (the “Court”) issued an opinion favorable to Altera Corporation (“Altera”) with respect to Altera’s litigation with the Internal Revenue Service (“IRS”). The litigation relates to the treatment of stock-based compensation expense in an inter-company cost-sharing arrangement with Altera’sContinues on next pageLam Research Corporation 2016 10-K 70foreign subsidiary. In its opinion, the Court accepted Altera’s position of excluding stock-based compensation from its inter-company cost-sharing arrangement. However, the U.S. Department of the Treasury has not withdrawn the requirement to include stock-based compensation from its regulations. The Company has evaluated the opinion and has recorded a tax benefit of $87.7 million related to reimbursement of cost share payments for the previously shared stock-based compensation costs. The Company has also recorded a tax benefit of $11.2 million related to stock-based compensation expense. In addition, the Company has recorded a tax liability of $73.6 million for the U.S. tax cost of potential repatriation of the associated contingent foreign earnings because at this time the Company cannot reasonably conclude that it has the ability and the intent to indefinitely reinvest these contingent earnings. The Company will continue to monitor this matter and related potential impacts to the consolidated financial statements.Effective from fiscal year 2014 through June 2023, the Company has a 10 year tax ruling in Switzerland for one of its foreign subsidiaries. In the prior years, the Company had a tax holiday in Switzerland which was effective from fiscal year 2003 through June 2013. The impact of the tax ruling decreased taxes by approximately $4.3 million, $4.8 million $7.4 million and $10.8$7.4 million for fiscal years 2016, 2015 2014 and 2013,2014, respectively. The benefit of the tax ruling on diluted earnings per share was approximately $0.02 in fiscal year 2016, $0.03 in fiscal year 2015 $ 0.04and $0.04 in fiscal year 2014 and $0.06 in fiscal year 2013.Unremitted earnings of the Company’s foreign subsidiaries included in consolidated retained earnings aggregated to approximately $3.3$4.3 billion at June 28, 2015.26, 2016. These earnings are indefinitely reinvested in foreign operations. If these earnings were remitted to the United States, they would be subject to U.S. and foreign withholding taxes of approximately $859.0 million$1.2 billion at current statutory rates. The Company’s federal income tax provision includes U.S. income taxes on certain foreign-based income.As of June 28, 2015,26, 2016, the total gross unrecognized tax benefits were $363.6$417.4 million compared to $363.6 million as of June 28, 2015 and $352.1 million as of June 29, 2014 and $333.1 million as of June 30, 2013.2014. During fiscal year 2015,2016, gross unrecognized tax benefits$11.4$53.8 million. The amount of unrecognized tax benefits that, if recognized, would impact the effective tax rate was $323.4 million, $276.8 million $269.4 million and $257.7$269.4 million, as of June 26, 2016, June 28, 2015 and June 29, 2014 and June 30, 2013 respectively. The aggregate changes in the balance of gross unrecognized tax benefits were as follows: (in thousands) $ 343,837 (3,422 ) (51,422 ) 11,352 (11,281 ) 35,170 8,880 333,114 (16,048 ) 6,225 (4,182 ) 33,003 352,112 (2,108 ) (9,376 ) 3,729 (12,615 ) 31,810 $ 363,552 (in thousands) Balance as of June 30, 2013 $ 333,114 Lapse of statute of limitations (16,048 ) Increases in balances related to tax positions taken during prior periods 6,225 Decreases in balances related to tax positions taken during prior periods (4,182 ) Increases in balances related to tax positions taken during current period 33,003 Balance as of June 29, 2014 352,112 Settlements and effective settlements with tax authorities (2,108 ) Lapse of statute of limitations (9,376 ) Increases in balances related to tax positions taken during prior periods 3,729 Decreases in balances related to tax positions taken during prior periods (12,615 ) Increases in balances related to tax positions taken during current period 31,810 Balance as of June 28, 2015 363,552 Lapse of statute of limitations (10,992 ) Increases in balances related to tax positions taken during prior periods 18,200 Decreases in balances related to tax positions taken during prior periods (421 ) Increases in balances related to tax positions taken during current period 47,093 Balance as of June 26, 2016 $ 417,432 The Company recognizes interest expense and penalties related to the above unrecognized tax benefits within income tax expense. The Company had accrued $42.4 million, $35.5 million $29.5 million and $25.5$29.5 million cumulatively, for gross interest and penalties as of June 26, 2016, June 28, 2015 and June 29, 2014, and June 30, 2013, respectively.Continues on next pageLam Research Corporation 2016 10-K 71The Company is subject to audits by state and foreign tax authorities. The Company is unable to make a reasonable estimate as to when cash settlements, if any, with the relevant taxing authorities will occur.The Company files U.S. federal, U.S. state, and foreign income tax returns. As of June 28, 2015,26, 2016, tax years 2004-20142004-2015 remain subject to examination in the jurisdictions where the Company operates.The Company is in various stages of the examinations in connection with all of its tax audits worldwide and it is difficult to determine when these examinations will be settled. It is reasonably possible that over the next twelve-month period the Company may experience an increase or decrease in its unrecognized tax benefits. It is not possible to determine either the magnitude or the range of any increase or decrease at this time.Note 8:7: Net Income Per ShareBasic net income per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed using the treasury stock method, Year Ended June 28,
2015 June 29,
2014 June 30,
2013 (in thousands, except per share data) $ 655,577 $ 632,289 $ 113,879 159,629 164,741 168,932 3,193 2,864 2,558 13,530 6,898 1,940 715 — — 177,067 174,503 173,430 $ 4.11 $ 3.84 $ 0.67 $ 3.70 $ 3.62 $ 0.66 Year Ended June 26,
2016 June 28,
2015 June 29,
2014 (in thousands, except per share data) Numerator: Net income $ 914,049 $ 655,577 $ 632,289 Denominator: Basic average shares outstanding 158,919 159,629 164,741 Effect of potential dilutive securities: Employee stock plans 2,120 3,193 2,864 Convertible notes 13,464 13,530 6,898 Warrants 656 715 — Diluted average shares outstanding 175,159 177,067 174,503 Net income per share - basic $ 5.75 $ 4.11 $ 3.84 Net income per share - diluted $ 5.22 $ 3.70 $ 3.62 For purposes of computing diluted net income per share, weighted-average common shares do not include potentially dilutive securities that are anti-dilutive under the treasury stock method. The following potentially dilutive securities were excluded: Year Ended June 28,
2015 June 29,
2014 June 30,
2013 (in thousands) 330 78 534 Year Ended June 26,
2016 June 28,
2015 June 29,
2014 (in thousands) Number of options and RSUs excluded 149 330 78 Diluted shares outstanding include the effect of the Convertible Notes. Diluted shares outstanding do not include any effect resulting from note hedges associated with the Company’s 2016 or 2018 Notes (as described in Note 14)13) as their impact would have been anti-dilutive.Note 9:8: Financial InstrumentsFair ValueThe Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining theContinues on next pageLam Research Corporation 2016 10-K 72fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact, and it considers assumptions that market participants would use when pricing the asset or liability.A fair value hierarchy has been established that prioritizes the inputs to valuation techniques used to measure fair value. The level of an asset or liability in the hierarchy is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are classified and disclosed in one of the following three categories:Level 1: Valuations based on quoted prices in active markets for identical assets or liabilities with sufficient volume and frequency of transactions.Level 2: Valuations based on observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or model-derived valuations techniques for which all significant inputs are observable in the market or can be corroborated by, observable market data for substantially the full term of the assets or liabilities.Level 3: Valuations based on unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities and based on non-binding, broker-provided price quotes and may not have been corroborated by observable market data.The Company’s primary financial instruments include cash and cash equivalents, short-term investments, restricted cash and investments, long-term investments, accounts receivable, accounts payable, long-term debt and capital leases, and foreign currency related derivatives. The estimated fair value of cash and cash equivalents, accounts receivable and accounts payable approximates their carrying value due to the short period of time to their maturities. The estimated fair values of capital lease obligations approximate their carrying value as the substantial majority of these obligations have interest rates that adjust to market rates on a periodic basis. Refer to Note 1413 to the Consolidated Financial Statements for additional information regarding the fair value of the Company’s Convertible Notes and Senior Notes.Continues on next pageLam Research Corporation 2016 10-K 73InvestmentsThe following table sets forth the Company’s cash, cash equivalents, short-term investments, restricted cash and investments, and other assets measured at fair value on a recurring basis as of June 28, 201526, 2016 and June 29, 2014: June 28, 2015 (Reported Within) Cost Unrealized
Gain Unrealized
(Loss) Fair Value Cash and
Cash
Equivalents Short-Term
Investments
Cash & Other
Assets (in thousands) $ 276,663 $ — $ — $ 276,663 $ 271,452 $ — $ 5,211 $ — 177,567 ��� — 177,567 44,738 — 132,829 — 1,177,875 — — 1,177,875 1,177,875 — — — 349,009 72 (861 ) 348,220 — 315,291 32,929 — 30,584 2,926 (47 ) 33,463 — — — 33,463 $ 1,735,035 $ 2,998 $ (908 ) $ 1,737,125 $ 1,222,613 $ 315,291 $ 165,758 $ 33,463 659,550 429 (335 ) 659,644 7,474 652,170 — — 4,007 — (4 ) 4,003 — 4,003 — — 53,612 2 (249 ) 53,365 — 53,365 — — 50,336 31 (161 ) 50,206 — 50,206 — — 1,329,587 685 (3,797 ) 1,326,475 — 1,326,475 — — 32,231 72 (292 ) 32,011 — 32,011 — — 141,988 44 (606 ) 141,426 — 141,426 — — $ 2,271,311 $ 1,263 $ (5,444 ) $ 2,267,130 $ 7,474 $ 2,259,656 $ — $ — $ 4,283,009 $ 4,261 $ (6,352 ) $ 4,280,918 $ 1,501,539 $ 2,574,947 $ 170,969 $ 33,463 June 29, 2014 (Reported Within) Cost Unrealized
Gain Unrealized
(Loss) Fair Value Cash and
Cash
Equivalents Short-Term
Investments Other
Assets (in thousands) $ 285,031 $ — $ — $ 285,031 $ 279,126 $ — $ 5,905 $ — 132,549 — — 132,549 — — 132,549 — 1,168,261 — — 1,168,261 1,168,261 — — — 212,436 178 (27 ) 212,587 — 204,549 8,038 — 18,784 2,974 — 21,758 — — — 21,758 $ 1,532,030 $ 3,152 $ (27 ) $ 1,535,155 $ 1,168,261 $ 204,549 $ 140,587 $ 21,758 334,329 1,108 (4 ) 335,433 5,290 330,143 — — 27,666 41 (15 ) 27,692 — 27,692 — — 35,438 57 (28 ) 35,467 — 35,467 — — 874,540 2,034 (335 ) 876,239 — 876,239 — — 27,067 59 (182 ) 26,944 — 26,944 — — 112,642 100 (809 ) 111,933 — 111,933 — — $ 1,411,682 $ 3,399 $ (1,373 ) $ 1,413,708 $ 5,290 $ 1,408,418 $ — $ — $ 3,228,743 $ 6,551 $ (1,400 ) $ 3,233,894 $ 1,452,677 $ 1,612,967 $ 146,492 $ 21,758 June 26, 2016 (Reported Within) Cost Unrealized
Gain Unrealized
(Loss) Fair Value Cash and
Cash
Equivalents Short-Term
Investments Restricted
Cash &
Investments Other
Assets (in thousands) Cash $ 418,216 $ — $ — $ 418,216 $ 412,573 $ — $ 5,643 $ — Level 1: Time Deposit 904,243 — — 904,243 659,465 — 244,778 — Money Market Funds 3,904,288 — — 3,904,288 3,904,288 — — — US Treasury and Agencies 446,530 2,041 (2 ) 448,569 62,996 385,573 — — Mutual Funds 39,318 1,400 (397 ) 40,321 — — — 40,321 Level 1 Total 5,294,379 3,441 (399 ) 5,297,421 4,626,749 385,573 244,778 40,321 Level 2: Municipal Notes and Bonds 265,386 355 (16 ) 265,725 — 265,725 — — US Treasuries and Agencies 8,068 151 — 8,219 — 8,219 — — Government-Sponsored Enterprises 31,885 91 (13 ) 31,963 — 31,963 — — Foreign Government Bonds 41,440 76 (4 ) 41,512 — 41,512 — — Corporate Notes and Bonds 979,566 4,341 (566 ) 983,341 — 983,341 — — Mortgage Backed Securities - Residential 17,395 37 (152 ) 17,280 — 17,280 — — Mortgage Backed Securities - Commercial 55,129 30 (160 ) 54,999 — 54,999 — — Level 2 Total 1,398,869 5,081 (911 ) 1,403,039 — 1,403,039 — — Total $ 7,111,464 $ 8,522 $ (1,310 ) $ 7,118,676 $ 5,039,322 $ 1,788,612 $ 250,421 $ 40,321 Continues on next pageLam Research Corporation 2016 10-K 74 June 28, 2015 (Reported Within) Cost Unrealized
Gain Unrealized
(Loss) Fair Value Cash and
Cash
Equivalents Short-Term
Investments Restricted
Cash &
Investments Other
Assets (in thousands) Cash $ 276,663 $ — $ — $ 276,663 $ 271,452 $ — $ 5,211 $ — Level 1: Time Deposit 177,567 — — 177,567 44,738 — 132,829 — Money Market Funds 1,177,875 — — 1,177,875 1,177,875 — — — US Treasury and Agencies 349,009 72 (861 ) 348,220 — 315,291 32,929 — Mutual Funds 30,584 2,926 (47 ) 33,463 — — — 33,463 Level 1 Total 1,735,035 2,998 (908 ) 1,737,125 1,222,613 315,291 165,758 33,463 Level 2: Municipal Notes and Bonds 659,550 429 (335 ) 659,644 7,474 652,170 — — US Treasuries and Agencies 4,007 — (4 ) 4,003 — 4,003 — — Government-Sponsored Enterprises 53,612 2 (249 ) 53,365 — 53,365 — — Foreign Government Bonds 50,336 31 (161 ) 50,206 — 50,206 — — Corporate Notes and Bonds 1,329,587 685 (3,797 ) 1,326,475 — 1,326,475 — — Mortgage Backed Securities - Residential 32,231 72 (292 ) 32,011 — 32,011 — — Mortgage Backed Securities - Commercial 141,988 44 (606 ) 141,426 — 141,426 — — Level 2 Total 2,271,311 1,263 (5,444 ) 2,267,130 7,474 2,259,656 — — Total $ 4,283,009 $ 4,261 $ (6,352 ) $ 4,280,918 $ 1,501,539 $ 2,574,947 $ 170,969 $ 33,463 The Company accounts for its investment portfolio at fair value. Realized gains (losses) for investment sales are specifically identified. Management assesses the fair value of investments in debt securities that are not actively traded through consideration of interest rates and their impact on the present value of the cash flows to be received from the investments. The Company also considers whether changes in the credit ratings of the issuer could impact the assessment of fair value. Net realized gains (losses) on investments included other-than-temporary impairment charges of $3.7 million in fiscal year 2013. There were no other-than-temporary impairment charges in fiscal year 2016, 2015, or 2014. Additionally, gross realized gains/(losses) from sales of investments were $2.0 million and $(3.0) million in fiscal year 2016, $2.8 million and $(2.1) million in fiscal year 2015, and $1.5 million and $(2.0) million in fiscal year 2014, and $1.6 million and $(1.5) million in fiscal year 2013, respectively.Continues on next pageLam Research Corporation 2016 10-K 75The following is an analysis of the Company’s cash, cash equivalents, short-term investments, and restricted cash and investments in unrealized loss positions: June 28, 2015 Unrealized Losses
Less Than 12 Months Unrealized Losses
12 Months or Greater Total Fair Value Gross
Unrealized
Loss Fair Value Gross
Unrealized
Loss Fair Value Gross
Unrealized
Loss (in thousands) $ 272,388 $ (335 ) $ — $ — $ 272,388 $ (335 ) 296,237 (865 ) — — 296,237 (865 ) 3,532 (47 ) — — 3,532 (47 ) 49,184 (249 ) — — 49,184 (249 ) 34,882 (161 ) — — 34,882 (161 ) 889,064 (3,750 ) 16,586 (47 ) 905,650 (3,797 ) 20,913 (196 ) 2,190 (96 ) 23,103 (292 ) 100,388 (431 ) 19,729 (175 ) 120,117 (606 ) $ 1,666,588 $ (6,034 ) $ 38,505 $ (318 ) $ 1,705,093 $ (6,352 ) June 26, 2016 Unrealized Losses
Less Than 12 Months Unrealized Losses
12 Months or Greater Total Fair Value Gross
Unrealized
Loss Fair Value Gross
Unrealized
Loss Fair Value Gross
Unrealized
Loss (in thousands) Municipal Notes and Bonds $ 43,084 $ (10 ) $ 1,994 $ (6 ) $ 45,078 $ (16 ) US Treasury & Agencies 65,997 (2 ) — — 65,997 (2 ) Retail Funds 7,539 (397 ) — — 7,539 (397 ) Government-Sponsored Enterprises 1,211 (13 ) — — 1,211 (13 ) Foreign Government Bonds 9,201 (4 ) — — 9,201 (4 ) Corporate Notes and Bonds 185,982 (317 ) 46,761 (249 ) 232,743 (566 ) Mortgage Backed Securities - Residential 12,402 (68 ) 1,328 (84 ) 13,730 (152 ) Mortgage Backed Securities - Commercial 39,588 (102 ) 6,179 (58 ) 45,767 (160 ) $ 365,004 $ (913 ) $ 56,262 $ (397 ) $ 421,266 $ (1,310 ) The amortized cost and fair value of cash equivalents, short-term investments, and restricted cash and investments with contractual maturities are as follows: Cost Estimated Fair
Value (in thousands) $ 1,651,592 $ 1,651,673 1,944,674 1,940,529 379,496 378,590 $ 3,975,762 $ 3,970,792 Cost Estimated
Fair Value (in thousands) Due in one year or less $ 5,429,726 $ 5,430,010 Due after one year through five years 1,128,304 1,134,632 Due in more than five years 95,900 95,497 $ 6,653,930 $ 6,660,139 Management has the ability, if necessary, to liquidate any of its cash equivalents and short-term investments in order to meet the Company’s liquidity needs in the next 12 months. Accordingly, those investments with contractual maturities greater than one year from the date of purchase nonetheless are classified as short-term on the accompanying Consolidated Balance Sheets.Derivative Instruments and HedgingThe Company carries derivative financial instruments (“derivatives”) on its Consolidated Balance Sheets at their fair values. The Company enters into foreign currency forward contracts and foreign currency options with financial institutions with the primary objective of reducing volatility of earnings and cash flows related to foreign currency exchange rate fluctuations. The counterparties to these foreign currency forward contracts and foreign currency options are large global financial institutions that the Company believes are creditworthy, and therefore, it does not consider the risk of counterparty nonperformance to be material.Cash Flow HedgesThe Company’s financial position is routinely subjected to market risk associated with foreign currency exchange rate fluctuations on non-US dollar transactions or cash flows, primarily from Japanese yen-denominated revenuesContinues on next pageLam Research Corporation 2016 10-K 76the foreign exchange risk arising from the fluctuations in the value of these non-U.S. dollar denominated transactions or cash flows through a foreign currency cash flow hedging program, using foreign currency forward contractsand options that generally expire within twelve12 months and no later than 24 months. These foreign currency forwardhedge contracts are designated as cash flow hedges and are carried on the Company’s balance sheet at fair value with the effective portion of the contracts’ gains or losses included in accumulated other comprehensive income (loss) and subsequently recognized in revenue/expense in the same period the hedged items are recognized.In addition, during the twelve months ended June 28, 2015, the Company entered into and settled a series of forward-starting interest rate swap agreements during the twelve months ended June 26, 2016 and June 28, 2015, with a total notional value of $375$600.0 million and $375.0 million, respectively, to hedge against the variability of cash flows due to changes in the benchmark interest rate of fixed rate debt. These instruments were designated as cash flow hedges at inception and were settled in conjunction with the issuance of debt during the three months ended June 26, 2016 and March 29, 2015.2015, respectively. The effective portion of the contracts’ gain/loss is included in accumulated other comprehensive (loss) and will amortize into income as the hedged item impacts earnings.At inception and at each quarter end, hedges are tested prospectively and retrospectively for effectiveness using regression analysis. Changes in the fair value of the forward contracts due to changes in time value are excluded from the assessment of effectiveness and are recognized in revenue or expense in the current period. The change in time value related to these contracts was not material for all reported periods. Changes in the fair value of foreign exchange options due to changes in time value are included in the assessment of effectiveness. To qualify for hedge accounting, the hedge relationship must meet criteria relating both to the derivative instrument and the hedged item. These criteria include identification of the hedging instrument, the hedged item, the nature of the risk being hedged and how the hedging instrument’s effectiveness in offsetting the exposure to changes in the hedged item’s fair value or cash flows will be measured. There were no material gains or losses during the twelve monthsfiscal year ended June 28, 201526, 2016 or June 29, 201428, 2015 associated with ineffectiveness or forecasted transactions that failed to occur.To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge and the hedges must be tested to demonstrate an expectation of providing highly effective offsetting changes to future cash flows on hedged transactions. When derivative instruments are designated and qualify as effective cash flow hedges, the Company recognizes effective changes in the fair value of the hedging instrument within accumulated other comprehensive income (loss) until the hedged exposure is realized. Consequently, with the exception of excluded time value and hedge ineffectiveness recognized, the Company’s results of operations are not subject to fluctuation as a result of changes in the fair value of the derivative instruments. If hedges are not highly effective or if the Company does not believe that the underlying hedged forecasted transactions will occur, the Company may not be able to account for its derivative instruments as cash flow hedges. If this were to occur, future changes in the fair values of the Company’s derivative instruments would be recognized in earnings. Additionally, related amounts previously recorded in other comprehensive income would be reclassified to income immediately. As of June 28, 2015,26, 2016, the Company had losses of $2.9$15.6 million accumulated in other comprehensive income, net of tax, including, $0.2$14.8 million gainslosses related to foreign exchange which it expects to reclassify from other comprehensive income into earnings over the next 12 months and $3.1$0.8 million losses related to interest rate contracts which it expects to reclassify from other comprehensive income into earnings over the next 9.710.0 years.Fair Value HedgesDuring the fiscal year ended June 26, 2016, the Company entered into a series of interest rate contracts with a total notional value of $400.0 million whereby the Company receives fixed rates and pays variable rates based on certain benchmark interest rates, resulting in a net increase or decrease to interest expense, a component of Other expense, net in our Consolidated Statement of Operations. These interest rate contracts are designated as fair value hedges and hedge against changes in the fair value of our debt portfolio. The Company concluded that these interest rate contracts meet the criteria necessary to qualify for the short-cut method of hedge accounting, and as such an assumption is made that the change in the fair value of the hedged debt, due to changes in the benchmark rate, exactly offsets the change in the fair value of the interest rate swap. Therefore, the derivative is considered to be effective at achieving offsetting changes in the fair value of the hedged liability, and no ineffectiveness is recognized.Continues on next pageLam Research Corporation 2016 10-K 77Balance Sheet HedgesThe Company also enters into foreign currency forwardhedge contracts to hedge fluctuations associated with foreign currency denominated monetary assets and liabilities, primarily third party accounts receivables, accounts payables and intercompany receivables and payables. These foreign currency forwardhedge contracts are not designated for hedge accounting treatment. Therefore, the change in fair value of these derivatives is recorded as a component of other income (expense) and offsets the change in fair value of the foreign currency denominated assets and liabilities, which are also recorded in other income (expense).As of June 28, 2015,26, 2016, the Company had the following outstanding foreign currency forward contracts that were entered into under its cash flow and balance sheet hedge program: Derivatives Designated as
Hedging Instruments: Derivatives Not Designated as
Hedging Instruments: (in thousands) Buy Contracts Sell Contracts Buy Contracts Sell Contracts $ — $ 18,946 $ — $ 49,924 — — — 3,346 34,377 — 4,049 — 7,269 — 8,945 — — — 33,239 11,162 $ 41,646 $ 18,946 $ 46,233 $ 64,432 Derivatives Designated as
Hedging Instruments: Derivatives Not Designated as
Hedging Instruments: (in thousands) Foreign Currency Forward Contracts Buy Contracts Sell Contracts Buy Contracts Sell Contracts Japanese yen $ — $ 219,148 $ — $ 56,870 Swiss franc — — 4,467 — Euro 36,303 — 16,048 — Korean won 8,577 — — 4,971 Chinese Renminbi — — 9,105 — Singapore Dollar — — 18,273 — Taiwan dollar — — 23,341 — $ 44,880 $ 219,148 $ 71,234 $ 61,841 Foreign Currency Option Contracts Buy Put Sell Put Buy Put (1) Sell Put Japanese yen $ — $ — $ 39,135 $ 39,135 (1) Contracts were entered into and designated as cash flow hedges under ASC 815, during the fiscal year as part of our cash flow hedge program. The contracts were subsequently de-designated during the fiscal year ended June 26, 2016, changes in fair market value subsequent to de-designation effect current earnings.Continues on next pageLam Research Corporation 2016 10-K 78The fair value of derivatives instruments in the Company’s consolidated balance sheet as of June 28, 201526, 2016 and June 29, 201428, 2015 were as follows: June 28, 2015 June 29, 2014 Fair Value of Derivative Instruments (Level 2) Fair Value of Derivative Instruments (Level 2) Asset Derivatives Liability
Derivatives Asset Derivatives Liability
Derivatives Balance Sheet
Location Fair
Value Balance
Sheet
Location Fair
Value Fair
Value
Sheet Fair
Value (in thousands) Prepaid expense
and other assets $ 3,388 Accrued
liabilities $ 957 Prepaid expense
and other assets $ 483 Accrued
liabilities $ 805 Prepaid expense
and other assets 8 Accrued
liabilities 960 Prepaid expense
and other assets 1,109 Accrued
liabilities 118 $ 3,396 $ 1,917 $ 1,592 $ 923 June 26, 2016 June 28, 2015 Fair Value of Derivative Instruments (Level 2) Fair Value of Derivative Instruments (Level 2) Asset Derivatives Liability
Derivatives Asset Derivatives Liability
DerivativesBalance Sheet
Location Fair
Value Balance
Sheet
Location Fair
Value Balance Sheet
Location Fair
Value Balance
Sheet
Location Fair
Value (in thousands) Derivatives designated as hedging instruments: Foreign exchange contracts Prepaid
expense
and other
assets $ 249 Accrued
liabilities $ 16,585 Prepaid
expense
and other assets $ 3,388 Accrued
liabilities $ 957 Interest rate contracts, short-term Accrued expenses and other current liabilities 50 Prepaid expense and other assets 159 Accrued expenses and other current liabilities — Prepaid expense and other assets — Interest rate contracts, long-term Other long-term liabilities 8,661 Other long-term liabilities — Derivatives not designated as hedging instruments: Foreign exchange contracts Prepaid
expense
and other
assets 107 Accrued
liabilities 1,529 Prepaid expense
and other assets 8 Accrued
liabilities 960 Total derivatives $ 9,067 $ 18,273 $ 3,396 $ 1,917 Under the master agreements with the respective counterparties to the Company’s foreign exchange contracts, subject to applicable requirements, the Company is allowed to net settle transactions of the same currency with a single net amount payable by one party to the other. However, the Company has elected to present the derivative assets and derivative liabilities on a gross basis in the Company’s balance sheet. As of June 26, 2016, the potential effect of rights of set-off associated with the above foreign exchange contracts would be an offset to both assets and liabilities by $6.4 million, resulting in a net derivative asset of $2.7 million and net derivative liability of $11.9 million. As of June 28, 2015, the potential effect of rights of set-off associated with the above foreign exchange contracts would be an offset to both assets and liabilities by $1.9 million, resulting in a net derivative asset of $1.5 million. As of June 29, 2014, the potential effect of rights of set-off associated with the above foreign exchange contracts would be an offset to both assets and liabilities by $0.5 million, resulting in a net derivative asset of $1.1 million. The Company is not required to pledge, nor is the Company entitled to receive, cash collateral related to these derivative transactions.Continues on next pageLam Research Corporation 2016 10-K 79The effect of derivative instruments designated as cash flow hedges, before tax, on the Company’s Consolidated Statements of Operations was as follows: Year Ended June 28, 2015 Year Ended June 29, 2014
Gain (Loss)
Recognized in or
Reclassified into
Income Effective Portion Ineffective
Portion and
Amount
Excluded from
Effectiveness Effective Portion Ineffective
Portion and
Amount
Excluded from
Effectiveness Derivatives Designated as
Hedging Instruments Gain (Loss)
Reconginzed
in AOCI Gain (Loss)
Reclassified
from AOCI
into Income Gain (Loss)
Recognized
in Income Gain
Recognized
in AOCI Gain
Reclassified
from AOCI
into Income Gain (Loss)
Recognized
in Income (in thousands) (in thousands) Revenue $ 13,678 $ 11,375 $ 258 $ 7,939 $ 9,027 $ 277 Cost of goods sold (6,318 ) (4,349 ) (75 ) 812 2,393 (52 ) Selling, general, and administrative (2,579 ) (2,618 ) (39 ) 318 1,087 (23 ) Other expense, net (5,071 ) (112 ) (231 ) — — — $ (290 ) $ 4,296 $ (87 ) $ 9,069 $ 12,507 $ 202 Year Ended June 26, 2016 Year Ended June 28, 2015 Location of
Gain (Loss)
Recognized in or
Reclassified into
IncomeEffective Portion Ineffective
Portion and
Amount
Excluded from
Effectiveness Effective Portion Ineffective
Portion and
Amount
Excluded from
EffectivenessDerivatives Designated as
Hedging
InstrumentsGain (Loss)
Recognized
in AOCI Gain (Loss)
Reclassified
from AOCI
into Income Gain (Loss)
Recognized
in Income Gain
Recognized
in AOCI Gain
Reclassified
from AOCI
into Income Gain (Loss)
Recognized
in Income (in thousands) (in thousands) Foreign exchange contracts Revenue $ (22,575 ) $ (2,950 ) $ 1,009 $ 13,678 $ 11,375 $ 258 Foreign exchange contracts Cost of goods
sold81 (2,423 ) (172 ) (6,318 ) (4,349 ) (75 ) Foreign exchange contracts Selling, general, and
administrative188 5 (69 ) (2,579 ) (2,618 ) (39 ) Foreign exchange contracts Other
expense, net— — (11 ) — — — Interest rate contracts Other
expense, net3,329 (360 ) 96 (5,071 ) (112 ) (231 ) $ (18,977 ) $ (5,728 ) $ 853 $ (290 ) $ 4,296 $ (87 ) The effect of derivative instruments not designated as cash flow hedges on the Company’s Consolidated Statement of Operations was as follows: Year Ended June 28, 2015 June 29, 2014 Derivatives Not Designated as Hedging
Instruments: Location of Gain Recognized
in Income Gain
Recognized
in Income Gain
Recognized
in Income (in thousands) Other income $ 1,784 $ 8,205 Year Ended June 26, 2016 June 28, 2015 Derivatives Not Designated as Hedging Instruments: Location of (Loss) Gain
Recognized
in IncomeLoss
Recognized
in Income Gain
Recognized
in Income (in thousands) Foreign Exchange Contracts Other income $ (16,208 ) $ 1,784 Concentrations of Credit RiskFinancial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, short term investments, restricted cash and investments, trade accounts receivable, and derivative financial instruments used in hedging activities. Cash is placed on deposit in large global financial institutions. Such deposits may be in excess of insured limits. Management believes that the financial institutions that hold the Company’s cash are creditworthy and, accordingly, minimal credit risk exists with respect to these balances.The Company’s over-all portfolio of available-for-sale securities must maintain an average minimum rating of “AA-” or “Aa3” as rated by Standard and Poor’s or Moody’s Investor Services, respectively. To ensure diversification and minimize concentration, the Company’s policy limits the amount of credit exposure with any one financial institution or commercial issuer.Continues on next pageLam Research Corporation 2016 10-K 80The Company is exposed to credit losses in the event of nonperformance by counterparties on the foreign currency forward contracts that are used to mitigate the effect of exchange rate fluctuations and on contracts related to structured share repurchase agreements. These counterparties are large global financial institutions and, to date, no such counterparty has failed to meet its financial obligations to the Company.Credit risk evaluations, including trade references, bank references and Dun & Bradstreet ratings, aeare performed on all new customers and the Company monitors its customers’ financial statements and payment performance. In general, the Company does not require collateral on sales.As of June 26, 2016, three customers accounted for approximately 24%, 19%, and 11% of accounts receivable. As of June 28, 2015, four customers accounted for approximately 17%, 13%, 12%, and 11% of accounts receivable. As of June 29, 2014, four customers accounted for approximately 15%, 13%, 12%, and 12% of accounts receivable. No other customers accounted for more than 10% of accounts receivable.Note 10:9: InventoriesInventories are stated at the lower of cost (first-in, first-out method) or market. System shipments to Japanese customers, for which title does not transfer until customer acceptance, are classified as finished goods inventory and carried at cost until title transfers. Inventories consist of the following: June 28,
2015 June 29,
2014 (in thousands) $ 566,645 $ 449,623 141,264 126,564 235,437 164,316 $ 943,346 $ 740,503 June 26,
2016 June 28,
2015 (in thousands) Raw materials $ 536,844 $ 566,645 Work-in-process 151,406 141,264 Finished goods 283,661 235,437 $ 971,911 $ 943,346 Note 11:10: Property and EquipmentProperty and equipment, net, consist of the following: June 28,
2015 June 29,
2014 (in thousands) $ 717,788 $ 612,688 137,623 131,184 53,391 52,784 238,631 199,544 81,899 80,569 21,629 20,026 1,250,961 1,096,795 (629,543 ) (553,299 ) $ 621,418 $ 543,496 June 26,
2016 June 28,
2015 (in thousands) Manufacturing, engineering and office equipment $ 824,532 $ 717,788 Computer equipment and software 157,125 137,623 Land 46,047 53,391 Buildings 213,364 238,631 Leasehold improvements 96,649 81,899 Furniture and fixtures 23,609 21,629 1,361,326 1,250,961 Less: accumulated depreciation and amortization (721,718 ) (629,543 ) $ 639,608 $ 621,418 Depreciation expense, including amortization of capital leases, during fiscal years 2016, 2015, and 2014, and 2013, was $134.7 million, $120.3 million, and $129.1 million, respectively.The Company recorded a $15.2 million gain on sale of real estate and $126.5 million, respectively. During therelated development rights, net of associated exit costs, in fiscal year 2015,2016 in selling, general and administrative expenses in the Company invested $12.7 million to purchase a commercial building in Fremont, California.During the fiscal year 2014, theConsolidated Statement of Operations. The Company recorded an $83.1 million gain on sale of real estate in the Consolidated Statement of Operations in fiscal year 2014. No significant gains on sale were realized in fiscal year 2015 or 2013.Continues on next pageLam Research Corporation 2016 10-K 81Note 12:11: Goodwill and Intangible AssetsGoodwillGoodwilldecreased towas $1.4 billion as of June 28, 2015, as compared to, $1.5 billion as of June 29, 2014. The primarily cause of the decrease was recognition of a $79.4 million impairment on the Company’s single-wafer clean reporting unit during the quarter ended26, 2016 and June 28, 2015. Uncertainty surrounding future revenue growth in certain products resulted in the estimated discounted cash flows falling below the carrying valueAs of June 26, 2016, $61.1 million of the goodwill balance. Following fiscal year 2015’s impairment, there is no remaining balance of the Company’s goodwill attributable to the single-wafer clean systems reporting unit.Of the $1.4 billion goodwill balance, $61.1 million is tax deductible and the remaining balance is not tax deductible due to purchase accounting and applicable foreign law.Intangible AssetsThe following table provides the Company’s intangible assets, other than goodwill, as of June 28, 2015: Gross Accumulated
Amortization Net (in thousands) $ 615,490 $ (234,968 ) $ 380,522 643,919 (313,071 ) 330,848 33,553 (26,431 ) 7,122 35,914 (35,366 ) 548 1,328,876 (609,836 ) 719,040 9,100 9,100 9,100 9,100 $ 1,337,976 $ (609,836 ) $ 728,140 Gross Accumulated
Amortization Net (in thousands) Customer relationships $ 615,272 $ (300,711 ) $ 314,561 Existing technology 643,433 (401,036 ) 242,397 Patents 36,053 (28,701 ) 7,352 Other intangible assets 36,114 (35,503 ) 611 Total intangible assets $ 1,330,872 $ (765,951 ) $ 564,921 The following table provides details of the Company’s intangible assets, other than goodwill, as of June 29, 2014: Gross Accumulated
Amortization Net (in thousands) $ 615,618 $ (169,162 ) $ 446,456 643,922 (224,246 ) 419,676 32,253 (24,407 ) 7,846 35,270 (35,270 ) — 1,327,063 (453,085 ) 873,978 11,000 11,000 9,100 9,100 20,100 20,100 $ 1,347,163 $ (453,085 ) $ 894,078 Gross Accumulated
Amortization Net (in thousands) Customer relationships $ 615,490 $ (234,968 ) $ 380,522 Existing technology 643,919 (313,071 ) 330,848 Patents 33,553 (26,431 ) 7,122 Other intangible assets 35,914 (35,366 ) 548 Intangible assets subject to amortization 1,328,876 (609,836 ) 719,040 Development rights 9,100 9,100 Intangible assets not subject to amortization 9,100 9,100 Total intangible assets $ 1,337,976 $ (609,836 ) $ 728,140 The Company recognized $156.3 million, $157.7 million, $163.2 million, and $177.6$163.2 million in intangible asset amortization expense during fiscal years 2016, 2015, and 2014, and 2013, respectively. During the fiscal year 2016, the company transferred ownership of the development rights previously recognize as a component of a real estate sale, see Note 10 for additional information regarding this transaction.The Company recognized a $9.8 million impairment of existing technology during the fiscal year 2015, resulting from current market demand for the technology. The Company recognized a $4.0 million impairment of in process research and development during fiscal year 2014, due to the cancellation of a project.Continues on next pageLam Research Corporation 2016 10-K 82The estimated future amortization expense of intangible assets, excluding those with indefinite lives, as of June 28, 201526, 2016 was as follows:Fiscal Year Amount (in thousands) $ 156,074 154,122 152,918 114,846 49,700 91,380 $ 719,040 Fiscal Year Amount (in thousands) 2017 $ 154,592 2018 153,379 2019 115,306 2020 50,107 2021 47,597 Thereafter 43,940 $ 564,921 Note 13:12: Accrued Expenses and Other Current LiabilitiesAccrued expenses and other current liabilities consist of the following: June 28,
2015 June 29,
2014 (in thousands) $ 314,516 $ 311,054 93,209 68,324 39,275 93,934 47,659 29,240 154,779 101,744 $ 649,438 $ 604,296 June 26,
2016 June 28,
2015 (in thousands) Accrued compensation $ 331,528 $ 314,516 Warranty reserves 100,321 93,209 Income and other taxes payable 86,723 39,275 Dividend payable 48,052 47,659 Other 206,286 154,779 $ 772,910 $ 649,438 Continues on next pageLam Research Corporation 2016 10-K 83Note 14:13: Long Term Debt and Other BorrowingsAs of June 26, 2016 and June 28, 2015, the Company's outstanding debt consisted of the following: June 26, 2016 June 28, 2015 Amount(in thousands) Effective Interest Rate Amount(in thousands) Effective Interest Rate Fixed-rate 0.50% Convertible Notes Due May 15, 2016 ("2016 Notes") $ — — $ 450,000 (3) 4.29 % Fixed-rate 1.25% Convertible Notes Due May 15, 2018 ("2018 Notes") 449,954 (1) 5.27 % 450,000 (3) 5.27 % Fixed-rate 2.75% Senior Notes Due March 15, 2020 ("2020 Notes") 500,000 2.88 % 500,000 2.88 % Fixed-rate 2.80% Senior Notes Due June 15, 2021 ("2021 Notes") 800,000 2.95 % — — Fixed-rate 3.45% Senior Notes Due June 15, 2023 ("2023 Notes") 600,000 3.60 % — — Fixed-rate 3.80% Senior Notes Due March 15, 2025 ("2025 Notes") 500,000 3.87 % 500,000 3.87 % Fixed-rate 3.90% Senior Notes Due June 15, 2026 ("2026 Notes") 1,000,000 4.01 % — — Fixed-rate 2.625% Convertible Notes Due May 15, 2041 ("2041 Notes") 699,895 (1) 4.28 % 699,935 (3) 4.28 % Total debt outstanding, at par 4,549,849 2,599,935 Unamortized discount (232,727 ) (247,849 ) Fair value adjustment - interest rate contracts 8,552 — Total debt outstanding, at carrying value $ 4,325,674 $ 2,352,086 Reported as: Current portion of long-term debt $ 942,298 (2) $ 1,358,126 (2) Long-term debt 3,383,376 993,960 Total debt outstanding, at carrying value $ 4,325,674 $ 2,352,086 (1)(2) As of the report date the market value of the Company's Common Stock was greater than 130% of the convertible notes conversion price for 20 or more of the 30 consecutive trading days preceding the quarter-end. As a result, the convertible notes were classified in current liabilities and a portion of the equity component, representing the unamortized discount, was classified in temporary equity on the Company's Consolidated Balance Sheets.(3) As of June 28, 2015, these notes were convertible at the option of the bond holder, as a result of the condition described in (2) above.The Company’s contractual cash obligations relating to its outstanding debt as of June 26, 2016 were as follows:Payments Due By Fiscal Year: Long-term
Debt (in thousands) 2017(1)$ 1,149,849 2018 — 2019 — 2020 500,000 2021 800,000 Thereafter 2,100,000 Total $ 4,549,849 __________________________________(1) As noted above, the conversion period for the 2018 and 2041 Notes is open as of June 26, 2016. As there is the potential for conversion at the option of the holder, the principal balance of the 2018 and 2041 Notes have been included in the one year payment period.Continues on next pageLam Research Corporation 2016 10-K 84Convertible Senior NotesIn May 2011, the Company issued and sold $450$450.0 million in aggregate principal amount of 0.50%0.5% Convertible Senior Notes due May 2016 (the “2016 Notes”) at par. At the same time, the Company issued and sold $450$450.0 million in aggregate principal amount of 1.25% Convertible Senior Notes due May 2018 (the “2018 Notes”) at par. The Company pays cash interest at an annual rate of 0.5% and 1.25%, respectively, on the 2016 Notes and the 2018 Notes, on a semi-annual basis on May 15 and November 15 of each year.In June 2012, with the acquisition of Novellus, the Company assumed $700$700.0 million in aggregate principal amount of 2.625% Convertible Senior Notes due May 2041 (the “2041 Notes,” collectively with the 2016 Notes (prior to the 2016 Notes current period maturity) and the 2018 Notes, the “Convertible Notes”). The Company pays cash interest at an annual rate of 2.625%, on a semi-annual basis on May 15 and November 15 of each year on the 2041 Notes. The 2041 Notes also have a contingent interest payment provision that may require the Company to pay additional interest, up to 0.60% per year, based on certain thresholds, beginning with the semi-annual interest payment on May 15, 2021, and upon the occurrence of certain events, as outlined in the indenture governing the 2041 Notes.The Company separately accounts for the liability and equity components of the Convertible Notes. The initial liability components of the Convertible Notes were valued based on the present value of the future cash flows using the Company’s borrowing rate at the date of the issuance or assumption for similar debt instruments without the conversion feature, which equals the effective interest rate on the liability component disclosed in the followingtable, respectively. table. The equity component was initially valued equal to the principle value of the notes, less the present value of the future cash flows using the Company’s borrowing rate at the date of the issuance or assumption for similar debt instruments without a conversion feature, which equated to the initial debt discount.Under certain circumstances, the Convertible Notes may be converted into shares of the Company’s Common Stock. The number of shares each debenture is convertible into is based on conversion rates, disclosed in the following table. The conversion rates are adjusted for certain corporate events, including dividends on the Company’s Common Stock. At June 28, 2015,In addition to the market valueconversion of the Company’s Common Stock was greater than 130%2016 Notes described above, during the year ended June 26, 2016, 99 of the Convertible Notes, conversion prices for 20 or morewith a total par value of $99.0 thousand were settled at the note holders’ option. In conjunction with the conversions in the year ended June 26, 2016, 475 shares of common stock were issued. Additionally, during the year ended June 26, 2016, the Company received notice of note holders' intention to convert 12 of the 30 consecutive trading days preceding2041 Notes, the quarter end. As a result,Company expects those conversions to settle in the three months ended September 25, 2016.Continues on next pageLam Research Corporation 2016 10-K 85Selected additional information regarding the Convertible Notes are convertible at the optionoutstanding as of the bondholder. The carrying amount of the Convertible Notes was classified in current liabilitiesJune 26, 2016 and a portion of the equity component, representing the unamortized debt discount, was classified in temporary equity on the Company’s Consolidated Balance Sheets. Upon closure of the conversion period, the 2018 and 2041 Notes not converted will be reclassified back into noncurrent liabilities, the 2016 Notes will remain in current liabilities due to its scheduled maturity, and the temporary equity will be reclassified into permanent equity. At June 29, 2014 the 2041 Notes were convertible at the option of the bondholder.As of June 28, 2015 and June 29, 2014, the Convertible Notes consisted of the following: June 28, 2015 June 29, 2014 2016
Notes 2018
Notes 2016
Notes 2018
Notes 2041
Notes (in thousands, except years, percentages, conversion rate, and
conversion price) $ — $ — $ — $ 419,561 $ 387,338 $ — 435,493 402,320 520,313 — — 516,586 14,507 47,680 179,622 30,439 62,662 183,349 $ 450,000 $ 450,000 $ 699,935 $ 450,000 $ 450,000 $ 699,935 $ 61,723 $ 57,215 $ 148,487 $ 76,230 $ 104,895 $ 144,760 $ 14,507 $ 47,679 $ 179,622 $ — $ — $ 183,349 0.9 2.9 25.9 4.29% 5.27% 4.28% $ 604,004 $ 643,500 $ 1,679,844 16.0806 16.0806 28.8585 $ 62.19 $ 62.19 $ 34.65 $ 149,598 $ 149,598 $ 973,758 June 26, 2016 June 28, 2015 2018
Notes 2041
Notes 2016
Notes 2018
Notes 2041
Notes (in thousands, except years, percentages, conversion rate, and conversion price) Carrying amount of permanent equity component, net of tax $ 72,992 $ 152,397 $ 61,723 $ 57,215 $ 148,487 Carrying amount of temporary equity component, net of tax $ 31,894 $ 175,658 $ 14,507 $ 47,679 $ 179,622 Remaining amortization period (years) 1.9 24.9 Fair Value of Notes (Level 2) $ 645,009 $ 1,732,240 Conversion rate (shares of common stock per $1,000 principal amount of notes) 16.3354 29.3158 Conversion price (per share of common stock) $ 61.22 $ 34.11 If-converted value in excess of par value $ 154,818 $ 988,326 Estimated share dilution using average quarterly stock price of $80.08 per share 1,731 11,778 Convertible Note Hedges and WarrantsConcurrent with the issuance of the 2016 Notes and 2018 Notes, the Company purchased a convertible note hedge and sold warrants. At expiration, the Company may, at its option, elect to settle the warrants on a net share basis. As of June 28, 2015,26, 2016, the warrants had not been exercised and remained outstanding. The exercise price is adjusted for certain corporate events, including dividends on the Company’s Common Stock.In conjunction with the convertible note hedge, counterparties agreed to sell to the Company shares of Common Stock equal to the number of shares issuable upon conversion of the 2016 Notes and 2018 Notes in full. Theshares andshares. The note hedges will terminate upon the earlier of (i) the maturity date, or (ii) the first day none of the respective notes remain outstanding, due to conversion or otherwise. Settlement of the convertible note hedge in net shares, based on the number of shares issued upon conversion of the 2016 and 2018 Notes, on the expiration date would result in the Company receiving net shares equivalent to the number of shares issuable by the Company upon conversion of the 2016 Notes and 2018 Notes. The Company exercised the convertible note hedge related to the 2016 Notes in the year ended June 26, 2016, to offset the impact of the Company's Common Stock issued for conversions just prior to scheduled maturity, as described above. Additionally, the impact of the Company's exercise of the note hedge associated with the 2016 Notes and 2018 Notes converted during the year ended June 26, 2016 was the receipt of 79 shares of the Company's Common Stock. The exercise price is adjusted for certain corporate events, including dividends on the Company’s Common Stock.The following table presents the details of the warrants and convertible note hedge arrangements as of June 28, 2015: 2016 Notes 2018 Notes (shares in thousands) 7,236 7,236 $70.40 $75.10 August 15 - October 21, 2016 August 15 - October 23, 2018 7,236 7,236 $62.19 $62.19 2016 Notes 2018 Notes (shares in thousands) Warrants: Number of shares to be delivered upon exercise 7,351 7,350 Estimated share dilution using average quarterly stock price $80.08 per share 990 565 Exercise price $ 69.30 $ 73.93 Expiration date range August 15 - October 21, 2016 August 15 - October 23, 2018 Convertible Note Hedge: Number of shares available from counterparties — 7,350 Exercise price — $ 61.22 Continues on next pageLam Research Corporation 2016 10-K 86Senior NotesOn March 12, 2015, the Company completed a public offering of $500$500.0 million aggregate principal amount of the Company’s Senior Notes due March 2020 (the “2020 Notes”) and $500$500.0 million aggregate principal amount of the Company’s Senior Notes due March 2025 (the “2025 Notes”, together with the 2020 Notes, the “Senior Notes”). The Company will pay interest at an annual rate of 2.75% and 3.80%, respectively, on the 2020 Notes and 2025 Notes, on a semi-annual basis on March 15 and September 15 of each year, beginning September 15, 2015.The Company may redeem the Senior Notes at a redemption price equal to 100% of the principal amount of such series (“par”), plus a “make whole” premium as described in the indenture in respect of the Senior Notes and accrued and unpaid interest before February 15, 2020, for the 2020 Notes and before December 15, 2024, for the 2025 Notes. The Company may redeem the Senior Notes at par, plus accrued and unpaid interest at any time on or after February 15, 2020 for the 2020 Notes and on or after December 24, 2024 for the 2025 Notes. In addition, upon the occurrence of certain events, as described in the indenture, the Company will be required to make an offer to repurchase the Senior Notes at a price equal to 101% of the principal amount of the Senior Notes, plus accrued and unpaid interest.AsOn June 7, 2016, The Company completed a public offering of $800.0 million aggregate principal amount of Senior Notes due June 28,2021 (the "2021 Notes"), $600.0 million aggregate principal amount of Senior Notes due June 2023 (the "2023 Notes") and $1.0 billion aggregate principal amount of Senior Notes due June 2026 (the "2026 Notes" together with the 2020, 2021, 2023, and 2025 Notes, the “Senior Notes”). The Company will pay interest at an annual rate of 2.80%, 3.45% and 3.90%, respectively, on the 2021 Notes, 2023 Notes and 2026 Notes, on a semi-annual basis on June 15 and December 15 of each year, beginning December 15, 2016.The Company may redeem the 2021 Notes, 2023 Notes, and 2026 Notes at a redemption price equal to 100% of the principal amount of such series (“par”), plus a “make whole” premium as described in the indenture in respect to the 2021 Notes, 2023 Notes, and 2026 Notes and accrued and unpaid interest before May 15, 2021, for the 2021 Notes, before April 15, 2023 for the 2023 Notes, and before March 15, 2026, for the 2026 Notes. The Company may redeem the 2021 Notes, 2023 Notes, and 2026 Notes at par, plus accrued and unpaid interest at any time on or after May 15, 2021 for the 2021 Notes, on or after April 15, 2023 for the 2023 Notes, and on or after March 15, 2026 for the 2026 Notes. In addition, upon the occurrence of certain events, as described in the indenture, the Company will be required to make an offer to repurchase the 2021 Notes, 2023 Notes and 2026 Notes at a price equal to 101% of the principal amount of the respective note, plus accrued and unpaid interest.In the event (i) the proposed merger with KLA-Tencor is not completed on or prior to December 30, 2016, or (ii) the Agreement and Plan of Merger and Reorganization, dated as of October 20, 2015, by and among us, KLA-Tencor, Topeka Merger Sub 1, Inc., and Topeka Merger Sub 3, Inc. (as assignee of Topeka Merger Sub 2), is terminated on or at any time prior to such date (each such event referred to as a “Special Mandatory Redemption Event”), the Company will be required to redeem all of the 2023 Notes and the 2026 Notes then outstanding, at a special mandatory redemption price equal to 101% of the aggregate principal amount of such notes, plus accrued and unpaid interest from the date of initial issuance, or the most recent interest payment date on which interest was paid, whichever is later, to, but not including, the Special Mandatory Redemption Date (as defined below). The 2021 Notes are not subject to this special mandatory redemption. The “Special Mandatory Redemption Date” means the date specified in the notice of special mandatory redemption to be delivered to the holders of the notes within five business days following the Special Mandatory Redemption Event, which Special Mandatory Redemption Date shall be three business days after such notice is mailed.Continues on next pageLam Research Corporation 2016 10-K 87Selected additional information regarding the Senior Notes consistedoutstanding as of the following: June 28, 2015 2020 Notes 2025 Notes (in thousands, except years) $ 497,053 $ 496,907 2,947 3,093 $ 500,000 $ 500,000 4.7 9.7 $ 497,805 $ 492,945 Interest CostThe following table presents the amount of interest cost recognized relating to both the contractual interest coupon and amortization of the debt discount, issuance costs, and effective portion of interest rate contracts with respect to the Senior Notes and the Convertible Notes during the twelve months ended June 29, 2015, June 28, 2014, and June 30, 2013. Twelve Months Ended June 28,
2015 June 29,
2014 June 30,
2013 (in thousands) $ 36,074 $ 26,248 $ 26,248 34,886 33,065 31,560 2,435 2,362 2,362 113 — — $ 73,508 $ 61,675 $ 60,170 Revolving Credit Facility26, 2016 is as follows: Remaining Amortization period Fair Value of Notes (Level 2) (years) (in thousands) 2020 Notes 3.7 $ 506,250 2021 Notes 5.0 $ 818,104 2023 Notes 7.0 $ 614,970 2025 Notes 8.7 $ 510,750 2026 Notes 10.0 $ 1,049,510 Term Loan AgreementOn March 12, 2014, the CompanyMay 13, 2016, we entered into a $300 million revolving unsecured credit facilityan Amended and Restated Term Loan Agreement (the “Amended and Restated Term Loan Agreement”), which amends and restates the Term Loan Agreement we entered into on November 10, 2015 with a syndicate of lenders. The Amended and Restated Term Loan Agreement provides for a $1,530.0 million senior unsecured term loan facility maturescomposed of two tranches; (i) a $1,005.0 million tranche of 3-year senior unsecured loans (the "3-Year Tranche") maturing on the 3-year anniversary of the closing date of the acquisition of KLA-Tencor subject to several conditions; and (ii) a $525.0 million tranche of 5-year senior unsecured loans (the "5-Year Tranche") maturing on the 5-year anniversary of the closing date of the acquisition of KLA-Tencor subject to several conditions. The Amended and Restated Term Loan will terminate on October 20, 2016 if the merger has not been consummated by such date.Interest on amounts borrowed under the Amended and Restated Term Loan Agreement is, at the Company’s option, based on (i) a base rate, defined as the greatest of (a) prime rate, (b) Federal Funds rate plus 0.50%, or (c) one-month LIBOR plus 1.00%, plus a spread of 0.00% to 0.75% for the 3-Year Tranche or 0.125% to 1.000% for the 5-Year Tranche or (ii) LIBOR multiplied by the statutory reserve rate, plus a spread of 1.000% to 1.750% for the 3-Year Tranche or 1.125% to 2.000% for the 5-Year Tranche, in each case as the applicable spread is determined based on the rating of the Company’s non-credit enhanced, senior unsecured long-term debt.Principal and accrued and unpaid interest is due and payable in equal quarterly amounts as set forth in the Amended and Restated Term Loan Agreement, with any remaining balance due and accrued and unpaid interest due at maturity. Additionally, the Company will pay the lenders a quarterly commitment fee that varies based on the Company’s rating described above. The Amended and Restated Term Loan Agreement also contains financial covenants that require the Company to maintain (i) a consolidated debt to capitalization ratio of no more than 0.50 to 1.00 (the “Capitalization Covenant”), provided that, until and including the earlier of (x) the end of the first two consecutive full fiscal quarters following the Amended and Restated Term Loan Agreement's closing date that the Company is in compliance with the Capitalization Covenant and (y) December 31, 2017, if the Company is not in compliance with the Capitalization Covenant, the Company will be deemed not to have violated the Capitalization Covenant so long as the Company’s consolidated debt to adjusted EBITDA ratio is less than or equal to 4.50 to 1.00 for the period of four fiscal quarters then ended, and (ii) liquidity of no less than $1.0 billion, in each case determined in accordance with the Amended and Restated Term Loan Agreement. The funding of the loans under the Amended and Restated Term Loan Agreement will be on the closing date of the acquisition of KLA-Tencor subject to several conditions.Revolving Credit FacilityOn November 10, 2015, we entered into an Amendment and Restatement Agreement (as amended on April 26, 2016 by Amendment No. 1 to the Amended and Restated Credit Agreement, and as further amended, restated, supplemented or otherwise modified from time to time, the “Amended and Restated Credit Agreement”), which amends and restates the Company's prior unsecured Credit Agreement, dated March 12, 2019.2014 (as amended by Amendment No. 1, dated March 5, 2015). The Amended and Restated Credit Agreement provides for an increase to our revolving unsecured credit facility, from $300.0 million to $750.0 million with a syndicate of lenders. It includes an expansion option, subject to certain requirements, for the Companyus to request an increase in the facility of up to an additional $200$250.0 million, for a potential total commitment of $500 million.$1.0 billion. Proceeds from the credit facility can be used for general corporate purposes.Continues on next pageLam Research Corporation 2016 10-K 88Interest on amounts borrowed under the credit facility is, at the Company’s option, based on (i) a base rate, defined as the greatest of (a) prime rate, (b) Federal Funds rate plus 0.5%, or (c) one-month LIBOR plus 1.0%, plus a spread of 0.0% to 0.5%, or (ii) LIBOR multiplied by the statutory rate, plus a spread of 0.9% to 1.5%, in each case as the applicable spread is determined based on the rating of the Company’s non-credit enhanced, senior unsecured long-term debt. Principal and any accrued and unpaid interest is due and payable upon maturity. Additionally, the Company will pay the lenders a quarterly commitment fee that varies based on the Company’s rating described above.credit rating. The credit facilityRestated Credit Agreement contains certain restrictiveaffirmative covenants, including maintaining a total consolidated indebtednessnegative covenants, financial covenants and events of default that are substantially similar to consolidated capitalization ratio of no more than 0.5 to 1.0those in the Amended and maintaining unrestricted or unencumbered cash and investments of no less than $1.0 billion.Restated Term Loan Agreement. As of June 28, 2015,26, 2016, the Company had no borrowings outstanding under the credit facility and was in compliance with all financial covenants.Contractual ObligationsBridge FacilityOn October 20, 2015, the Company obtained a commitment for $4.2 billion of bridge financing from Goldman Sachs Bank USA and Goldman Sachs Lending Partners LLC (“the Commitment Parties”) to finance, in part, the acquisition of KLA-Tencor. The Company’s contractual cash obligationsCommitment Parties' commitment to provide financing (the “Bridge Facility”) is subject to certain conditions, including consummation of the merger with KLA-Tencor. On November 10, 2015, the Company entered into the Term Loan Agreement for $0.9 billion and the Bridge Facility was reduced to $3.3 billion, correspondingly, both with a syndicate of lenders. Following the execution of our June 2016 debt offering and other available credit modifications (see Note 13), this commitment was terminated during the three months ended June 26, 2016.Interest CostThe following table presents the amount of interest cost recognized relating to its Convertible Notesboth the contractual interest coupon and amortization of the debt discount, issuance costs, and effective portion of interest rate contracts with respect to the long-term debt and other long-term debt as ofborrowings during the fiscal years ended June 26, 2016, June 28, 2015, were as follows: Long-term
Debt (in thousands) $ 1,599,935 — — — 500,000 500,000 2,599,935 1,599,935 $ 1,000,000
and June 29, 2014.*As noted above, the conversion periods for the Convertible Notes are open as of June 28, 2015. As there is the potential for conversion at the option of the holder, the principal balance of the 2018 and 2041 Notes have been included in the one year payment period. As of August 6, 2015, none of the Convertible Notes have been converted during fiscal year 2015 or 2014. June 26,
2016 June 28,
2015 June 29,
2014 (in thousands) Contractual interest coupon $ 63,053 $ 36,074 $ 26,248 Amortization of interest discount 35,206 34,886 33,065 Amortization of issuance costs 35,315 2,435 2,362 Amortization of interest rate contract 359 113 — Total interest cost recognized $ 133,933 $ 73,508 $ 61,675 The increase in interest expense during the fiscal year ended June 26, 2016 is primarily the result of the issuance of $1.0 billion Senior Notes in March 2015. The increase in amortization of issuance costs during the year ended June 26, 2016 is primarily due the amortization of bridge loan financing issuance costs of approximately $31.9 million.Note 15:14: Retirement and Deferred Compensation PlansEmployee Savings and Retirement PlanThe Company maintains a 401(k) retirement savings plan for its eligible employees in the United States. Each participant in the plan may elect to contribute from 1% to 75% of annual eligible earnings to the plan, subject to statutory limitations. The Company makes matching employee contributions in cash to the plan at the rate of 50% of the first 6% of earnings contributed. Employees participating in the 401(k) retirement savings plan are fully vested in the Company matching contributions, and investments are directed by participants. The Company made matching contributions of $13.2 million, $11.8 million, $10.2 million, and $8.7$10.2 million, in fiscal years 2016, 2015, and 2014, and 2013, respectively.Continues on next pageLam Research Corporation 2016 10-K 89Deferred Compensation ArrangementsThe Company has an unfunded, non-qualified deferred compensation plan whereby certain executives may defer a portion of their compensation. Participants earn a return on their deferred compensation based on their allocation of their account balance among various mutual funds. The Company controls the investment of these funds and the participants remain general creditors of the Company. Participants are able to elect the payment of benefits on a specified date at least three years after the opening of a deferral subaccountsub-account or upon retirement. Distributions are made in the form of lump sum or annual installments over a period of up to 20 years as elected by the participant. If no alternate election has been made, a lump sum payment will be made upon termination of a participant’s employment with the Company. As of June 28, 201526, 2016 and June 29, 201428, 2015, the liability of the Company to the plan participants was $113.4$122.9 million and $93.8$113.4 million, respectively, which was recorded in accrued expenses and other current liabilities on the Consolidated Balance Sheets. As of June 28, 201526, 2016 and June 29, 201428, 2015, the Company had investments in the aggregate amount of $138.9$149.8 million and $116.7$138.9 million, respectively, which correlate to the deferred compensation obligations, which were recorded in other assets on the Consolidated Balance Sheets.Postretirement Healthcare PlanThe Company maintains a postretirement healthcare plan for certain executive and director retirees. Coverage continues through the duration of the lifetime of the retiree or the retiree’s spouse, whichever is longer. The benefit obligation was $30.2$37.0 million and $29.0$30.2 million as of June 26, 2016 and June 28, 2015, and June 29, 2014, respectively.Note 16:15: Commitments and ContingenciesThe Company has certain obligations to make future payments under various contracts, some of these are recorded on its balance sheet and some are not. Obligations that are recorded on the Company’s balance sheet include the Company’s capital lease obligations. Obligations that are not recorded on the Company’s balance sheet include contractual relationships for operating leases, purchase obligations, and certain guarantees. The Company’s commitments relating to capital leases and off-balance sheet agreements are included in the tables below. These amounts exclude $202.9$231.5 million of liabilities related to uncertain tax benefits because the Company is unable to reasonably estimate the ultimate amount or time of settlement. See Note 76 of the Consolidated Financial Statements for further discussion.Capital LeasesCapital leases reflect building and office equipment leases. The Company’s contractual cash obligations relating to its existing capital leases, including interest, as of June 28, 201526, 2016 were as follows: Capital
Leases (in thousands) $ 1,630 7,223 77 77 70 9,077 131 1,524 $ 7,422 Payments Due By Fiscal Year: Capital
Leases (in thousands) 2017 $ 7,208 2018 83 2019 77 2020 57 2021 — Total 7,425 Interest on capital leases 24 Current portion of capital leases 7,196 Long-term portion of capital leases $ 205 Continues on next pageLam Research Corporation 2016 10-K 90Operating Leases and Related GuaranteesThe Company leases the majority of its administrative, R&D and manufacturing facilities, regional sales/service offices and certain equipment under non-cancelable operating leases. Certain of the Company’s facility leases for buildings located at its Fremont, California headquarters and certain other facility leases provide the Company with options to extend the leases for additional periods or to purchase the facilities. Certain of the Company’s facility leases provide for periodic rent increases based on the general rate of inflation. The Company’s rental expense for facilities occupied during fiscal years 2016, 2015, 2014, and 20132014 was approximately $16 million, $15 million, and $12 million, and $14 million, respectively.The Company has operating leases regarding certain improved properties in Fremont and Livermore, California (the “Operating Leases”). The Company is required to maintain cash collateral in an aggregate of approximately $132.5$244.8 million in separate interest-bearing accounts and marketable securities collateral in an aggregate of approximately $32.9 million, as security for the Company’s obligations. These amounts are recorded with other restricted cash and investments in the Company’s Consolidated Balance Sheet as of June 28, 2015.During the term of the Operating Leases and when the terms of the Operating Leases expire, the property subject to those Operating Leases may be remarketed.re-marketed. The Company has guaranteed to the lessor that each property will have a certain minimum residual value. The aggregate guarantee made by the Company under the Operating Leases is generally no more than $219.0 million; however, under certain default circumstances, the guarantee with regard to an Operating Lease may be 100% of the lessor’s aggregate investment in the applicable property, which in no case will exceed $249.9 million, in the aggregate.The Company’s contractual cash obligations with respect to operating leases, excluding the residual value guarantees discussed above, as of June 28, 201526, 2016 were as follows: Operating
Leases (in thousands) $ 17,593 14,004 6,544 5,223 4,847 10,811 (478 ) $ 58,544 Payments Due By Fiscal Year: Operating
Leases (in thousands) 2017 $ 20,393 2018 10,495 2019 9,407 2020 7,418 2021 6,152 Thereafter 8,758 Less: Sublease Income (206 ) Total $ 62,417 Other GuaranteesThe Company has issued certain indemnifications to its lessors for taxes and general liability under some of its agreements. The Company has entered into insurance contracts that are intended to limit its exposure to such indemnifications. As of June 28, 2015,26, 2016, the Company had not recorded any liability on its Consolidated Financial Statements in connection with these indemnifications, as it does not believe that it is probable that any amounts will be paid under these guarantees.Generally, the Company indemnifies, under pre-determined conditions and limitations, its customers for infringement of third-party intellectual property rights by the Company’s products or services. The Company seeks to limit its liability for such indemnity to an amount not to exceed the sales price of the products or services subject to its indemnification obligations. The Company does not believe that it is probable that any material amounts will be paid under these guarantees.The Company provides guarantees and standby letters of credit to certain parties as required for certain transactions initiated during the ordinary course of business. As of June 28, 2015,26, 2016, the maximum potential amount of future payments that the Company could be required to make under these arrangements and letters of creditContinues on next pageLam Research Corporation 2016 10-K 91was $15.5$12.1 million. The Company does not believe, based on historical experience and information currently available, that it is probable that any amounts will be required to be paid.Purchase ObligationsPurchase obligations consist of non-cancelable significant contractual obligations either on an annual basis or over multi-year periods. The contractual cash obligations and commitments table presented below contains the Company’s minimum obligations at June 28, 201526, 2016 under these arrangements and others. For obligations with cancellation provisions, the amounts included in the following table were limited to the non-cancelable portion of the agreement terms or the minimum cancellation fee. Actual expenditures will vary based on the volume of transactions and length of contractual service provided.The Company’s commitments related to these agreements as of June 28, 201526, 2016 were as follows: Purchase
Obligations (in thousands) $ 189,955 980 980 970 970 $ 193,855 Payments Due By Fiscal Year: Purchase
Obligations (in thousands) 2017 $ 221,312 2018 2,179 2019 2,179 2020 2,144 2021 2,061 Thereafter 1,711 Total $ 231,586 WarrantiesThe Company provides standard warranties on its systems. The liability amount is based on actual historical warranty spending activity by type of system, customer, and geographic region, modified for any known differences such as the impact of system reliability improvements.Changes in the Company’s product warranty reserves were as follows: Year Ended June 28,
2015 June 29,
2014 (in thousands) $ 69,385 $ 58,078 119,119 87,922 (100,196 ) (80,280 ) 4,901 3,665 $ 93,209 $ 69,385 Year Ended June 26,
2016 June 28,
2015 (in thousands) Balance at beginning of period $ 93,209 $ 69,385 Warranties issued during the period 124,582 119,119 Settlements made during the period (114,008 ) (100,196 ) Changes in liability for pre-existing warranties (3,462 ) 4,901 Balance at end of period $ 100,321 $ 93,209 Legal ProceedingsWhile the Company is not currently a party to any legal proceedings that it believes material, the Company is either a defendant or plaintiff in various actions that have arisen from time to time in the normal course of business, including intellectual property claims. The Company accrues for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Significant judgment is required in both the determination of probability and the determination as to whether a loss is reasonably estimable. To the extent there is a reasonable possibility that the losses could exceed the amounts already accrued, the Company believes that the amount of any such additional loss would be immaterial to the Company’s business, financial condition, and results of operations.Note 17:16: Stock Repurchase ProgramOn April 29, 2014, the Board of Directors authorized the repurchase of up to $850$850.0 million of Common Stock. These repurchases can be conducted on the open market or as private purchases and may include the use of derivative contracts with large financial institutions, in all cases subject to compliance with applicable law. Repurchases are funded using the Company’s on-shore cash and on-shore cash generation. This repurchase program has no termination date and may be suspended or discontinued at any time.Continues on next pageLam Research Corporation 2016 10-K 92Repurchases under the repurchase program were as follows during the periods indicated:Period Total Number
of Shares
Repurchased Total
Cost of
Repurchase Average
Price Paid
Per Share* Amount Available
Under Repurchase
Program (in thousands, except per share data) $ 830,895 3,818 $ 296,721 $ 70.01 $ 534,174 869 $ 45,694 $ 77.31 $ 488,480 1,434 $ 112,477 $ 78.45 $ 376,003 754 $ 59,416 $ 78.80 $ 316,587 *Average price paid per share excludes accelerated share repurchases for which cost was incurred during the September 2014 quarter, but that did not settle until the December 2014 quarter. See the section below for discussion regarding average price associated with the transaction.Period Total Number
of Shares
Repurchased Total
Cost of
Repurchase Average
Price Paid
Per Share Amount Available
Under Repurchase
Program (in thousands, except per share data) Available balance as of June 28, 2015 $ 316,587 Quarter Ended September 27, 2015 1,205 $ 87,493 $ 72.61 $ 229,094 Quarter Ended December 27, 2015 — $ — $ — $ 229,094 Quarter Ended March 27, 2016 — $ — $ — $ 229,094 Quarter Ended June 26, 2016 — $ — $ — $ 229,094 In addition to shares repurchased under the Board-authorized repurchase program shown above, the Company acquired 761,883924,823 shares at a total cost of $58.8$67.6 million, during the twelve months ended June 28, 2015,26, 2016, which the Company withheld through net share settlements to cover minimum tax withholding obligations upon the vesting of restricted stock unit awards granted under the Company’s equity compensation plans. The shares retained by the Company through these net share settlements are not a part of the Board-authorized repurchase program but instead are authorized under the Company’s equity compensation plans.As part of its share repurchase program, the The Company mayis restricted from time-to-time enter into structured share repurchase arrangements with financial institutions using general corporate funds.During the three months ended September 28, 2014, the Company entered into a collared accelerated share repurchase (“ASR”) transaction under a master repurchase arrangement. Under the ASR, the Company made an up-front cash payment of $250 million, in exchange for an initial delivery of approximately 3.2 million shares of its Common Stock.The number of shares to ultimately be repurchased by the Company was based generally on the volume-weighted average price (“VWAP”) of therepurchasing Common Stock duringpursuant to the termKLA-Tencor merger agreement.Continues on next pageLam Research Corporation 2016 10-K 93Note 18:17: Comprehensive Income (Loss)The components of accumulated other comprehensive loss, net of tax at the end of the period, as well as the activity during the period, were as follows: Accumulated
foreign currency
translation
adjustment Accumulated
unrealized holding
gain (loss) on
cash flow hedges Accumulated
unrealized holding
gain (loss) on
available-for-sale
investments Accumulated
unrealized
components of
defined benefit
plans Total (in thousands) $ (12,986 ) $ (66 ) $ 1,557 $ (17,160 ) $ (28,655 ) (18,438 ) 1,595 (5,389 ) 1,109 (21,123 ) (3,701 ) (4,388 )(1) 71 (2) — (8,018 ) $ (22,139 ) $ (2,793 ) $ (5,318 ) $ 1,109 $ (29,141 ) $ (35,125 ) $ (2,859 ) $ (3,761 ) $ (16,051 ) $ (57,796 ) Accumulated
foreign currency
translation
adjustment Accumulated
unrealized holding
gain (loss) on
cash flow hedges Accumulated
unrealized holding
gain (loss) on
available-for-sale
investments Accumulated
unrealized
components of
defined benefit
plans Total (in thousands) Balance as of June 28, 2015 $ (35,125 ) $ (2,859 ) $ (3,761 ) $ (16,051 ) $ (57,796 ) Other comprehensive (loss) income before reclassifications (4,287 ) (17,725 ) 9,028 (3,027 ) (16,011 ) (Gains) losses reclassified from accumulated other comprehensive income (loss) to net income (116 ) 4,961 (1) (371 ) (2) — 4,474 Net current-period other comprehensive (loss) income (4,403 ) (12,764 ) 8,657 (3,027 ) (11,537 ) Balance as of June 26, 2016 $ (39,528 ) $ (15,623 ) $ 4,896 $ (19,078 ) $ (69,333 ) __________________________________(1) Amount of after tax gain reclassified from accumulated other comprehensive income into net income located in revenue: $10,136$2,623 gain, cost of goods sold: $3,704 loss, selling, general and administrative expenses: $1,974 loss,$2,111 gain, and other income and expense: $70 Loss$227 gain.(2) Amount of after tax gain reclassified from accumulated other comprehensive income into net income located in other expense, netnet.Continues on next pageLam Research Corporation 2016 10-K 94Tax related to the components of other comprehensive income during the period were as follows: Year Ended June 28,
2015 June 29,
2014 June 30,
2013 (in thousands) $ 1,885 $ (1,065 ) $ (1,312 ) (92 ) 1,615 818 1,793 550 (494 ) 1,796 (735 ) 1,428 31 493 (2,026 ) 1,827 (242 ) (598 ) (871 ) 1,895 586 $ 2,749 $ 2,203 $ (506 ) Year Ended June 26,
2016 June 28,
2015 June 29,
2014 (in thousands) Tax benefit (expense) on change in unrealized gains/losses on cash flow hedges: Tax benefit (expense) on unrealized gains/losses arising during the period $ 1,252 $ 1,885 $ (1,065 ) Tax (benefit) expense on gains/losses reclassified to earnings (767 ) (92 ) 1,615 485 1,793 550 Tax (expense) benefit on change in unrealized gains/losses on available-for-sale investments: Tax (expense) benefit on unrealized gains/losses arising during the period (2,764 ) 1,796 (735 ) Tax expense (benefit) on gains/losses reclassified to earnings 245 31 493 (2,519 ) 1,827 (242 ) Tax benefit (expense) on change in unrealized components of defined benefit plans 1,648 (871 ) 1,895 Tax (expense) benefit on other comprehensive (loss) income $ (386 ) $ 2,749 $ 2,203 Note 19:18: Segment, Geographic Information and Major CustomersThe Company operates in one reportable business segment: manufacturing and servicing of wafer processing semiconductor manufacturing equipment. The Company’s material operating segments qualify for aggregation due to their customer base and similarities in economic characteristics, nature of products and services, and processes for procurement, manufacturing and distribution.The Company operates in seven geographic regions: United States, Europe, Japan, Korea, Taiwan, China and Southeast Asia. For geographical reporting, revenue is attributed to the geographic location in which the customers’ facilities are located while long-lived assets are attributed to the geographic locations in which the assets are located.Revenues and long-lived assets by geographic region were as follows: Year Ended June 28,
2015 June 29,
2014 June 30,
2013 (in thousands) $ 1,406,617 $ 1,127,406 $ 603,821 1,084,239 1,049,214 1,026,548 890,891 622,022 734,324 661,094 623,408 319,282 623,575 634,131 368,095 314,546 303,730 292,432 278,350 247,398 254,414 $ 5,259,312 $ 4,607,309 $ 3,598,916 June 28,
2015 June 29,
2014 June 30,
2013 (in thousands) $ 505,814 $ 429,548 $ 484,273 86,779 89,221 109,934 18,230 18,776 991 8,908 4,259 2,953 960 846 2,291 378 454 680 349 392 2,788 $ 621,418 $ 543,496 $ 603,910 Year Ended June 26,
2016 June 28,
2015 June 29,
2014 (in thousands) Revenue: Taiwan $ 1,485,037 $ 1,084,239 $ 1,049,214 Korea 1,057,331 1,406,617 1,127,406 China 1,039,951 661,094 623,408 Japan 983,821 623,575 634,131 Southeast Asia 605,236 278,350 247,398 United States 495,123 890,891 622,022 Europe 219,394 314,546 303,730 Total revenue $ 5,885,893 $ 5,259,312 $ 4,607,309 Continues on next pageLam Research Corporation 2016 10-K 95 June 26,
2016 June 28,
2015 June 29,
2014 (in thousands) Long-lived assets: United States $ 529,316 $ 505,814 $ 429,548 Europe 81,377 86,779 89,221 Korea 17,281 18,230 18,776 Taiwan 8,647 8,908 4,259 China 1,339 960 846 Japan 980 378 454 Southeast Asia 668 349 392 $ 639,608 $ 621,418 $ 543,496 In fiscal year 2016, four customers accounted for approximately 17%, 16%, 12%, and 10% of total revenues. In fiscal year 2015, three customers accounted for approximately 28%, 12%, and 11% of total revenues. In fiscal year 2014, three customers accounted for approximately 23%, 15%, and 14% of total revenues. In fiscal year 2013, three customers accounted for approximately 19%, 15%, and 11% of total revenues. No other customers accounted for more than 10% of total revenues.Note 19 – Business CombinationsOn October 20, 2015, the Company entered into an Agreement and Plan of Merger and Reorganization with KLA-Tencor, under which KLA-Tencor will ultimately become (assuming satisfaction or waiver of all conditions to closing) a direct or indirect wholly-owned subsidiary of Lam Research.Each KLA-Tencor stockholder may elect to receive, for all shares of KLA-Tencor common stock they hold at the closing of the transaction, one of the following, determined on a per-share basis: (1) mixed consideration, consisting of both (i) 0.5 of a share of Common Stock and (ii) $32.00 in cash; (2) all-stock consideration, consisting of a number of shares of Common Stock equal to (i) 0.5 plus (ii) the quotient of $32.00 divided by the five day volume weighted average price of Common Stock over a five trading day period ending shortly before the closing of the transaction (“the five day VWAP”); or (3) all-cash consideration, consisting of (i) $32.00 plus (ii) the product of 0.5 times the five day VWAP. KLA-Tencor stockholders who do not make an election will be deemed to have elected the mixed consideration. All-cash and all-stock elections will be subject to proration in accordance with the terms of the merger agreement. The stock component of the consideration is expected to represent a tax-free exchange. Completion of the transaction is subject to certain closing conditions, including but not limited to receipt of all required regulatory approvals, and other customary conditions. On February 19, 2016, at special meetings of the stockholders of the Company and KLA-Tencor, respectively, the Company's stockholders approved the issuance of Common Stock to KLA-Tencor stockholders in connection with the merger and KLA-Tencor's stockholders adopted the merger agreement, satisfying two of the conditions to closing. If the merger agreement is terminated, under specific circumstances specified in the terms of the merger agreement, the Company would be required to pay KLA-Tencor a termination fee of up to $290.0 million. The merger agreement is terminable by either party on or after October 20, 2016; unless the parties mutually agree to extend the outside date.On May 13, 2016, Lam Research and KLA-Tencor each received a request for additional information and documentary material (commonly referred to as a "Second Request") from the United States Department of Justice ("DOJ") in connection with the proposed transaction between the companies. The companies are working with the staff of the DOJ on the terms of a consent decree. The Company and KLA-Tencor are continuing to work diligently to secure the necessary regulatory approvals. The companies have received clearance from competition authorities in Germany, Ireland, Israel and Taiwan and are in discussions with competition regulators in other jurisdictions.The Company has entered into (1) a senior unsecured term loan agreement which provides up to $1.53 billion in term loans, subject to certain conditions; and (2) senior notes providing approximately $2.4 billion. The Company has also entered into an amendment and restatement of its existing revolving credit agreement pursuant toContinues on next pageLam Research Corporation 2016 10-K 96which, among other things, the revolving lenders agreed to increase their aggregate commitments under the revolving credit agreement from $300.0 million to $750.0 million.The Company intends to fund the cash component of the merger consideration and related fees and expenses and to prepay KLA-Tencor’s term loan with a combination of the combined companies’ balance sheet cash and proceeds of approximately $4.0 billion under various financing arrangements (see Note 13). In connection with the close of the anticipated merger, the Company expects to offer to holders of KLA-Tencor’s outstanding $2.5 billion aggregate principal amount of senior unsecured notes (the “KLA-Tencor Senior Notes”) new series of Lam Research senior unsecured notes in exchange for the KLA-Tencor Senior Notes.During the 12 months ended June 26, 2016, the Company expensed as incurred acquisition-related costs of $51.0 million, respectively, within selling, general, and administrative expense in the Consolidated Statement of Operations.Continues on next pageLam Research Corporation 2016 10-K 97Report of Independent Registered Public Accounting FirmThe Board of Directors and Stockholders of Lam Research CorporationWe have audited the accompanying consolidated balance sheets of Lam Research Corporation as of June 28, 201526, 2016 and June 29, 2014,28, 2015, and the related consolidated statements of operations, comprehensive income, stockholders’stockholders' equity and cash flows for each of the three years in the period ended June 28, 2015.26, 2016. Our audits also included the financial statement schedule listed in the Index at Item 15(a)(2). These financial statements and schedule are the responsibility of the Company’s management. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements and schedule based on our audits.We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of Lam Research Corporation at June 28, 201526, 2016 and June 29, 2014,28, 2015, and the consolidated results of its operations and its cash flows for each of the three years in the period ended June 28, 2015,26, 2016, in conformity with U.S. generally accepted accounting principles. Also, in our opinion, the related financial statement schedule, when considered in relation to the basic financial statements taken as a whole, presents fairly in all material respects the information set forth therein.We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), Lam Research Corporation’s internal control over financial reporting as of June 28, 2015,26, 2016, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated August 13, 201516, 2016 expressed an unqualified opinion thereon./s/ ERNST & YOUNG LLPSan Jose, CaliforniaAugust 13, 2015Continues on next pageLam Research Corporation 2016 10-K 98Report of Independent Registered Public Accounting FirmThe Board of Directors and Stockholders of Lam Research CorporationWe have audited Lam Research Corporation’s internal control over financial reporting as of June 28, 2015,26, 2016, based on criteria established in Internal Control — IntegratedControl-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). Lam Research Corporation’s management is responsible for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management’s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the company’s internal control over financial reporting based on our audit.We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.In our opinion, Lam Research Corporation maintained, in all material respects, effective internal control over financial reporting as of June 28, 2015,26, 2016, based on the COSO criteria.We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the 20152016 Consolidated Financial Statements of Lam Research Corporation and our report dated August 13, 201516, 2016 expressed an unqualified opinion thereon./s/ ERNST & YOUNG LLPSan Jose, CaliforniaAugust 13, 2015Continues on next pageLam Research Corporation 2016 10-K 99Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure Item 9A. Controls and ProceduresDesign of Disclosure Controls and Procedures and Internal Control over Financial ReportingWe maintain disclosure controls and procedures and internal control over final reporting that are designed to comply with Rule 13a-15 of the Exchange Act. In designing and evaluating the controls and procedures associated with each, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and that the effectiveness of controls cannot be absolute because the cost to design and implement a control to identify errors or mitigate the risk of errors occurring should not outweigh the potential loss caused by the errors that would likely be detected by the control. Moreover, we believe that a control system cannot be guaranteed to be 100% effective all of the time. Accordingly, a control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met.Disclosure Controls and ProceduresAs required by Rule 13a-15(b) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of June 28, 2015,26, 2016, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rule 13a-15(e). Based upon that evaluation, our Chief Executive Officer and our Chief Financial Officer each concluded that our disclosure controls and procedures are effective, as of June 26, 2016, at the reasonable assurance level.We intend to review and evaluate the design and effectiveness of our disclosure controls and procedures on an ongoing basis and to correct any material deficiencies that we may discover. Our goal is to ensure that our senior management has timely access to material information that could affect our business.Changes in Internal Control Over Financial ReportingThere has been no change in our internal control over financial reporting during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.Management’s Report on Internal Control Over Financial ReportingManagement is responsible for establishing and maintaining adequate “internal control over financial reporting”, as that term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). Management conducted an evaluation of the effectiveness of internal control over financial reporting based on the framework in Internal Controls — Integrated Framework used by the Committee of Sponsoring Organizations of the Treadway Commission (2013 Framework). Based on that evaluation, management has concluded that the Company’s internal control over financial reporting was effective as of June 28, 201526, 2016 at providing reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP.Ernst & Young LLP, an independent registered public accounting firm, has audited the Company’s internal control over financial reporting, as stated in their report, which is included in Part II, Item 8 of this 20152016 Form 10-K.Effectiveness of ControlsWhile we believe the present design of our disclosure controls and procedures and internal control over financial reporting is effective at the reasonable assurance level, future events affecting our business may cause us to modify our disclosure controls and procedures or internal controls over financial reporting.Item 9B. Other Information None.Continues on next pageLam Research Corporation 2016 10-K 100PART IIIWe have omitted from this 20152016 Form 10-K certain information required by Part III because we, as the Registrant, will file a definitive proxy statement with the SEC within 120 days after the end of our fiscal year, pursuant to Regulation 14A, as promulgated by the SEC, for our Annual Meeting of Stockholders expected to be held on or about November 4, 20159, 2016 (the “Proxy Statement”), and certain information included in the Proxy Statement is incorporated into this report by reference. (However, the Reports of the Audit Committee and Compensation Committee in the Proxy Statement are expressly not incorporated by reference into this report.)Item 10.Directors, Executive Officers, and Corporate GovernanceItem 10. Directors, Executive Officers and Corporate GovernanceFor information regarding our executive officers, see Part I, Item 1 of this 20152016 Form 10-K under the caption “Executive Officers of the Company,” which information is incorporated into Part III by reference.The information concerning our directors required by this Item is incorporated by reference to our Proxy Statement under the heading “Voting Proposals — Proposal No. 1: Election of Directors — 2016 Nominees for Directors.”The information concerning our audit committee and audit committee financial experts required by this Item is incorporated by reference to our Proxy Statement under the heading “Governance Matters — Corporate Governance — Board Committees" and "Governance Matters — Corporate Governance — Board Committees — Audit Committee.”The information concerning compliance by our officers, directors and 10% shareholders with Section 16 of the Exchange Act required by this Item is incorporated by reference to our Proxy Statement under the heading “Share“Stock Ownership – Section 16(a) Beneficial Ownership Reporting Compliance.”The Company has adopted a Corporate Code of Ethics that applies to all employees, officers, and directors of the Company. Our Code of Ethics is publicly available on the investor relations page of our website at http://investor.lamresearch.com. To the extent required by law, any amendments to, or waivers from, any provision of the Code of Ethics will promptly be disclosed to the public. To the extent permitted by applicable legal requirements, we intend to make any required public disclosure by posting the relevant material on our website in accordance with SEC rules.Item 11.Executive CompensationItem 11. Executive CompensationThe information required by this Item is incorporated by reference to our Proxy Statement under the heading “Compensation Matters — Executive Compensation and Other Information.”Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters The information required by this Item is incorporated by reference to our Proxy Statement under the headings “Voting Proposals — Proposal No. 1: Election of Directors,” “Compensation Matters — Executive Compensation and Other Information Compensation Committee Interlocks and Insider Participation,” “Compensation Matters — Executive Compensation and Other Information — Compensation Committee Report,” “Share“Stock Ownership — Security Ownership of Certain Beneficial Owners and Management” and “Compensation Matters — Securities Authorized for Issuance Under Equity Compensation Plans.”Item 13. Certain Relationships and Related Transactions, and Director Independence The information required by this Item is incorporated by reference to our Proxy Statement under the headings “Audit Matters — Certain Relationships and Related Transactions” and “Governance Matters — Corporate Governance”.Governance — Director Independence Policies."Item 14. Principal Accounting Fees and Services The information required by this Item is incorporated by reference to our Proxy Statement under the heading “Audit Matters — Relationship with Independent Registered Public Accounting Firm.”Continues on next pageLam Research Corporation 2016 10-K 101PART IVItem 15. Exhibits, Financial Statement SchedulesItem 15.Exhibits, Financial Statement Schedules(a) The following documents are filed as part of this Annual Report on Form 10-K 1. Index to Financial Statements Page and June 30, 20134928, 2015, June 29, 2014, and June 30, 201350Consolidated Balance Sheets —26, 2016, June 28, 2015, and June 29, 201451Consolidated Statements of Cash Flows — Years Ended June 26, 2016, June 28, 2015, and June 29, 2014 and June 30, 201352 and June 30, 20135455 89 96 (b) The list of Exhibits follows page 96105 of this 20152016 Annual Report on Form 10-K and is incorporated herein by this reference.Continues on next pageLam Research Corporation 2016 10-K 102SIGNATURESPursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.August 16, 2016 LAM RESEARCH CORPORATION(Registrant)ByBy: Martin B. Anstice Martin B. Anstice Martin B. Anstice President and Chief Executive Officer Dated: August 13, 2015Continues on next pageLam Research Corporation 2016 10-K 103POWER OF ATTORNEY AND SIGNATURESBy signing this Annual Report on Form 10-K below, I hereby appoint each of Martin B. Anstice and Douglas R. Bettinger, jointly and severally, as my attorney-in-fact to sign all amendments to this Form 10-K on my behalf, and to file this Form 10-K (including all exhibits and other related documents) with the Securities and Exchange Commission. I authorize each of my attorneys-in-fact to (1) appoint a substitute attorney-in-fact for himself and (2) perform any actions that he believes are necessary or appropriate to carry out the intention and purpose of this Power of Attorney. I ratify and confirm all lawful actions taken directly or indirectly by my attorneys-in-fact and by any properly appointed substitute attorneys-in-fact.Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.Signatures Title Date Principal Executive Officer /s/ Martin B. Anstice Martin B. Anstice President, Chief Executive Officer and Director August 13, 201516, 2016 Martin B. Anstice Principal Financial Officer and PrincipalAccounting Officer /s/ Douglas R. Bettinger Douglas R. Bettinger Executive Vice President, Chief Financial Officer, and Chief Accounting Officer August 13, 201516, 2016 Douglas R. Bettinger Other Directors /s/ Stephen G. Newberry Stephen G. Newberry Chairman August 13, 2015 Stephen G. Newberry /s/ Eric K. Brandt Eric K. Brandt Director August 13, 201516, 2016 Eric K. Brandt /s/Director Michael R. Cannon Michael R. Cannon/s/ Youssef A. El-Mansy Director August 13, 201516, 2016/s/ Youssef A. El-Mansy Youssef A. El-Mansy/s/ Christine Heckart Director August 13, 201516, 2016 Christine Heckart /s/ Christine Heckart Christine Heckart Director August 13, 201516, 2016 Catherine P. Lego /s/ Grant M. Inman Grant M. Inman Director August 13, 201516, 2016 Krishna Saraswat/s/ Catherine P. Lego Catherine P. Lego Director August 13, 201516, 2016/s/ Krishna Saraswat Krishna Saraswat Director August 13, 2015/s/ William R. Spivey William R. SpiveyDirectorAugust 13, 2015/s/ Abhi Talwalkar Abhi TalwalkarDirectorAugust 13, 2015Continues on next pageLam Research Corporation 2016 10-K 104LAM RESEARCH CORPORATIONSCHEDULE II — VALUATION AND QUALIFYING ACCOUNTS(in thousands) Additions Description Balance atBeginning of Period Charged to Costsand Expenses Write-offs, Net ofRecoveries Balance at End ofPeriodYEAR ENDED JUNE 26, 2016 Deducted from asset accounts: Allowance for doubtful accounts $ 4,890 $ — $ 265 $ 5,155 YEAR ENDED JUNE 28, 2015 Deducted from asset accounts: Allowance for doubtful accounts $ 4,962 $ 8 $ (80 ) $ 4,890 YEAR ENDED JUNE 29, 2014 Deducted from asset accounts: Allowance for doubtful accounts $ 5,448 $ 14 $ (500 ) $ 4,962 Continues on next page Additions Description Balance at
Beginning of Period Charged to Costs
and Expenses Write-offs, Net of
Recoveries (1) Balance at End of
Period $ 4,962 $ 8 $ (80 ) $ 4,890 $ 5,448 $ 14 $ (500 ) $ 4,962 $ 5,248 $ 200 $ — $ 5,448 Lam Research Corporation 2016 10-K 105LAM RESEARCH CORPORATIONANNUAL REPORT ON FORM 10-KEXHIBIT INDEX Agreement and Plan of Merger and Reorganization, dated as of October 20, 2015, by and among Lam Research Corporation, Topeka Merger Sub 1, Inc., Topeka Merger Sub 2, Inc., and KLA-Tencor Corporation.3.1(2) Certificate of Incorporation of the Registrant, dated September 7, 1989; as amended by the Agreement and Plan of Merger, Dated February 28, 1990; the Certificate of Amendment dated October 28, 1993; the Certificate of Ownership and Merger dated December 15, 1994; the Certificate of Ownership and Merger dated June 25, 1999 and the Certificate of Amendment effective as of March 7, 2000; and the Certificate of Amendment effective as of November 5, 2009. 3.2(15) Bylaws of the Registrant, as amended and restated, dated November 7, 2014. Certificate of Designation, Preferences and Rights of Series A Junior Participating Preferred Stock dated January 30, 1997. 4.1(7) Indenture (including Form of Notes), dated as of May 11, 2011, by and between Lam Research Corporation, and The Bank of New York Mellon Trust Company, N.A, as trustee, with respect to the 2016 NotesNotes. 4.2(7) Indenture (including Form of Notes), dated as of May 11, 2011, by and between Lam Research Corporation, and The Bank of New York Mellon Trust Company, N.A, as trustee, with respect to the 2018 NotesNotes. 4.14(4)4.15(24)*Lam Research Corporation 2004 Executive Incentive Plan, as amended. 4.15(27)* Lam Research Corporation 2007 Stock Incentive Plan, as amended. 4.16(8)4.16(7)* Lam Research Corporation Elective Deferred Compensation Plan. 4.17(8)4.17(7)* Lam Research Corporation Elective Deferred Compensation Plan II. 4.18(9) Indenture between Novellus Systems, Inc. as Issuer and The Bank of New York Mellon Trust Company, N.A. as Trustee, dated as of May 10, 2011, including the form of 2.625% Senior Convertible Notes due 2041. 4.19(6) Supplemental Indenture among the Registrant, as Guarantor, Novellus Systems, Inc. as Issuer and The Bank of New York Mellon Trust Company, N.A. as Trustee, dated as of June 4, 2012. 4.20(16)* Lam Research Corporation 1999 Employee Stock Purchase Plan, as amended. 4.21(23) Indenture (including Form of Notes), dated as of February 13, 2015, between Registrant and The Bank of New York Mellon Trust Company, N.A. 4.22(25) First Supplemental Indenture, dated as of March 12, 2015, by and between Lam Research Corporation and The Bank of New York Mellon Trust Company, N.A., as trustee Second Supplemental Indenture, dated as of June 7, 2016, by and between Lam Research Corporation and The Bank of New York Mellon Trust Company, N.A., as trustee. 4.24(26)* 2004 Executive Incentive Plan, as Amended and Restated. 4.25(26)* 2015 Stock Incentive Plan. 10.3(1)* Form of Indemnification Agreement. Form of Restricted Stock Unit Award Agreement—Outside Directors (U.S. Agreement) — Lam Research Corporation 2007 Stock Incentive Plan. Form of Restricted Stock Unit Award Agreement—Outside Directors (non-U.S. Agreement) — Lam Research Corporation 2007 Stock Incentive Plan. 10.148(5)10.148(4)*Form of Indemnification Agreement.ExhibitDescription10.151(6)* Form of Indemnification Agreement. 10.162(10)10.151(5)*Form of Indemnification Agreement. 10.162(9)* Form of Novellus Directors and Officers Indemnification Agreement. 10.168(11) Lease Guaranty between Novellus and Phoenix Industrial Investment Partners, L.P. dated January 21, 2003. Continues on next pageLam Research Corporation 2016 10-K 10610.169(12)Exhibit Description 10.169(11) Binding Memorandum of Understanding between Novellus, and Applied Materials, Inc., effective as of September 3, 2004. Portions of this exhibit have been omitted pursuant to a request for confidential treatment. 10.170(13)10.170(12)* Novellus Amended Executive Voluntary Deferred Compensation Plan, as amended. 10.171(14)10.171(13)* Novellus Accelerated Stock Vesting Retirement Plan Summary. 10.172(17)10.172(16)* Novellus Systems, Inc. 2011 Stock Incentive Plan, as amended July 18, 2012. 10.181(18)10.181(17)* Form of Restricted Stock Unit Award Agreement (U.S. Participants) — Lam Research Corporation 2007 Stock Incentive Plan 10.182(18)10.182(17)* Form of Restricted Stock Unit Award Agreement (International Participants) — Lam Research Corporation 2007 Stock Incentive Plan 10.183(18)10.183(17)* Form of Nonstatutory Stock Option Award Agreement (U.S. Participants) — Lam Research Corporation 2007 Stock Incentive Plan 10.184(18)10.184(17)* Form of Nonstatutory Stock Option Award Agreement (International Participants) — Lam Research Corporation 2007 Stock Incentive Plan 10.187(18)10.187(17)* Form of Restricted Stock Unit Award Agreement (U.S. Participants) — Lam Research Corporation (Novellus Systems, Inc.) 2011 Stock Incentive Plan (As Amended) 10.188(18)10.188(17)* Form of Restricted Stock Unit Award Agreement (International Participants) — Lam Research Corporation (Novellus Systems, Inc.) 2011 Stock Incentive Plan (As Amended) 10.189(18)10.189(17)* Form of Nonstatutory Stock Option Award Agreement (U.S. Participants) — Lam Research Corporation (Novellus Systems, Inc.) 2011 Stock Incentive Plan (As Amended) 10.191(18)10.191(17)* Form of Nonstatutory Stock Option Award Agreement (International Participants) — Lam Research Corporation (Novellus Systems, Inc.) 2011 Stock Incentive Plan (As Amended) 10.194(18)Participation Agreement between Lam Research Corporation and BTMU Capital Leasing & Finance, Inc., dated December 31, 201310.195(18)Amended and Restated Lease Agreement (1 Portola Avenue Building) between Lam Research Corporation and BTMU Capital Leasing & Finance, Inc., dated December 31, 201310.196(18)Pledge Agreement (1 Portola Avenue Building) between Lam Research Corporation and BTMU Capital Leasing & Finance, Inc., dated December 31, 201310.197(18)Amended and Restated Lease Agreement (101 Portola Avenue Building) between Lam Research Corporation and BTMU Capital Leasing & Finance, Inc., dated December 31, 201310.198(18)Pledge Agreement (101 Portola Avenue Building) between Lam Research Corporation and BTMU Capital Leasing & Finance, Inc., dated December 31, 201310.199(18)Amended and Restated Lease Agreement (Fremont Building #1) between Lam Research Corporation and BTMU Capital Leasing & Finance, Inc., dated December 31, 201310.200(18)Pledge Agreement (Fremont Building #1) between Lam Research Corporation and BTMU Capital Leasing & Finance, Inc., dated December 31, 2013ExhibitDescription10.201(18)Amended and Restated Lease Agreement (Fremont Building #3) between Lam Research Corporation and BTMU Capital Leasing & Finance, Inc., dated December 31, 201310.202(18)Pledge Agreement (Fremont Building #3) between Lam Research Corporation and BTMU Capital Leasing & Finance, Inc., dated December 31, 201310.203(18)Amended and Restated Lease Agreement (Fremont Building #3E) between Lam Research Corporation and BTMU Capital Leasing & Finance, Inc., dated December 31, 201310.204(18)Pledge Agreement (Fremont Building #3E) between Lam Research Corporation and BTMU Capital Leasing & Finance, Inc., dated December 31, 201310.205(18)Amended and Restated Lease Agreement (Fremont Building #4) between Lam Research Corporation and BTMU Capital Leasing & Finance, Inc., dated December 31, 201310.206(18)Pledge Agreement (Fremont Building #4) between Lam Research Corporation and BTMU Capital Leasing & Finance, Inc., dated December 31, 201310.207(18)Construction Agency Agreement (Fremont Building #3E) between Lam Research Corporation and BTMU Capital Leasing & Finance, Inc., dated December 31, 201310.211(19)10.211(18)* Form of Market-Based Performance Restricted Stock Unit Award Agreement (U.S. Participants) — Lam Research Corporation 2007 Stock Incentive Plan 10.212(19)10.212(18)* Form of Market-Based Performance Restricted Stock Unit Award Agreement (International Participants)—Lam Research Corporation 2007 Stock Incentive Plan 10.213(19)10.213(18)* Form of Market-Based Performance Restricted Stock Unit Award Agreement (U.S. Participants) — Lam Research Corporation (Novellus Systems, Inc.) 2011 Stock Incentive Plan (As Amended) 10.214(19)10.214(18)* Form of Market-Based Performance Restricted Stock Unit Award Agreement (International Participants) — Lam Research Corporation (Novellus Systems, Inc.) 2011 Stock Incentive Plan (As Amended) 10.221(20)Credit Agreement dated March 12, 2014 among Lam Research Corporation and the lenders party thereto, JPMorgan Chase Bank, N.A., as administrative agent, Bank of America, N.A., as syndication agent, BNP Paribas, Barclays Bank PLC, Citibank, N.A. and Deutsche Bank Securities Inc., as co-documentation agents, and J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated, as joint bookrunners and joint lead arrangers10.231(21)10.231(19)* Employment Agreement with Martin B. Anstice, dated January 13, 2015 10.232(21)10.232(19)* Employment Agreement with Timothy M. Archer, dated January 13, 2015 10.233(21)10.233(19)* Employment Agreement with Douglas R. Bettinger, dated January 13, 2015 10.234(21)10.234(19)* Employment Agreement with Richard A. Gottscho, dated January 13, 2015 10.235(21)10.235(19)* Form of Change in Control Agreement. 10.236(22) Chairman’s Agreement with Stephen G. Newberry, dated January 13,December 14, 201510.237(22) Form of Confidentiality Agreement 10.242(24) First Commitment Letter, dated October 20, 2015, by and among Lam Research
Corporation, Goldman Sachs Bank USA and Goldman Sachs Lending Partners LLC.10.244(26)* Form of Restricted Stock Unit Award Agreement (U.S. Participants) - 2015 Stock Incentive Plan. 10.245(26)* Form of Restricted Stock Unit Award Agreement (International Participants) - 2015 Stock Incentive Plan. 10.246(26)* Form of Restricted Stock Unit Award Agreement (Outside Directors) - 2015 Stock Incentive Plan. 10.247(26)* Form of Option Award Agreement (U.S. Participants) - 2015 Stock Incentive Plan. 10.248(26)* Form of Option Award Agreement (International Participants) - 2015 Stock Incentive Plan. 10.249(26)* Form of Market-Based Performance Restricted Stock Unit Award Agreement (U.S. Participants) - 2015 Stock Incentive Plan. Continues on next pageLam Research Corporation 2016 10-K 107Exhibit Description 10.250(26)* Form of Market-Based Performance Restricted Stock Unit Award Agreement (International Participants) - 2015 Stock Incentive Plan. 10.251(27) Amendment to Creditand Restatement Agreement, dated March 5,November 10, 2015 among Lam Research Corporation, JPMorgan Chase Bank, N.A., as administrative agent, and the other agents and lenders listed therein, and all exhibits and schedules attached thereto.10.252(27) Joinder Agreement, dated as of November 10, 2015, among Lam Research Corporation and the other agents and lenders listed therein, and the schedules attached thereto. 10.253(29) Amended and Restated Term Loan Agreement, dated May 13, 2016, among Lam Research Corporation, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agentagent.20.1(26)Amendment No. 1 to the Amended and Restated Credit Agreement, dated April 26, 2016 among Lam Research Corporation, JPMorgan Chase Bank, N.A., as administrative agent, and the other agents and lenders listed therein, and all exhibits and schedules attached thereto. 20.1(23) Notices of Adjustment of Conversion Rate pursuant to the Indentures dated May 11, 2011, by and between Lam Research Corporation and The Bank of New York Mellon Trust Company, N.A. as Trustee with respect to the 0.500% Senior Convertible Notes Due 2016 and the 1.250% Senior ExhibitDescription Convertible Notes Due 2018, and Notice of Adjustment of Conversion Rate pursuant to the indenture dated May 10, 2011, by and between Novellus Systems Incorporated and The Bank of New York Mellon Trust company, N.A. as Trustee with respect to the 2.625% Senior Convertible Notes Due 2041. Subsidiaries of the Registrant. Consent of Independent Registered Public Accounting Firm. Power of Attorney (See Signature page) Rule 13a — 14(a) / 15d — 14(a) Certification (Principal Executive Officer) Rule 13a — 14(a) / 15d — 14(a) Certification (Principal Financial Officer) Section 1350 Certification — (Principal Executive Officer) Section 1350 Certification — (Principal Financial Officer) XBRL Instance Document XBRL Taxonomy Extension Schema Document XBRL Taxonomy Extension Calculation Linkbase Document XBRL Taxonomy Extension Definition Linkbase Document XBRL Taxonomy Extension Label Linkbase Document XBRL Taxonomy Extension Presentation Linkbase Document __________________________________(1) Incorporated by reference to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended April 3, 1988 (SEC File No. 000-12933). (2) Incorporated by reference to Registrant’s Amendment No. 2 to its Annual Report on Form 10K/A filed on May 2, 2001, and Registrant’s Current Report on Form 8-K filed on November 10, 2009 (SEC File No. 000-12933). (3) Incorporated by reference to Registrant’s Quarterly Report on Form 10-Q filed on April 30, 2007 (SEC File No. 000-12933). (4)Incorporated by reference to Registrant’s Annual Report on Form 10-K filed on August 23, 2010 (SEC File No. 000-12933).(5)(4)Incorporated by reference to Registrant’s Current Report on Form 8-K filed on November 13, 2008 (SEC File No. 000-12933). (6)(5) Incorporated by reference to Registrant’s Current Report on Form 8-K filed on June 4, 2012 (SEC File No. 000-12933). (7)(6) Incorporated by reference to Registrant’s Current Report on Form 8-K filed on May 11, 2011 (SEC File No. 000-12933). (8)(7) Incorporated by reference to Registrant’s Annual Report on Form 10-K filed on August 19, 2011 (SEC File No. 000-12933) (9)(8) Incorporated by reference to Novellus’ Current Report on Form 8-K filed on May 10, 2011 (SECFile No. 000-17157). Continues on next pageLam Research Corporation 2016 10-K 108(10)(9) Incorporated by reference to Novellus’ Current Report on Form 10-Q filed on August 13, 2002 (SEC File No. 000-17157). (11)(10) Incorporated by reference to Novellus’ Annual Report on Form 10-K filed on March 5, 2003 (SEC File No. 000-17157). (12)(11) Incorporated by reference to Novellus’ Current Report on Form 8-K filed on September 24, 2004 (SEC File No. 000-17157). (13)(12) Incorporated by reference to Novellus’ Quarterly Report on Form 10-Q filed on November 5, 2008 (SECFile No. 000-17157). (14)(13) Incorporated by reference to Novellus’ Quarterly Report on Form 10-Q filed on November 2, 2010 (SEC File No. 000-17157). (15)(14) Incorporated by reference to Registrant’s Current Report on Form 8-K filed on November 12, 2014 (SEC File No. 000-12933). (16)(15) Incorporated by reference to Registrant’s Quarterly Report on Form 10-Q filed on January 31, 2013 (SEC File No. 000-12933). (17)(16) Incorporated by reference to Registrant’s Annual Report on Form 10-K filed on August 22, 2012 (SEC File No. 000-12933). (18)(17) Incorporated by reference to Registrant’s Quarterly Report on Form 10-Q filed on February 6, 2014 (SEC File No. 000-12933). (19)(18) Incorporated by reference to the Registrant’s Current Report on Form 8-K filed on February 18, 2014 (SEC File No. 000-12933). (20)Incorporated by reference to the Registrant’s Current Report on Form 8-K filed on March 13, 2014 (SEC File No. 000-12933).(21)(19)Incorporated by reference to the Registrant’s Current Report on Form 8-K filed on January 16, 2015 (SEC File No. 000-12933). (22)(20) Incorporated by reference to the Registrant’s Quarterly Report on Form 10-Q filed on February 3, 2015 (SEC File No. 000-12933). (23)(21) Incorporated by reference to the Registrant’s Registration Statement on Form S-3 filed on February 13, 2015 (SEC File No. 333-202110). (24)Incorporated by reference to the Registrant’s Current Report on Form 8-K filed on March 11, 2015 (SEC File No. 000-12933).(25)(22)Incorporated by reference to the Registrant’s Current Report on Form 8-K filed on March 12, 2015 (SEC File No. 000-12933). (26)(23) Incorporated by reference to the Registrant’s Current Report on Form 8-K filed on June 16, 2015 (SEC File No. 000-12933). (27)(24) Incorporated by reference to Registrant’s Annual Report on Form 10-K filed on August 27, 2013 (SEC File No. 000-12933) (25) Incorporated by reference to the Registrant’s Current Report on Form 8-K filed on October 21, 2015 (SEC File No. 000-12933). (26) Incorporated by reference to the Registrant’s Current Report on Form 8-K filed on November 5, 2015 (SEC File No. 000-12933). (27) Incorporated by reference to the Registrant’s Current Report on Form 8-K filed on November 12, 2015 (SEC File No. 000-12933). (28) Incorporated by reference to the Registrant’s Quarterly Report on Form 10-Q filed on February 3, 2016 (SEC File No. 000-12933). (29) Incorporated by reference to the Registrant’s Current Report on Form 8-K filed on May 13, 2016 (SEC File No. 000-12933). (30) Incorporated by reference to the Registrant’s Current Report on Form 8-K filed on June 7, 2016 (SEC File No. 000-12933). * Indicates management contract or compensatory plan or arrangement in which executive officers of the Company are eligible to participate. 101Continues on next pageLam Research Corporation 2016 10-K 109